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Abstract 
The study of cell signalling in schistosomes is crucial in deepening our knowledge of the 
biology of these blood flukes, which affect hundreds of millions of people worldwide. 
Here, Akt/protein kinase B (PKB) signalling has been functionally characterised and 
mapped in Schistosoma mansoni; an Akt variant of approximately 52 kDa has been 
characterised and RNA interference of the S. mansoni Akt gene, resulted in an 84% 
reduction in Akt expression. The phosphorylation (activation) status of the characterised 
Akt protein was increased by host molecules, including insulin and L-arginine in somules 
and adult worms, and L-arginine and linoleic acid in cercariae. Akt phosphorylation 
(activation) was also attenuated by Akt Inhibitor X and herbimycin A treatment. 
Immunohistochemistry/confocal laser scanning microscopy revealed phosphorylated Akt 
in all S. mansoni human infective/resident life stages. Somules and adult worms 
displayed activated Akt primarily in the tegument, particularly the tubercles and 
gynaecophoric canal of adult males. Cercariae exhibited activated Akt in the nervous 
system and punctate regions along the length of the tail prompting investigation into the 
role of Akt in cercarial motility. Behavioural studies demonstrated a significant increase 
in cercarial swimming in response to host factors, which was attenuated following 
exposure to Akt inhibitor X. The striking activation of Akt observed in the tegument of 
adult worms stimulated research into its possible role in glucose uptake in this host-
interactive layer. RNAi of Akt resulted in a 59% and 47% reduction in SGTP4 glucose 
transporter expression in male and female adult worms respectively with a concomitant 
reduction in glucose uptake by the parasite. In somules, the expression of SGTP4 and 
its evolution at the apical tegument membrane during transformation were significantly 
attenuated by Akt Inhibitor X; a 74% reduction in glucose uptake was also demonstrated 
following Akt inhibition. Bioinformatic analysis of S. mansoni Akt interacting proteins 
uncovered a putative connection between Akt and Rab vesicle trafficking proteins and a 
mechanistic model illuminating the possible role of Akt in the translocation of SGTP4 to 
the parasite surface was proposed. Collectively, this research highlights the significance 
of Akt in schistosome homeostasis and host-parasite interactions and thus demonstrates 
that Akt may be a suitable target for anti-schistosome drug development strategies.  
  
         v 
 
Table of Contents 
CHAPTER 1 – INTRODUCTION ........................................................................ 1 
    1.1 SCHISTOSOMIASIS – A NEGLECTED TROPICAL DISEASE ................................... 2 
 1.1.1 Epidemiology ............................................................................................................ 2 
 1.1.2 Disease pathology .................................................................................................... 2 
 1.1.3 Schistosomiasis control strategies ............................................................................ 5 
 1.1.4 The future of schistosomiasis ................................................................................... 5 
1.2 SCHISTOSOMES AND THEIR LIFE CYCLE .......................................................... 6 
1.2.1 Biology of Cercariae ................................................................................................. 9 
1.2.2 Biology of Somules ................................................................................................. 11 
1.2.3 Biology of Adult Worms .......................................................................................... 13 
 1.2.3.1 Sexual maturation and reproduction ....................................................... 13 
 1.2.3.2 The adult worm tegument ....................................................................... 15 
   1.3 CELL SIGNALLING IN S. MANSONI .................................................................. 16 
 1.3.1 Protein kinases ....................................................................................................... 16 
 1.3.2 Protein kinases in S. mansoni ................................................................................ 17 
 1.3.2 Protein kinase B/Akt ............................................................................................... 19 
  1.3.2.1 Discovering Akt ....................................................................................... 19 
  1.3.2.2 Structure and activation mechanism of the Akt protein ........................... 19 
  1.3.2.3 Akt in other organisms ............................................................................ 21 
  1.3.2.4 Akt in S. mansoni .................................................................................... 22 
    1.4 INSULIN SIGNALLING ................................................................................... 22 
   1.5 GLUCOSE UPTAKE IN S. MANSONI ................................................................ 23 
    1.6 STUDY CONTEXT, CONTRIBUTION TO KNOWLEDGE AND RESEARCH AIMS ........ 24 
 
CHAPTER 2 – MATERIALS AND METHODS ................................................. 26 
   2.1 MATERIALS ................................................................................................ 27 
 2.1.1 Antibodies ............................................................................................................... 27 
     2.1.2 KITS ......................................................................................................................... 27 
     2.1.3 STIMULANTS AND INHIBITORS ..................................................................................... 27 
     2.1.4 OTHER REAGENTS .................................................................................................... 28 
    2.2 ETHICS STATEMENT .................................................................................... 28 
    2.3 SNAIL HUSBANDRY ..................................................................................... 28 
   2.4 ADULT SCHISTOSOMES ............................................................................... 29 
    2.5 ISOLATION OF CERCARIAE AND MECHANICAL TRANSFORMATION INTO SOMULES
 .......................................................................................................................... 29 
    2.6 EXPOSURE OF PARASITES TO HOST MOLECULES OR KINASE INHIBITORS ........ 30 
     2.6.1 Sample preparation for western blotting ................................................................. 31 
     2.6.2 Sample preparation for immunohistochemistry ....................................................... 32 
     2.6.3 Sample preparation for immunoprecipitation with kinase assay ............................. 32 
     2.6.4 Sample preparation for crosslink immunoprecipitation ........................................... 32 
         vi 
 
    2.7 TEGUMENT STRIPPING ................................................................................ 33 
    2.8 PROTEOME PROFILER ASSAY ...................................................................... 33 
    2.9 WESTERN BLOTTING .................................................................................. 34 
    2.10 LAMBDA PHOSPHATASE TREATMENT .......................................................... 35 
    2.11 IMMUNOPRECIPITATION (IP) – KINASE ASSAY ............................................. 36 
    2.12 CROSSLINK IMMUNOPRECIPITATION ........................................................... 37 
    2.13 FRACTIONING SAMPLES ............................................................................ 38 
    2.14 RNAI ...................................................................................................... 38 
 2.14.1 Designing small interfering RNA........................................................................... 38 
 2.14.2 Performing RNAi .................................................................................................. 38 
    2.15 IMMUNOHISTOCHEMISTRY ......................................................................... 39 
    2.16 BIOINFORMATICS ...................................................................................... 40 
 2.16.1 Gene Alignment ................................................................................................... 40 
    2.16.2 STRINGdb ............................................................................................................ 40 
 2.16.3 Blast2GO .............................................................................................................. 40 
 2.16.4 Kinasephos phosphorylation site prediction ......................................................... 41 
    2.17 HISTOLOGY .............................................................................................. 41 
    2.18 MEASUREMENT AND ANALYSIS OF TEGUMENT TUBERCLES .......................... 42 
     2.18.1 Tubercle analysis of Akt Inhibitor X treated worms ............................................... 42 
     2.18.2 Tubercle analysis of histology worms ................................................................... 42 
    2.19 SGTP4 EXPRESSION AT THE SOMULE TEGUMENT DURING TRANSFORMATION
 .......................................................................................................................... 43 
    2.20 GLUCOSE UPTAKE ASSAY – PROMEGA GLUCOSE UPTAKE GLO ASSAY ......... 43 
    2.21 CERCARIAE VIDEO ANALYSIS ..................................................................... 44 
    2.22 STATISTICAL ANALYSIS ............................................................................. 45 
 
CHAPTER 3 – RESULTS 1 – CHARACTERISATION OF FUNCTIONALLY 
ACTIVE AKT IN S. MANSONI ......................................................................... 46 
3.1 PROTEOME PROFILER 96 KIT ...................................................................... 47 
3.2 INITIAL DETECTION OF PHOSPHORYLATED AKT IN S. MANSONI ....................... 49 
3.3 IMMUNOPRECIPITATION OF SMAKT AND ACTIVITY ASSAY ............................... 55 
3.4 RNAI KNOCKDOWN .................................................................................... 57 
3.5 IMMUNOLOCALISATION OF AKT AND ACTIVATED AKT IN S. MANSONI ................ 58 
3.5.1 Immunohistochemistry of Akt in cercariae .............................................................. 59 
3.5.2 Immunohistochemistry of Akt in somules ............................................................... 60 
3.5.3 Immunohistochemistry of Akt in adult worms ......................................................... 60 
3.6 THE EFFECTS OF HUMAN HOST FACTORS AND OTHER AGENTS ON S. MANSONI 
AKT PHOSPHORYLATION .................................................................................. 65 
 3.6.1 Effects of serum on S. mansoni Akt phosphorylation ............................................. 65 
 3.6.2 Effects on insulin on S. mansoni Akt phosphorylation ............................................ 66 
 3.6.3 Effects of L-arginine on S. mansoni Akt phosphorylation ....................................... 67 
 3.6.4 Effect of alternative Akt pathway stimulators on S. mansoni Akt ............................ 68 
         vii 
 
 
3.7 THE EFFECTS OF AKT PATHWAY INHIBITORS ON S. MANSONI AKT      
PHOSPHORYLATION ......................................................................................... 68 
 3.7.1 Effects of LY294002 on S. mansoni Akt phosphorylation ....................................... 68
 3.7.2 Effects of GSK2334470 on S. mansoni Akt phosphorylation  ................................. 69
 3.7.3 Effects of Akt Inhibitor X on S. mansoni Akt phosphorylation  ................................ 70 
 3.7.4 Effects of Herbimycin A on S. mansoni Akt phosphorylation  ................................. 71 
     SUMMARY ....................................................................................................... 73 
 
CHAPTER 4 – RESULTS 2 – DOWNSTREAM AKT SIGNALLING IN S. 
MANSONI ......................................................................................................... 74 
4.1 AKT SUBSTRATE LOCALISATION IN S. MANSONI ............................................. 75 
4.1.1 Akt substrate immunoblotting in three life stages .................................................... 75 
 4.1.2 Immunolocalisation of Akt substrates in cercariae, somules and adult worms ........ 77 
     4.2 AKT IN THE S. MANSONI GENOME ................................................................ 80 
     4.3 PROTEIN INTERACTIONS WITH AKT IN S. MANSONI ........................................ 80 
     4.4 GENE ONTOLOGY WITH HIGH CONFIDENCE AKT-INTERACTING PROTEIN       
SEQUENCES........................................................................................................ 83 
 4.4.1 Blast2GO analysis .................................................................................................. 85 
 4.4.2 Gene ontology with medium confidence Akt protein interactions ............................ 91 
    4.5 ANALYSIS OF DOWNSTREAM SUBSTRATE PROTEINS ..................................... 91 
 4.5.1 Bioinformatic analysis of putative substrates .......................................................... 91 
 4.5.2 S. mansoni homologues of human Akt substrate -GSK-3 ....................................... 94 
      SUMMARY ...................................................................................................... 97 
 
CHAPTER 5 – RESULTS 3 – AKT IN THE TEGUMENT: A ROLE IN 
GLUCOSE UPTAKE FROM THE HOST .......................................................... 98 
    5.1 ACTIVATION OF AKT IN THE TEGUMENT OF S. MANSONI ................................. 99 
     5.2 INHIBITION OF ADULT S. MANSONI AKT BY AKT INHIBITOR X ......................... 100 
 5.2.1 The role of Akt in S. mansoni tegument morphology ............................................ 100 
 5.2.2 The effect of Akt inhibition on worm phenotype by histological analysis ............... 103 
     5.3 A ROLE FOR AKT IN GLUCOSE TRANSPORT IN S. MANSONI .......................... 104 
 5.3.1 SGTP4 in the apical tegument membrane ............................................................ 104 
5.3.2 Akt regulates the surface expression of SGTP4 in somules ................................. 105 
 5.3.3 Inhibition of Akt blunts SGTP4 expression at the somule surface ......................... 106 
 5.3.4 Glucose assay in somules .................................................................................... 110 
     5.4 THE ROLE OF SGTP4 IN ADULT S. MANSONI ............................................. 111 
 5.4.1 RNAi of Akt attenuates SGTP4 expression in adult worms .................................. 111 
 5.4.2 SGTP4 in adult S. mansoni is affected by Akt inhibition ....................................... 111 
         viii 
 
 5.4.3 Glucose assay in adult worms .............................................................................. 113 
      SUMMARY .................................................................................................... 115 
 
CHAPTER 6 – RESULTS 4 – A PUTATIVE ROLE FOR AKT IN S. MANSONI 
CERCARIAE .................................................................................................. 116 
    6.1 CERCARIAE DISPLAY DISTINCT PHOSPHORYLATED AKT LOCALISATION 
PATTERNS ........................................................................................................ 117 
    6.2 EXPOSURE OF CERCARIAE TO HOST FACTORS ............................................ 118 
 6.2.1 The effects of L-arginine on Akt phosphorylation in cercariae .............................. 118 
 6.2.2 The effects of linoleic acid on Akt phosphorylation in cercariae ........................... 119 
    6.3 AKT INHIBITOR X TREATMENT .................................................................... 122 
    6.4 THE EFFECT OF AKT PATHWAY STIMULATION AND INHIBITION ON CERCARIAL              
SWIMMING ........................................................................................................ 123 
Summary ........................................................................................................ 126 
 
CHAPTER 7 - DISCUSSION .......................................................................... 127 
    7.1 DETERMINING THE PRESENCE OF AN AKT IN S. MANSONI ............................. 128 
 7.1.1 Validating the ~52 kDa protein ............................................................................. 128 
 7.1.2 A putative second Akt isoform .............................................................................. 131 
 7.1.3 Akt in S. mansoni cercariae .................................................................................. 132 
    7.2 AKT IN THE BIGGER PICTURE OF S. MANSONI SIGNALLING ............................ 134 
 7.2.1 Glycogen synthase kinase ................................................................................... 135 
 7.2.2 p70S6K ................................................................................................................... 136 
 7.2.3 Ras superfamily G proteins .................................................................................. 136 
 7.2.4 A functional role for small GTPase Rab11 in S. mansoni ..................................... 138 
    7.3 A FUNCTIONAL ROLE FOR AKT IN S. MANSONI ............................................. 139 
    7.4 PRIORITIES FOR FUTURE WORK ................................................................ 145 
 
REFERENCES ............................................................................................... 146 






         ix 
 
List of Figures 
Chapter 1 
Figure 1.1 The global distribution of human schistosomiasis. ............................................. 4 
Figure 1.2 Life cycle of S. mansoni.  ........................................................................................ 6 
Figure 1.3 The schistosome cercaria.  ..................................................................................... 9 
Figure 1.4 The general stages of somule skin migration and the possible host immune 
responses encountered.  ........................................................................................ 13 
Figure 1.5 Drawing of an adult female residing in the gynaecophoric canal of an adult 
male.  ...................................................................................................................... 14 
Figure 1.6 The tegument surface of a male adult S. mansoni worm.  .............................. 15 
Figure 1.7 Illustration of the adult S. mansoni tegument and associated cell body.  ...... 16 
Figure 1.8 Simplified diagrammatic representation of human Akt activation.  ................. 20 
Figure 1.9 Diagrammatic representation of the human Akt signalling network.  ............. 21 
Figure 1.10 Schematic diagram of Insulin and IGF signalling in humans.  ...................... 24 
 
Chapter 3 
Figure 3.1 Composition of the Proteome Profiler kit (Human Phospho-Kinase Array 1). 
 ..................................................................................................................................................... 48 
Figure 3.2 Multiple phosphorylated S. mansoni kinases are captured and detected by 
the Human Phospho-Kinase Array 1. .................................................................. 49 
Figure 3.3 Full pair-wise alignment of S. mansoni Akt with Akt proteins from three other 
organisms.  ............................................................................................................... 51 
Figure 3.4 Partial pair-wise alignment of S. mansoni Akt and Akt from three other 
organisms shows good homology of important phosphorylation motifs.  ....... 53 
Figure 3.5 Detection of an Akt-like protein in S. mansoni.  ................................................. 54 
Figure 3.6 Different S. mansoni life stages show similar banding profiles when blotted 
with antibodies against Akt.  .................................................................................. 55 
Figure 3.7 Phosphorylation of the GSK-3 substrate by an immunoprecipitated S. 
mansoni Akt-like protein.  ....................................................................................... 56 
Figure 3.8 Reciprocal immunoprecipitation (IP) of S. mansoni Akt.  ................................. 57 
Figure 3.9 Fractionation columns reveal Akt-like activity in 0-50 kDa fraction of S. 
mansoni homogenates.  ......................................................................................... 57 
         x 
 
Figure 3.10 Knockdown of Akt expression in adult S. mansoni.  ...................................... 58 
Figure 3.11 Negative control parasites display little non-specific binding of the 
secondary antibody.  ............................................................................................ 59 
Figure 3.12 Immunolocalisation of Akt and phosphorylated Akt in cercariae and 
somules.  ............................................................................................................. 61 
Figure 3.13 In situ immunolocalization of phosphorylated (activated) Akt in intact S. 
mansoni adults.  .................................................................................................... 62 
Figure 3.14 In situ immunolocalization of phosphorylated (activated) Akt in intact S. 
mansoni adults.  .................................................................................................... 63 
Figure 3.15 In situ immunolocalization of total Akt in intact S. mansoni adults.  ............ 64 
Figure 3.16 Serum treatment induces Akt activation in S. mansoni somules at 5-10 min. 
 ..................................................................................................................................................... 65 
Figure 3.17 Exogenous insulin activates Akt in intact S. mansoni.  .................................. 66 
Figure 3.18 L-arginine activates Akt in S. mansoni somules. ............................................ 67 
Figure 3.19 SC79 does not consistently stimulate S. mansoni Akt.  ................................ 68 
Figure 3.20 LY294002 shows inconsistent inhibition of S. mansoni Akt. ......................... 69 
Figure 3.21 GSK2334470 shows moderate inhibition of S. mansoni Akt. ....................... 70 
Figure 3.22 Akt Inhibitor X blocks Akt activation in S. mansoni somules. ....................... 71 
Figure 3.23 Herbimycin A inhibits Tyr315 phosphorylation in S. mansoni somules, 
implicating Src as an upstream kinase. ............................................................ 72 
Chapter 4 
Figure 4.1 Akt phosphorylates more cellular substrates as S. mansoni matures.  ......... 76 
Figure 4.2 Akt-directed phosphorylation of putative Akt substrates is reduced by Akt 
Inhibitor X. ............................................................................................................. 76 
Figure 4.3  Cercariae display phosphorylated Akt substrates in the nervous system and 
other anatomical regions. ...................................................................................... 77 
Figure 4.4 Somules display considerable internal signal for phosphorylated Akt 
substrates. ............................................................................................................. 78 
Figure 4.5 Adult worms display phosphorylated Akt substrates in the tegument. .......... 79 
Figure 4.6 Corrections have been made to the originally annotated Akt gene product. 80 
Figure 4.7 Medium confidence putative protein interaction map for S. mansoni Akt. .... 81 
Figure 4.8 High confidence putative protein interaction map for S. mansoni Akt 
classified in 12 categories. .................................................................................... 82 
         xi 
 
Figure 4.9 Over half the putative Akt interacting proteins are categorised under the GO 
term ‘molecular function’. ....................................................................................... 84 
Figure 4.10 82% of putative Akt interacting sequences have 10 or less GO annotations. 
 ..................................................................................................................................................... 85 
Figure 4.11 GO Level 3 contains the greatest number of annotations across the three 
domains at once. ................................................................................................... 86 
Figure 4.12 Direct GO count for the high confidence Akt interacting proteins within the 
biological process (BP) domain. ......................................................................... 87 
Figure 4.13 Direct GO count for the high confidence Akt interacting proteins within the 
molecular function (MF) domain. ........................................................................ 87 
Figure 4.14 Direct GO count for the high confidence Akt interacting proteins within the 
cellular component (CC) domain. ....................................................................... 88 
Figure 4.15 The biological process domain contains the most terms at Level 3 for the 
high confidence Akt interacting proteins. .......................................................... 89 
Figure 4.16 Level 3 biological processes domain contains 19 nodes. .............................. 90 
Figure 4.17 Level 3 molecular function domain contains 6 nodes. ................................... 90 
Figure 4.18 Level 3 cellular components domain contains 10 nodes. .............................. 91 
Figure 4.19 Multiple pairwise alignment of Schistosoma mansoni (Sm)GSK-3 with 
human (Hs)GSK-3α/β proteins. ....................................................................... 94 
Figure 4.20 Detection of GSK-3α/β in S. mansoni. .............................................................. 95 
Figure 4.21 S. mansoni GSK-3α/β phosphorylation (activation) is increased when Akt is 
inhibited. .............................................................................................................. 96 
 
Chapter 5 
Figure 5.1 Akt is present in the tegument of adult S. mansoni and can be activated by 
human insulin. ........................................................................................................ 100 
Figure 5.2 Incubation of adult worms in Akt Inhibitor X promotes an upward trend in 
tubercle size over 5 days. .................................................................................... 102 
Figure 5.3 Male adult worm tubercle morphology is affected by treatment with Akt 
Inhibitor X. ............................................................................................................ 103 
Figure 5.4 SGTP4 is expressed exclusively in the apical tegument membrane of S. 
mansoni somules and adult worms .................................................................. 114 
Figure 5.5 Inhibition of Akt reduces SGTP4 expression in S. mansoni somules. ......... 105 
         xii 
 
Figure 5.6 Inhibition of Akt supresses the expression of SGTP4 at the S. mansoni 
somule surface during transformation ............................................................... 106 
Figure 5.7 SGTP4 localisation is consistent across all 15 individual S. mansoni 
somules ................................................................................................................ 107 
Figure 5.8 Akt Inhibitor X attenuates SGTP4 expression in S. mansoni somules ........ 108 
Figure 5.9 Akt Inhibitor X reduces glucose uptake over time in S. mansoni somules . 109 
Figure 5.10 SGTP4 expression is reduced in adult S. mansoni by the knockdown of Akt
 ................................................................................................................................................... 110 
Figure 5.11 SGTP4 expression is inhibited in adult S. mansoni by Akt Inhibitor X ...... 111 
Figure 5.12 Akt Inhibitor X reduces SGTP4 expression at the surface of adult S. 
mansoni ............................................................................................................... 112 
Figure 5.13 Glucose uptake in adult S. mansoni is reduced by Akt Inhibitor X treatment
 ................................................................................................................................................... 113 
 
Chapter 6 
Figure 6.1 Akt activation near the surface of cercariae occurs in multiple distinct 
punctate regions.................................................................................................... 118 
Figure 6.2 L-arginine stimulates Akt phosphorylation in S. mansoni cercariae ............ 120 
Figure 6.3 Linoleic acid treatment reveals inconsistent Akt phosphorylation in S. 
mansoni cercariae ................................................................................................ 121 
Figure 6.4 Akt Inhibitor X treatment supresses Akt phosphorylation in S. mansoni 
cercariae ................................................................................................................. 122 
Figure 6.5 Cercarial swim duration is affected by Akt Inhibitor X, L-arginine, and linoleic 
acid ....................................................................................................................... 124 
Figure 6.6 Cercarial swimming drops 63 % in the first 10 min of treatment with 10 μM 
Akt Inhibitor X ........................................................................................................ 125 
 
Chapter 7 
Figure 7.1 Schematic diagram illustrating the main finding during the current research 
project................................................................................................................... 129 
Figure 7.2 Schematic diagram of the postulated mechanism of Akt-dependent SGTP4 
expression/translocation in S. mansoni .......................................................... 144 
 
 
         xiii 
 
List of Tables 
Chapter 1 
Table 1.1 Protein kinases identified in S. mansoni listed in chronological order of 
investigation ............................................................................................................. 18 
 
Chapter 2 
Table 2.1 Reagents and volumes required to make up the 2DG6P detection reagent as 
detailed in the Promega Glucose uptake Glo assay protocol .......................... 43 
 
Chapter 4 
Table 4.1 Several putative Akt interacting proteins possess one or more potential Akt 
phosphorylation sites ........................................................................................... 93 
 
 
List of Videos 
Video 1 The effect of 100 μM L-arginine on cercarial swimming 
Video 2 The effect of 1 μM Akt Inhibitor X on cercarial swimming 
Video 3 The effect of 10 μM Akt Inhibitor X on cercarial swimming 














         xiv 
 





aa amino acid 
ATP adenosine triphosphate 
BME basal medium Eagles 
BSA bovine serum albumin 
cAMP cyclic adenosine monophospohate 
Cdc42 cell division control protein 42 
cm, mm, μm centimetre, millimetre, micrometer 
DMSO dimethyl sulfoxide 
EGF epidermal growth factor 
EGFR epidermal growth factor receptor 
ERK extracellular regulated kinase 
FCS fetal calf serum 
FTW filtered tap water 
g gravitational acceleration 
g, mg, μg gram, milligram, microgram 
GAP GTPase-activating protein 
GLUT4 glucose transporter 4 
GO gene ontology 
GPCRs G protein coupled receptors 
GSK-3 glycogen synthase kinase-3 
GTP guanine triphosphate 
h, min, sec hours, minutes, seconds 
HBSS Hanks balanced salt solution 
HRP horseradish peroxidase 
Hu human 
IC50 50% inhibitory concentration 
IGF-1 insulin-like growth factor 
IGF-1R insulin-like growth factor receptor 
IP immunoprecipitation 
IR insulin receptor 
kDa Kilodalton 
l, ml, μl litres, millilitres, microliters 
LA linoleic acid 
M, mM, μM molar, millimolar, micromolar 
MAPK mitogen activated protein kinase 
mTOR mechanistic target of rapamycin 
NTD neglected tropical disease 
p70S6K 70 kDa ribosomal protein S6 kinase 1 
PBS phosphate buffered saline 
PDGF platelet derived growth factor 
PDK1 phosphoinositide-dependent protein kinase-1 
PH plecktstrin homology 
PI3K phosphoinositide 3-kinase 
PIP2 phosphatidylinositol 4,5-biphosphate 
         xv 
 
PIP3 phosphatidylinositol 3,4,5 triphosphate 
PK protein kinase 
PKA protein kinase A 
PKB protein kinase B 
PKC protein kinase C 
PMA Phorbol myristate acetate 
PTK protein tyrosine kinase 
PZQ Praziquantel 
RAC Related A and C kinase 
RIPA buffer radio immunoprecipitation assay buffer 
RNAi ribonucleic acid interference 
RPMI – 1640  Roswell park memorial institute – 1640 medium 
RK receptor kinase 
RTK receptor tyrosine kinase 
Ser serine 
SGTP1/4 schistosome glucose transporter 1/4 
SLK Ste20-like kinase 
Sm Schistosoma mansoni 
Smp Schistosoma mansoni protein 
Sos son of sevenless 
STK serine/threonine kinase 
TBS tris-buffered saline 
TGF-β transforming growth factor-β 
TK tyrosine kinase 
TGN trans-Golgi network 
Thr threonine 
Tris tris[hydroxyimethyl] amino-methane 
T-TBS Tween-20 tris-buffered saline 
Tyr tyrosine 
V volts 
VFT venus flytrap 
VKR venus kinase receptor 
WHO World Health Organisation 




























 Chapter 1 – Introduction        2 
 
1.1 Schistosomiasis – A Neglected Tropical Disease 
1.1.1 Epidemiology  
Human schistosomiasis, one of the most prevalent neglected parasitic diseases, is 
predominantly tropical and subtropical affecting between 200-250 million people across 
78 countries (Chitsulo et al., 2004; Hu et al., 2004; WHO, 2017) (Figure 1.1). Human 
schistosomiasis results from an infection of parasitic schistosomes; platyhelminth blood-
dwelling flukes with a complex life cycle, that ultimately reside in the mammalian host. 
The primary human-infecting species are Schistosoma mansoni and S. japonicum, which 
cause intestinal schistosomiasis, and S. haematobium which causes urinary 
schistosomiasis. Two further species, S. intercalatum and S. mekongi, can also cause 
human intestinal schistosomiasis but do not feature greatly in schistosomiasis disease 
research. S. mansoni is endemic in 52 of the 78 affected countries1, and the number of 
people at risk from S. mansoni infection has increased over time and currently stands at 
approximately 700 million. This has been largely due to population growth and 
subsequent water resource development projects such as dams and land reclamation 
(Chitsulo et al., 2000). Human schistosomiasis is caused by the parasite eggs becoming 
trapped in tissues, resulting in inflammation and obstruction in either the intestinal or 
urinary systems. Well known for its chronic nature, human schistosomiasis has a high 
morbidity rate, particularly in rural areas where individuals have had long-standing 
infections without treatment (Gryseels et al., 2006). In sub-Saharan Africa alone, there 
are still an estimated 280,000 deaths each year as a direct result of infection by human 
schistosomes (Berriman et al., 2009). 
1.1.2 Disease pathology 
Human schistosomiasis can present as an acute or chronic infection. Acute 
schistosomiasis, or Katayama fever, is more commonly seen in tourists and travellers 
exposed to cercariae in endemic areas. The syndrome begins as a temporary rash at 
the site of skin penetration up to one week after exposure, progressing often to include 
pulmonary and abdominal symptoms, headache, and bloody diarrhoea two to ten weeks 
post-infection (Ross et al., 2002; Bottieau et al., 2006). The source of the Katayama 
symptoms has been suggested as an allergic reaction to antigens released into the blood 
during somule migration (Bailek and Knobloch, 1999). Repeated treatments with the drug 
praziquantel (PZQ) are commonly used against acute cases of schistosomiasis (Ross et 
                                                          
1 http://www.who.int/mediacentre/factsheets/fs115/en/ [Accessed: March 31st, 2017] 
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al., 2002). Chronic schistosomiasis is found in endemic areas and can be characterised 
by intestinal lesions caused by eggs produced from the adult worms. Proteolytic 
enzymes and other molecules released from the eggs cause eosinophilic inflammatory 
and granulomatous reactions (Gryseels et al., 2006), mediated by egg antigen-specific 
CD4+ T helper (Th) lymphocytes (Stadecker, 1999). Collectively termed soluble egg 
antigens (SEA), eggs secrete a complex variety of glycoproteins and glycolipids (van 
Liempt et al., 2007) via microscopic pores (Ashton et al., 2001). The most abundant egg 
antigen is Sm-p40, making up 10% SEA (Nene et al., 1986; Chikunguwo et al., 1991). 
Characterised in mice, Sm-p40 is also immunogenic in humans (Stadecker, 1999), 
eliciting a Th1 biased immune response (Hernandez et al., 1998). Other major egg 
antigens include omega-,1 kappa-5 and IPSE/alpha1 (Dunne et al., 1986; Schramm et 
al., 2003). Usually, granulomas develop where the accumulation of eggs is greatest; for 
infections by S. mansoni this is typically the intestines and the liver. During the early 
stages of infection, SEAs mediate a Th1 response, developing to a Th2 response as the 
infection advances (Pearce et al., 1991; van Liempt et al., 2007). 
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1.1.3 Schistosomiasis drug control strategies 
Recent figures show that in 2015 at least 218 million people required preventative action 
for schistosomiasis, and 66.5 million were treated for the disease (World Health 
Organisation, 2017). In affected areas across Africa and South America, large-scale 
treatment programmes are running with PZQ as the only available drug to treat 
schistosomiasis of all species (Berriman et al., 2009; Fallon and Doenhoff, 1994). There 
are reports that drug resistance is developing after three decades of treatment 
exclusively with PZQ (Chitsulo et al., 2004) and drug resistance can certainly be 
developed in a laboratory setting (Doenhoff et al., 2002). Unfortunately, PZQ cannot 
prevent re-infection by the parasite and its efficacy is dependent on multiple parameters 
such as parasite gender and time of infection; juvenile schistosomes are not susceptible 
(Pica-Mattoccia and Cioli, 2004). There are also other possible reasons for treatment 
failures; PZQ has low water solubility and extensive first-pass metabolism through the 
liver, significantly decreasing the drug’s bioavailability (Cioli et al., 1995).  
In the last decade, a few alternatives to PZQ have been found, although with less efficacy 
(reviewed by Cioli et al., 1995). Oxamniquine has been used successfully in South 
America and Africa as a ‘complementary drug’ when PZQ treatment fails2. Oxamniquine 
is only effective against S. mansoni, but can be implemented at all stages of the disease 
with cure rates of 60-90 % (Bustinduy and King, 2014). Downsides of oxamniquine 
include its method of activation, which requires a schistosome sulfotransferase that is 
not present in drug-resistant worms (Pica-Mattoccia et al., 2006). Another drug, 
Metrifonate (2,2,2-trichloro-1-hydroxyethyl dimethyl phosphonate), was developed in the 
1950s originally as an insecticide (Lorenz et al., 1955). Metrifonate is particularly 
effective against S. haematobium and has been used in the past to treat urinary 
schistosomiasis, although is it now no longer available (Pottinger and Jong, 2017).  
1.1.4 The future of schistosomiasis 
With the World Health Organisation having announced an ambitious target to eliminate 
global schistosomiasis by 2025, focus is turning to control of the intermediate host snail. 
The genome of the gastropod snail Biomphalaria glabrata, a host for S. mansoni, has 
recently been published (Adema et al., 2017). This will facilitate new molecular research 
to help establish the mechanisms responsible for snail-schistosome host compatibility 
                                                          
2http://www.who.int/medicines/publications/essentialmedicines/20th_EML2017_FINAL_amendedAug2
017.pdf?ua=1 [Accessed September 4th 2017]. 
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and discover how the parasite evades the snail immune system. It is anticipated that in 
the future it may be possible to deploy genetically engineered snails in endemic areas 
that are refractory to schistosome infection/development. Given that PZQ does not guard 
against reinfection of schistosomes, halting transmission of the parasite at the snail host 
stage would aid enormously in the long-term aim to eradicate the disease. Although 
education and proper sanitation play an important part in an integrated control strategy 
to eliminate schistosomiasis, continued mass drug administration of PZQ combined with 
efforts to determine a novel drug or vaccine target against the schistosome and snail 
control methods are considered the best hope for achieving sustainable global 
elimination.  
1.2 Schistosomes and Their Life Cycle 
The life cycle of schistosomes is complex and each parasite life stage displays unique 
adaptations, allowing the parasite to make the difficult journey between intermediate 
snail and definitive human hosts and to survive within each host (Jones et al., 2008). 
These remarkable adaptations are manifest during a striking array of morphological and 
physiological changes that occur in the life cycle (Figure 1.2). Adult female S. mansoni 
worms can produce hundreds of eggs per day, each containing a developing larva called 
Figure 1.2 Life cycle of S. mansoni. The parasite develops through various life stages that 
are adapted for the specific environment encountered (Reproduced with kind permission from 
A.J. Walker).  
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a miracidium. Those eggs destined for excretion migrate to the lumen of the intestine, 
where they are expelled from the host in the faeces. On contact with fresh water miracidia 
are released from their egg capsules and immediately start swimming (Gryseels et al., 
2006; Ressurreição et al., 2011). The miracidium is approximately 150 µm long (Walker, 
2011) and viable for up to 24 hours (Gryseels et al., 2006). Miracidia use cilia to propel 
themselves through the water and search for their compatible intermediate host snails 
(e.g. Biomphalaria), aided by light, chemical signals and other environmental stimuli 
including water currents and temperature (Haas and Haberl, 1997; Gryseels et al., 2006; 
Walker, 2011). S. mansoni miracidia swim fast and can infect snail hosts up to 9 m and 
27 m away in standing and flowing water, respectively (Haas, 2003). The mechanism of 
penetration into the snail is unclear but is thought to result from a combination of 
proteases secreted from penetration glands of the miracidia and mechanical movement. 
After penetrating the snail, the miracidia shed their cilia and differentiate into asexually 
reproducing mother, and subsequently daughter, sporocysts, which eventually develop 
into cercariae (Walker, 2011). This asexual multiplication strategy ensures that large 
numbers of cercariae are produced from a single miracidium to provide optimal chances 
of definitive host infection. 
Four to six weeks post-infection, the infected snail begins to shed cercariae. Shedding 
is influenced by light, happens mostly during the day and can last for months with 
infection caused by just one miracidia. At this early stage, the parasites are already 
sexually differentiated (Boissier et al., 1999). Using their bi-furcated tails and glycogen 
reserves, the cercariae spin around and swim in the water for up to 72 hours, seeking a 
definitive host (Gryseels et al., 2006). Miracidial and cercarial stages do not feed and 
therefore have limited energy reserves to swim and find a host. Consequently, these life 
stages have developed mechanisms for successful host location and penetration in order 
to survive (Haas and Haberl, 1997). Host location by cercariae is achieved using water 
turbulence and specific skin chemicals including linoleic acid (Ressurreição et al., 2011). 
Attachment to the skin of the host is stimulated by L-arginine (Haas et al., 2002), and 
cercariae will creep along the skin to find a suitable point of entry using heat gradients 
as small as 0.15 °C/mm (Haas, 2003). Cercariae penetrate the skin of the host by 
releasing proteases and mucus from the pre- and post-acetabular glands respectively. 
The contents of these glands aid attachment to the host skin, tissue digestion and 
immune evasion (Haas et al., 1997). The tail is a temporary locomotion organ, which is 
shed once penetration has been achieved (Walker, 2011).  
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Cercariae start to develop into skin schistosomules (hereafter abbreviated to somules) 
when the tail is shed. At this point, several structural and physiological changes take 
place including release of the pre-acetabular gland contents, formation of a double 
bilayer outer membrane and production of new glycoproteins (Walker, 2011). The 
somules remain in the skin for an average 72 hours (for S. mansoni) before moving into 
the blood system, although movement has been reported to take up to 7 days (LoVerde 
et al., 2004). The somules migrate through the pulmonary capillaries in the lungs from 
which they are able to enter systemic circulation. At this stage, they are young worms. 
Ultimately, the liver is where the worms begin to feed and pair up (Walker, 2011); full 
maturity is reached after a further 4-6 weeks in the hepatic portal vein (Gryseels et al., 
2006). Males grow considerably larger than the females and display higher levels of 
mitotic activity (Walker, 2011).  
 
After maturing in the portal vein, the adult worms migrate to and settle in the mesenteric 
venous plexus, feeding on host blood and globulins via anaerobic glycolysis (Skelly and 
Shoemaker, 1995). The adult male flatworm is curled and appears cylindrical in shape, 
measuring an average 10 mm long (Machado-Silva et al., 1995). The adult female 
measures longer than the male at up to 20 mm. Like all other blood-dwelling parasites, 
S. mansoni possess a unique tegument consisting of a single double-bilayer membrane 
surrounded by a syncytium of fused cells (Van Hellemond et al., 2006). Other features 
include terminal suckers, a blind gut, and reproductive organs. The male worm curls 
round to form a gynaecophoric canal within which the thinner female lies, once pairing 
has occurred (LoVerde et al., 2004). Once coupled, the females and males fully develop 
and the female lays eggs which either pass through the epithelium of the host to the 
intestinal system to be excreted, or collect in tissues including the liver causing 
granuloma and fibrosis (Berriman et al., 2009). The sexual maturation of the female 
worm is crucially dependant on this pairing with the male, and very few other organisms 
make such permanent attachments, an example is Diplozoon paradoxum, where 
partners become fused at their point of contact (Kunz, 2001). The male schistosome 
regulates gene expression of the female via an uncharacterised mechanism (LoVerde et 
al., 2004). Several female-specific genes, signalling pathways and receptors have been 
identified as having a role in female reproductive development (LoVerde et al., 2009). 
The average life-span of an adult worm is 3-5 years but they have been recorded to live 
up to 30 years in some cases (Gryseels et al., 2006).  
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1.2.1 Biology of cercariae 
S. mansoni cercariae were first identified in 1915 in a specimen of Planorbis boissyi from 
Cairo (Khalil, 1922). S. mansoni cercariae are approximately 300 μm in length, 
comprising a body (head) and stage-specific tail ending in paired furcae. The head 
possesses a mouth at the anterior tip, an oral sucker, the acetabulum and acetabular 
glands (Mair et al., 2003) (Figure 1.3). The pre- and post-acetabular glands, two and 
three pairs respectively, fill approximately two thirds of the body cavity (Collins et al., 
2011). Cercariae are coated in a surface layer called the glycocalyx, which is rich in 
sugars and covers the trilaminate membrane tegument (Dorsey et al., 2002). The 
glycocalyx acts as a barrier against osmotic pressure in the cercariae’s aquatic 
environment (Samuelson and Caulfield, 1982). In addition to the glycocalyx, cercariae 
are also covered in actin-rich spines and ciliated sensory papillae which aid in host 
location (Collins et al., 2011). Sensory papillae are nerve terminals found at the surface 
of the tegument and allow the cercariae to connect to their environment. Located along 
the length of the whole parasite, unsheathed uni-ciliated papillae are the most abundant 
Figure 1.3 The schistosome cercaria. A. Schematic diagram of a cercariae showing the 
morphological features. (Ressurreicao, 2013, originally adapted from Dorsey et al., 2002). B. 
Fluorescence confocal image of a cercaria stained with rhodamine phalloidin to reveal various 
structures.  
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type of papillae, with a bulbous body and one projecting cilia approximately 7 μm wide 
anchored to a nerve fibre (Dorsey et al., 2002). A comprehensive atlas of cercarial 
structures and musculature has been composed by Collins et al. (2011).  
 
Beneath the tegument of cercariae lies a cytoplasmic layer containing three types of 
cells, connected to the surface membrane via cytoplasmic bridges (Hockley and 
McLaren, 1973). The most commonly distributed cell are the type 1 cytons; type 2 cytons 
are restricted to a small area in the dorso-anterior region of the cercarial body (Skelly 
and Shoemaker, 2001). The final subtegumental cell type is the head gland, which exists 
exclusively in the anterior organ (oral sucker) and possesses many connections to the 
tegument around the oral sucker (Dorsey, 1976). The membranous bodies contained 
within all three cell types migrate to the tegument through the cytoplasmic bridges during 
transformation from cercaria to somule. 
 
The free-swimming cercaria has four distinct muscle types; circular, diagonal, 
longitudinal and striated fibres. The latter is located only in the tail with the other three 
types making up the body wall of the cercariae. Circular muscles form the outer muscle 
layer, with longitudinal and diagonal muscles interweaved underneath (Collins et al., 
2011). Some of the musculature is specific to the cercariae, such as the striated muscle 
in the tail, but some is similar or identical to the muscles seen in adult schistosomes, 
such as in the oesophagus and body wall. Other adult features including the reproductive 
organs have yet to develop (Mair et al., 2003). 
 
Provided with only a limited supply of glycogen reserves metabolised by anaerobic 
respiration (Tielens, 1997), it is imperative that the cercaria is efficient at locating a 
definitive host. Despite S. mansoni being a very successful species, little was known 
about the swimming behaviours until the last decade (Brachs and Haas, 2008). S. 
mansoni cercariae accumulate in a water depth of 20-30 cm, a suitable environment to 
encounter swimming humans (Haas et al., 2008), but are seemingly generally 
unresponsive to shadow and light (Brachs and Haas, 2008). Brachs and Haas (2008) 
did report however, that higher light intensity induced longer active swimming phases 
and shorter passive phases. Active cercarial swimming is mainly backwards, with the tail 
facing the direction of travel. Forward travel is used to change direction. Passive phases 
involve the cercariae sinking head first. The swimming pattern displayed by S. mansoni 
cercariae is comparable to that of other species such as Trichobilharzia ocellata (Brachs 
and Haas, 2008).  
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Cercarial penetration through host skin has been the subject of much research dating 
back to the early 20th century (Fujinami and Nakamura, 1909), although the first study 
specifically on S. mansoni is not recorded until 1915 (Leiper, 1915). There are several 
stages to the process of penetrating the mammalian host, and each is stimulated by a 
different chemical cue derived from the skin. Initial attachment is promoted by L-arginine 
(Granzer and Haas, 1986), lingering on the skin by ceramides and acylglycerols (Woicke 
and Haas, 1989), and creeping to the point of entry stimulated by L-arginine (Haas et al., 
1989); penetration itself is stimulated by unsaturated fatty acids (Shiff et al., 1972). The 
chemicals are thought to be detected by the sensory papillae on the syncytial tegument 
that surrounds both the head and tail sections of the cercariae (Granzer and Haas, 1986).  
 
In addition to ceramides and acylglycerols, it is suggested that the contents of the post-
acetabular gland may also support prolonged contact to the host’s skin surface (Stirewalt 
and Kruidenier, 1961). The pre- and post-acetabular gland contents are released during 
creeping and penetration and contribute to host skin degradation, loss of the cercarial 
glycocalyx and protection against the host’s immune system for the newly transformed 
somule (McKerrow and Doenhoff, 1988). Typically, acetabular gland secretion is 
stimulated by host skin lipids and occurs only when required during invasion (Haas et 
al., 1997), but can also be induced by some chemical stimuli including PZQ (Matsumura 
et al., 1990).  
 
1.2.2 Biology of somules 
There are three recognised stages of a somule: skin, lung and liver somule, indicating 
the locations through which the somules pass on their voyage to the liver. There has 
been some debate over how long somules take to pass through the skin although 
consensus is up to five days with an average of three days (He et al., 2002; Wheater and 
Wilson, 1979). It was initially thought that cercariae utilised hair follicles as a route of 
entry into the skin, however research has shown that the parasites will penetrate any 
skin surface area (He et al., 2002). During skin transit, Wheater and Wilson (1979) 
observed the somule distribution change from the epidermis towards the dermis and 
blood vessels contained within (Figure 1.4). Somules have been observed to slow down 
at the epidermal-dermal junction (basement membrane) which must be degraded using 
acetabular gland secretions, before the larvae can pass through (He et al., 2002). The 
minimum time taken for somules to reach the blood is two days, after which time, 
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somules arrive in the lungs, locating themselves preferentially in the capillaries 
surrounding the pleural surface. This phase of somule migration can take anywhere from 
four to eighteen days and sees the somules elongate (Wheater and Wilson, 1979). 
Somules began to appear in branches of the hepatic portal vein as early as seven days 
post infection (He et al. 2002).  
Several important morphological events occur during the transformation from cercaria 
and subsequent growth of the somule. The contents of all cercarial glands are released 
and the tail is shed. The glycocalyx that surrounds cercariae is replaced with the start of 
the double bilayer lipid membrane tegument (Samuelson and Caulfield, 1985; Skelly and 
Shoemaker, 2001). The development of the tegument at this crucial stage became of 
interest over four decades ago, when a detailed report hypothesised that the trilaminate 
cercarial membrane is replaced by a heptalaminate membrane within three hours of 
transformation (Hockley and McLaren, 1973). Hockley and McLaren (1973) observed 
that the additional layers of membrane were gained from membranous vesicles, 
originating in the sub-tegumental cells, fusing with the apical membrane. Since the 
preliminary research, additional data confirmed that the syncytial tegument of the 
developing somule consists of a tightly opposed double bi-layer membrane (McLaren 
and Hockley, 1977).  
Figure 1.4 illustrates the passage of the somule through the skin layers and additionally 
the potential immune interactions occurring at each stage. Eight hours after infection, S. 
mansoni stimulates the production of cytokines IL-1 receptor agonist (IR-1ra), IL-10 and 
TNFα from Langerhans cells, keratinocytes and epidermal T lymphocytes in the 
epidermis (He et al., 2002). It is possible that the residual components of the cercarial 
glycocalyx are partly responsible for eliciting this response (Jenkins et al., 2005; 
Samuelson and Caulfield, 1982). Interestingly, infection by S. japonicum stimulates the 
production of many more cytokines, indicating a difference in immune response to a 
species, which migrates faster through the skin (Jenkins et al., 2005). During traversal 
through the skin layers, somules secrete immunoregulatory products such as 
prostaglandin D2 (Angeli et al., 2001) with the goal of suppressing the host immune 
system sufficiently for safe passage into the blood vessels (Fusco et al., 1986; Salafsky 
et al., 1987). Prostaglandin D2 inhibits the migration of Langerhans cells, preventing their 
departure from the epidermis and maturation into dendritic cells (Angeli et al., 2001). 
 
 




1.2.3 Biology of adult worms 
 1.2.3.1 Sexual maturation and reproduction 
Approximately 15 days post-exposure, somules reach the hepatoportal circulation where 
the maturation into adult male and female worms continues (LoVerde et al., 2004). 
Schistosomes are sexually differentiated from as early as the miracidium stage (Boissier 
et al., 1999) although it is not until adulthood that the sexes are morphologically 
discernible. Male S. mansoni are thicker and more muscular, although shorter, than the 
more slender females. Other morphological differences between the sexes are apparent 
upon inspection: male worms possess a tegument covered in tubercles, while the female 
surface is smooth. Males also form a gynaecophoric canal with which to hold the female 
worm once paired. Both sexes possess an oral and ventral sucker (Figure 1.5).  
Figure 1.4 The general stages of somule skin migration and the possible host immune 
responses encountered. APC – antigen presenting cells; K – keratinocyte; L – lymphocyte; 
N – neutrophil; M – macrophage; LHC – langerhans cell. Adapted by the author from Jenkins 
et al. (2005).  
 Chapter 1 – Introduction        14 
 
 
From ~28 days post-infection, the adult worms begin to mate (LoVerde et al., 2009). For 
female worms to reach and maintain sexual maturity, they must pair with a male worm 
and reside within its gynaecophoric canal (Popiel and Basch, 1984). When the worms 
become separated the female’s ovary and vitelline gland regress, with other reproductive 
structures apparently unaffected (Erasmus, 1973). Mature male S. mansoni worms 
possess four to nine testes (Gönnert, 1955) which produce sperm that is subsequently 
passed to the enveloped female via a cirrus located at the top of the gynaecophoric 
canal. Once inside the female, sperm migrate through the reproductive tract to the 
seminal receptacle, positioned adjacent to the ovary (Collins et al., 2011). From here, 
the sperm are able to fertilise the oocytes as they emerge from the ovary. Once passed 
through the oviduct, oocytes enter the vitelline duct, eventually reaching the Mehlis’ 
gland. The Mehlis’ gland is a cluster of secretory cells with several proposed roles within 
the reproductive process including uterus lubrication and egg shell biosynthesis 
(deWalick et al., 2012). The eggs gain their shells from material synthesised in the 
Figure 1.5 Drawing of an adult female residing in the gynaecophoric canal of an adult 
male (Beltran et al., 2010). 
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vitelline glands (Kunz, 2001) in the ootype before passing out of the female genital pore 
(Collins et al., 2011). 
 
 1.2.3.2 The adult worm tegument 
The success of schistosomes has been greatly reliant on their evolutionary-derived 
ability to ‘hide’ from the host by incorporating host antigens at the tegument surface, 
thereby effectively coating themselves in a protective barrier and suppressing the host 
immune response (Smithers et al., 1969). The tegument of S. mansoni is similar to 
previously described trematodes in that the outer syncytial layer is connected to sub-
tegumental nucleated regions in the parenchyma (Morris and Threadgold, 1968). These 
oval shaped nucleated regions/cell bodies/cytons vary in size from 3 x 6 μm to 6 x 12 μm 
(Wilson and Barnes, 1974). The S. mansoni tegument is composed of a double lipid 
bilayer, which when viewed by electron microscopy, appears as two trilaminate 
membranes each with an electron-transparent layer sandwiched by electron dense 
layers, and varies in overall thickness from 0.9 - 3 μm (Wilson and Barnes, 1974). At the 
apical surface, the membrane is highly invaginated, forming pits and channels (Wilson 
and Barnes, 1974). Conversely, the tegument also features tubercles, small raised 
portions of the tegument present along the length of male worms although more densely 
in the dorsal region (Morris and Threadgold, 1968) (Figure 1.6). In addition to tubercles, 
cuticular spines approximately 2 μm long (Gobert et al., 2003), are found at the surface 
of both male and female worms, including within the male gynaecophoric canal and 
suckers of both sexes (Hockley, 1968; Gobert et al., 2003). Figure 1.7 details the 
components of the adult tegument and indicates the position of subtegumental cell 
bodies, spines, and mitochondria within the tegument. 
 
Figure 1.6 The tegument surface of a male adult S. mansoni worm. Multiple tubercle 
protrusions with spines are evident; image captured by scanning electron microscopy (Shuhua 
et al., 2000). 
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1.3 Cell Signalling in S. mansoni 
The physiological complexity of schistosomes, which also differs between the 
morphologically distinct phases, renders this parasite a fascinating subject of research. 
Given that cellular signalling processes drive gene expression changes and modify 
cellular behaviour, investigating signalling in S. mansoni is critical to our understanding 
of the basic biology of this organism. As well as endogenous signalling, it is thought that 
schistosomes use cell signalling pathways to alter gene expression and cellular 
behaviour in response to external environmental stimuli such as host growth factors 
(Ressurreição et al., 2011).  
1.3.1 Protein kinases  
Signalling in eukaryotic organisms is orchestrated by protein kinases (PKs). Protein 
phosphorylation by these pivotal regulatory enzymes occurs via the addition of a 
phosphate group from ATP or GTP to an amino acid, instigating a conformational change 
(Hanks et al., 1988). Integrins, receptor tyrosine kinases (RTKs) and other receptors 
such as G-protein coupled receptors (GPCRs) bind ligands at the cell surface and their 
intracellular domains spark a chain of phosphorylations via PKs to effect changes at the 
molecular level (Beckman et al., 2012).  
Figure 1.7 Illustration of the adult S. mansoni tegument and associated cell body. 
Adapted by the author from Braschi et al., 2006a. Drawing is not to scale. 
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There are two superfamilies of protein kinase, the majority belonging to the eukaryotic 
protein kinase superfamily (ePKs) and the remainder belonging to the atypical protein 
kinase superfamily (aPKs) (Hanks et al., 1988). Within the ePKs there are eight groups: 
AGC (cAMP-dependent protein kinase/protein kinase G/protein kinase C extended), 
CAMK (Calcium/Calmodulin regulated kinases), CK1 (Cell Kinase I), CMGC (Cyclin-
dependent kinases), RGC (Receptor Guanylate Cyclases), STE (MAP Kinase cascade 
kinases), TK (Protein Tyrosine Kinase) and TKL (Tyrosine Kinase Like) but broadly, PKs 
can be divided into two classes based on their phosphorylation preferences, 
serine/threonine kinases (STKs) or tyrosine kinases (TKs)3 (Andrade et al., 2011). 
Structurally, PKs contain at minimum, a catalytic domain and a regulatory domain. The 
~250-300 amino acid catalytic domain contains residues capable of binding and 
phosphorylating target proteins (Andrade et al., 2011).  
PKs are now commonly used as targets against human diseases (Parasido et al., 2017) 
and consequently, are also of interest in the search for novel drug targets against 
schistosomiasis, although research is faced with several challenges, primarily the 
capacity for PKs to hold multiple functional roles within the different life stages (Walker, 
2011). The publication of the S. mansoni genome and kinome (Andrade et al., 2011; 
Berriman et al., 2009; Protasio, et al., 2012) has revealed 252 putative protein kinase 
genes, facilitating research into schistosome form and function and enabling 
comparisons to be made with other species. However, elucidating the precise functional 
roles for the kinases derived from these genes, remains a significant challenge.  
1.3.2 Protein kinases in S. mansoni 
Although 252 putative protein kinases have been identified in S. mansoni (Andrade et 
al., 2011), which is a similar number to those present in S. haematobium (Stroehlein et 
al., 2015), only a selection have been investigated in any detail. Amongst the first kinases 
to be studied in S. mansoni was receptor kinase 1 (SmRK1), discovered by Davies et al. 
(1998) (Table 2.1). Their hypothesis that schistosomes can detect host-derived signals 
via membrane-bound receptor proteins was inspired by previous work suggesting that in 
order for the complete and successful maturation of adult schistosomes, male and 
female worms must receive signals from their host and from each other (Basch and 
Rhine, 1983). SmRK1 is an STK and forms part of the Transforming Growth Factor-β 
(TGF-β) family of receptors. In 2001, Kapp et al. isolated SmTK5, the first S. mansoni 
                                                          
3 http://kinase.com/kinbase/ [Accessed August 10th 2017]. 
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protein tyrosine kinase (PTK). PTKs play a major role in forwarding extracellular signals 
to a variety of internal signalling pathways. Of the 252 protein kinases identified in S. 
mansoni, 90 have been classified as PTKs and approximately 43 as tyrosine-like kinases 
(Andrade et al., 2011). To date, SmTK3, SmTK4, SmTK5, SmTK6 and SmFes have been 
investigated in S. mansoni (Bahia et al., 2006) and roles for these SmTKs include 
reproduction, mitogenic activity, female egg production and larval transformation 
(reviewed in You et al., 2011). The first kinase of the AGC superfamily to be discovered 
in schistosomes was protein kinase C1 (PKC1) (Bahia et al., 2006). Since then, protein 
kinase A (PKA) and most recently, protein kinase B (PKB/Akt) have also been 
researched in S. mansoni (Swierczewsk and Davies, 2009; Morel et al., 2014a). Since 
work began on S. mansoni signalling proteins in 1991, at least one new kinase has been 
investigated almost anually. Table 1.1 lists S. mansoni signalling proteins in 
chronological order of their discovery. Many signalling pathways remain that have not 
been investigated in S. mansoni; the research described here focuses on the Akt 
signalling pathway. 
  
Signalling Proteins Studied in S.mansoni Reference 
S. mansoni epidermal growth factor receptor (SER) Ramachandran et al., 1996 
S. mansoni mitogen-activated protein kinase (MAP kinase)   Schuessler et al., 1997 
S. mansoni GTPase activating protein (GAP) Schuessler et al., 1997 
S. mansoni receptor kinase (SmRK1) Davies et al., 1998 
S. mansoni tyrosine kinase 5 (SmTK5) Kapp et al., 2001 
S. mansoni tyrosine kinase 4 (SmTK4) Knobloch et al., 2002 
S. mansoni receptor tyrosine kinase 1 (SmRTK1/SmVKR1) Vicogne et al., 2003 
S. mansoni receptor kinase 2 (SmRK2) Forrester et al., 2004 
S. mansoni tyrosine kinase 3 (SmTK3) Kapp et al., 2004 
S. mansoni protein kinase C (SmPKC1)  Bahia et al., 2006 
S. mansoni cytoplasmic protein-tyrosine kinase (SmFes) Bahia et al., 2007 
S. mansoni insulin receptor 1 and 2 (SmIR1, SmIR2) Khayath et al., 2007 
S. mansoni Ste20-like kinase (SmSLK)  Yan et al., 2007 
S. mansoni cAMP-dependant protein kinase (SmPKA-C) Swierczewsk and Davies, 2009 
S. mansoni protein kinase C β (PKCβ) Ludtmann et al., 2009 
S. mansoni tyrosine kinase 6 (SmTK6)   Beckmann et al., 2011 
S. mansoni p38 mitogen-activated protein kinase (p38MAPK) Ressurreição et al., 2011 
S. mansoni venus kinase receptor 1 (SmVKR1) Gouignard et al., 2012 
S. mansoni venus kinase receptor 2 (SmVKR2) Gouignard et al., 2012 
S. mansoni polo-like kinase 2 (SmSak) Long et al., 2012 
S. mansoni cAMP-dependant protein kinase (PKA)   de Saram et al., 2013 
S. mansoni fibroblast growth factor receptor (Smfgfr) Collins et al., 2013 
S. mansoni extracellular signal regulated Kinase (ERK) Ressurreição et al., 2014 
S. mansoni nucleotide kinases – deoxyriboside, uridine, 
cytidine 
Naguib and Kouni, 2014 
S. mansoni protein kinase B/Akt (SmAkt) Morel et al., 2014a 
Table 1.1 Protein kinases identified and studied in S. mansoni listed in chronological order 
of investigation. Adapted from Ressurreição (2009) and updated.  
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1.3.2 Protein kinase B/Akt 
 1.3.2.1 Discovering Akt 
Akt, also known as Protein Kinase B (PKB) (Alessi et al., 1996a), is an STK belonging to 
the AGC subfamily of protein kinases (Yang et al., 2002). Akt is critical to signalling in all 
higher eukaryotic cells (Manning and Cantley, 2007), and can be traced back to early 
metazoans (Bozulic and Hemmings, 2009). Originally discovered as a proto-oncogene 
in humans (Jones et al., 1991; Bellacosa et al., 1991; Coffer and Woodgett, 1991), Akt 
has since been implicated in various cellular processes such as insulin signalling, 
glucose metabolism, cell-cycle progression, apoptosis, transcriptional regulation and 
cancer progression4 (Brazil et al., 2004). There are three human isoforms of Akt; Akt-1, 
Akt-2 and Akt-3 (PKBα, PKBβ and PKBγ, respectively) (Manning and Cantley, 2007). 
Akt-1 is the cellular homologue of a protein known as v-Akt, which was isolated from 
rodent T-cell lymphoma in the genome of AKT-8 acute transforming retrovirus (Alessi et 
al., 1996b).  
 1.3.2.2 Structure and activation mechanism of the Akt protein 
All currently characterised forms of Akt have the same configuration: an N-terminal 
pleckstrin homology (PH) domain, a catalytic domain and a short C-terminal tail 
containing a hydrophobic motif (Bozulic and Hemmings, 2009). In humans, the catalytic 
domain displays 65% and 75% similarity to PKA and PKC respectively. Mammalian Akt 
signalling can be initiated by a variety of receptors including RTKs, integrins, B and T 
cell receptors (BCRs), cytokine receptors and GPCRs, among others. Each of these 
stimuli result in the activation of phosphoinositide 3-kinase (PI3K) and consequently, the 
production of phosphatidylinositol 3,4,5 triphosphate (PIP3). Accumulation of PIP3 at the 
plasma membrane provides docking sites for PH domains, as are found in Akt and its 
upstream kinase, phosphoinositide-dependent protein kinase-1 (PDK1). PDK1 mediates 
the phosphorylation of Akt at the T-loop on residue Thr308 (Alessi et al., 1997; Brazil et 
al., 2004; Mora et al., 2004) (Figure 1.8). Complete activation of Akt requires a series of 
phosphorylations, including on Ser473 in the hydrophobic motif and Thr308 found in the 
catalytic domain (Alessi et al., 1996a). However, prior to these events, tyrosine 
phosphorylation is also required at Tyr315/Tyr316 (in human Akt1/Akt2, respectively) (Chen 
et al., 2001). Once active, the effects of Akt on cell behaviour can last up to several hours 
(Alessi et al., 1997). The downstream targets of Akt vary depending on the function 
required. For instance, cell survival is mediated by Bcl-2-associated death promoter 
                                                          
4 http://www.cellsignal.com/reference/pathway/Akt_PKB.html [Accessed November 18th 2015]. 
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(BAD) and Forkhead Box O (FOXO), whereas Glycogen Synthase Kinase 3 (GSK3) is a 
target for metabolism (Norrmén and Suter, 2013). In humans, Akt can also exert effects 
















Figure 1.8 Simplified diagrammatic representation of human Akt activation.  
A flow diagram with explanatory boxes indicating the chain of events leading to the 
phosphorylation (activation) of human Akt. 




1.3.2.3 Akt in other organisms 
Most of the knowledge regarding Akt emanates from investigations on the human 
protein. However, several orthologues of Akt containing a PH domain have been 
identified in non-mammalian species, including Drosophila melanogaster (Andjelkovic et 
al., 1995), Dictyostelium discoideum (Meili et al., 1999) and Caenorhabditis elegans 
(Paradis and Ruvkun, 1998). In C. elegans there are two Akt genes: Akt-1 and Akt-2, 
with Akt1 giving rise to two splice variants, Akt-1a and Akt-1b (Paradis and Ruvkun, 
1998). C. elegans Akt-1 is regulated by phosphorylation sites equivalent to the human 
Thr308 and Ser473 residues, whereas the Akt-2 protein is activated only by the former, 
Figure 1.9 Diagrammatic representation of the human Akt signalling network 
(http://www.cellsignal.com/reference/pathway/Akt_PKB.html, [Accessed October 10th 2017]). 
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indicating that the two proteins are potentially differentially regulated (Paradis and 
Ruvkun, 1998). The D. melanogaster homologue of Akt (DAkt1) encodes two proteins of 
different sizes, a shorter protein of 66 kDa and a longer form measuring 85 kDa. Both 
proteins possess kinase activity and are differentially expressed between embryo and 
adult life stages, indicating putative functional differences (Andjelkovic et al., 1995).   
 1.3.2.4 Akt in S. mansoni 
During this PhD investigation, one article regarding Akt in S. mansoni was published 
(Morel et al., 2014a), with none existing previously. Morel et al. (2014a) confirmed the 
presence of Akt in S. mansoni and showed it to be a well conserved kinase, implicated 
in adult pairing and female worm egg laying. Their study focused on exposing the 
parasite to commercially available PK inhibitors and monitoring the physiological effects. 
The three inhibitors found to be most effective on adult worms and somules were Akt 
Inhibitor IV, Akt Inhibitor VIII and Akt Inhibitor X. In somules, 100 % parasite kill was 
observed with 1 μM Akt Inhibitor IV after 24 h. Although Morel et al. (2014a) assigned a 
likely functional role of Akt in worm reproduction and somule survival, the variety of Akt 
functions in mammals provided a rationale to investigate the importance of S. mansoni 
Akt in other cellular processes. An in depth biochemical validation of Akt signalling in S. 
mansoni was also warranted.  
1.4 Insulin Signalling 
Insulin is a polypeptide hormone crucial to normal metabolism and growth regulation 
(Dupont et al., 2001). Insulin plays a role in a wide range of processes in mammals 
including gene expression and protein degradation, glucose and lipid metabolism, cell 
growth, and DNA synthesis (Figure 1.10). The insulin pathway is stimulated by the 
binding of extracellular insulin or insulin-like growth factor (IGF) to transmembrane RTKs. 
These receptors are constitutively assembled heterotetramers consisting of an 
extracellular α-subunit and a membrane spanning β-subunit (α2β2), joined by a disulphide 
bridge (Huang et al., 1994, Khayath et al., 2007). Autophosphorylation of several tyrosine 
residues in the β-subunit is stimulated after ligand binding to the receptor. One of these 
residues makes up a well-conserved NPXY-motif, to which bind intracellular adaptor 
proteins such as those possessing a Src-homology 2 (SH2) motif (Teleman, 2010). 
Studies on the differences between insulin and IGF stimulation indicate that when the 
two bind to the same receptor, more than one intracellular pathway may be activated at 
the same time. Hence, there may be significant differences in the biological effect of 
these two ligands (Pandini et al., 2003). Hormone-receptor binding triggers various 
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pathways (Figure 1.8), the two major ones being the mitogen-activated protein kinase 
(MAPK) and the phosphatidylinositol 3-kinase (PI3K) pathways (You et al., 2009).  
Class II RTKs, including IR and IGF-1R, are among the most ancient proteins and are 
conserved across a wide range of organisms, from sponges to mammals (Schäke et al., 
1994, Khayath et al., 2007). In S. mansoni, two insulin receptors have been identified, 
SmIR-1 and SmIR-2 (Khayath et al., 2007), each with distinct properties. Both receptors 
have been found present in all major stages of the parasite; miracidia, sporocysts, 
cercariae, somules and adult worms, and can be detected on western blots with 
molecular weights of 140 kDa (SmIR-1) and 115 kDa (SmIR-2). SmIR-2 is generally 
more abundant in S. mansoni than SmIR-1 and is expressed at the same level 
throughout parasite development whereas SmIR-1 shows a stronger presence in 
cercariae and somules when compared with other stages (Khayath et al., 2007). 
Differences have also been found in the location of the two receptors; immunolocalisation 
reveals that SmIR-1 is specifically located in the musculature, intestinal epithelium and 
basal membrane of adult worms and at low levels in the tegument of somules (Khayath 
et al., 2007). SmIR-2 is more greatly expressed in the parenchyma of adult worms and 
somules, but cannot be seen in the tegument. Although present in SmIR-2, all 
mammalian insulin signalling systems and model organisms C. elegans and D. 
melanogaster, the NPXY and SH2 motifs could not be identified in SmIR-1 (Khayath et 
al., 2007). 
1.5 Glucose Uptake in S. mansoni 
The link between insulin signalling and glucose uptake in mammals is well known and 
the role of Akt in each of these processes has been investigated in detail (reviewed by 
Schultze et al., 2012). In schistosomes, research has confirmed the presence of these 
processes (Clemens and Basch, 1989; Skelly et al., 1998; Khayath et al., 2007), yet the 
lack of knowledge surrounding Akt in these parasites means functional homology has 
not yet been ascertained. Since Schistosoma glucose transporter proteins were 
characterised over two decades ago (Skelly et al., 1994), glucose uptake in S. mansoni 
has been researched thoroughly by Skelly and colleagues (Zhong et al., 1995; Skelly 
and Shoemaker, 1996; Skelly and Shoemaker, 2001), leading to a comprehensive 
understanding on the location and expression of schistosome glucose transporters, 
SGTP1 and SGTP4. SGTP4 presents at the apical membrane surface, binding 
extracellular glucose (Skelly and Shoemaker, 1996) and importing it into the tegument, 
while SGTP1 is located uniquely in the basal membrane, transporting glucose into the 
underlying tissues (Zhong et al., 1995).  
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1.6 Study Context, Contribution to Knowledge and Research Aims 
Given that the current status of schistosomiasis as an NTD remains second only to 
malaria in terms of morbidity, research into novel anthelmintic drug targets and strategies 
is of crucial importance. Of particular interest are the stages paramount to human host 
invasion and residency: cercariae, somules and adult worms. As the parasite develops 
through these three life stages, many distinct changes take place both biochemically and 
morphologically. Namely the development of the adult tegument, from trilaminate in 
cercariae to fully formed adult double lipid bilayer, is of great significance as the 
interacting barrier between parasite and host.  
Although steady progress is being made concerning schistosome cell signalling, little is 
known on the molecular systems within the tegument. As a fundamental protein in the 
insulin signalling network, Akt is a prime candidate for furthering knowledge of cell 
signalling within S. mansoni, to discover its role not only in insulin signalling, but also 
putative related pathways. Previous work on the effect of host molecules on the parasite 
(Ressurreição et al., 2015), and the publication of schistosome genomes, has set the 
Figure 1.10 Schematic diagram of Insulin and IGF signalling in humans (Murillo-Cuesta 
et al., 2011).  
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framework for this and future projects to investigate the importance of protein kinases in 
the complex developmental and metabolic processes during the life cycle of S. mansoni. 
A greater understanding of the mechanisms that control parasite homeostasis is of vital 
importance in the search for novel drug targets.  
Consequently, the aims of this study were to: 
i. Identify/detect an evolutionarily conserved Akt protein in S. mansoni life stages, 
using commercially available anti-Akt antibodies; validate antibodies to determine 
the activation status of the parasite Akt.  
ii. Determine the effect of host factors and signalling blockade on activated Akt in 
three mammalian infective and resident life stages: cercaria, somule and adult 
worms. 
iii. Investigate the potential downstream importance of Akt signalling within S. 
mansoni by localising putative substrates within the parasite and performing 
bioinformatic analysis on putative substrates and interacting proteins. 
iv. Identify a functional role(s) for Akt in S. mansoni human resident life stages. 
v. Investigate a possible role for Akt in cercarial host detection/penetration.  
vi. Contribute to the overall knowledge of S. mansoni cell signalling mechanisms 
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2.1 Materials  
2.1.1 Antibodies  
The anti-AKT 1/2/3 (total) polyclonal antibody (#126811) was obtained from Abcam 
(Cambridge, UK), Alexa Fluor 488 goat anti-rabbit IgG (#A11008) from Life Technologies 
(Thermo Fisher Scientific, Loughborough, UK), and the anti-phospho GSK3α/β 
(Tyr279/Tyr216) polyclonal Clone SG-2F (#05413) was purchased from Millipore (Watford, 
UK). The horse radish peroxidase (HRP)-conjugated actin (1-19) pAb; sc1616 (#B1815) 
and anti-phospho Akt 1/2/3 (Tyr315/316/312) pAb (#29309) were bought from Santa Cruz 
Biotechnology (Heidelberg, Germany) and the anti-SGTP4 antibody was kindly provided 
by Patrick Skelly (Tufts University, USA). The remaining antibodies used throughout the 
project were all obtained from Cell Signalling Technology (New England Biolabs, Hitchin, 
UK); anti-mouse IgG HRP-linked antibody (#7076) anti-rabbit IgG HRP-linked antibody 
(#7074) anti-rabbit IgG conformation-specific mouse mAb (#3678) anti-phospho Akt 
(Thr308) Rabbit mAb (#2965) anti-phospho Akt Substrates (RXXS*/T*) rabbit mAb 
(#9614) anti-phospho Akt (Thr308) XP rabbit mAb (#13038) anti-phospho p70 S6 Kinase 
(Thr389) rabbit mAb (#9234) and anti-phospho GSK-3α/β (Ser21/9) rabbit mAb (#9327). 
2.1.2 Kits 
The Glucose Uptake-Glo™ assay was obtained from Promega (Southampton, UK), the 
Pierce Crosslink immunoprecipitation (IP) kit was bought from Thermo Fisher Scientific 
and the Akt Kinase Assay kit from Cell Signalling Technology. The lambda protein 
phosphatase components were purchased from New England Biolabs. The Proteome 
profiler array 96 (human phospho kinase array 1) was bought from R&D systems 
(Abingdon, UK). 
2.1.3 Stimulants and Inhibitors 
Akt Inhibitor X was obtained from Merck (Nottingham, UK). The LY294002 inhibitor was 
bought from Cell Signalling Technology. Fetal bovine serum (FBS) was obtained from 
Gibco (Thermo Fisher Scientific), insulin (human) recombinant expressed in yeast, and 
SC79 were bought from Tocris (Abingdon, UK), and L-arginine, human serum, linoleic 
acid and the GSK2334470 inhibitor were purchased from Sigma Aldrich (Dorset, UK). 
siRNAs, labelled Akt_3 and Akt_16, were obtained from Integrated DNA Technology 
(IDT) (London, UK).  
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2.1.4 Other Reagents 
Radioimmunoprecipitation (RIPA) Buffer (x10), cell lysis buffer (x10) and protein A 
agarose beads (50% slurry) were obtained from Cell Signalling Technology. Amersham 
ECL Prime western blot detection reagent and Amersham Protran 0.45μm nitrocellulose 
blotting membrane were sourced from GE Healthcare (Chalfont St. Giles, UK). Gibco 
(Thermo Fisher Scientific) was the source for media: MEM vitamins solution (100x), 
Basal Medium Eagles (BME), RPMI Medium 1640 and OPTI-MEM®. The DS scrambled 
negative control sequence and siRNAs were obtained from IDT. Bolt™ 4-12% Bis-Tris 
Plus 15-well and 10-well gels were from Invitrogen (Thermo Fisher Scientific). 10% 
normal goat serum was bought from Life Technologies (Thermo Fisher Scientific), Dried 
skimmed milk powder was Marvel, and 18 x 18mm or 20 x 20mm cover slips were 
purchased from Menzel-Gläser (Thermo Fisher Scientific). Bolt LDS sample buffer (4x), 
Bolt sample reducing agent (10x), See Blue Plus 2 pre-stained markers and Bolt MES 
SDS running buffer (20x) were from Invitrogen. Bradford reagent, antibiotic/antimycotics 
solution (100x) stabilized Hanks Balanced Salt Solution (HBSS), bovine serum albumin 
(BSA), lactalbumin hydrolysate solution (50x), rhodamine phalloidin and HistoChoice® 
clearing agent were purchased from Sigma Aldrich (Dorset, UK). GelCode Blue stain 
reagent, Super Signal molecular weight protein standards, Restore™ western blot 
stripping buffer, Halt™ protease and phosphatase inhibitor cocktail, SuperSignal West 
Pico chemiluminescent substrate, 20x TBS Tween-20 (TTBS) buffer, 10% formaldehyde 
solution methanol free, glass slides and Histoplast PE paraffin, Whatman grade GB004 
botting paper and phosphate buffered saline (PBS) tablets were obtained from Thermo 
Fisher Scientific. Vectashield mounting medium for fluorescence was bought from Vector 
Laboratories (Peterborough, UK), ethanol absolute from VWR (Lutterworth, UK), and 
Immersol from Zeiss (Cambridge, UK). 
2.2 Ethics Statement 
Laboratory animal use was within a designated facility regulated under the terms of the 
UK Animals (Scientific Procedures) Act 1986, complying with all requirements therein. 
The University of Nottingham Ethical Review Committee approved experiments involving 
mice and work was carried out under Home Office licence 40/3595. 
2.3 Snail Husbandry 
Infected intermediate host snails for S. mansoni, B. glabrata (M-line), were provided by 
the Biomedical Research Institute (USA) via the National Institute of Health – National 
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Institute of Allergy and Infectious Disease (HIH-NIAID) Schistosomiasis Resource 
Center under (NIH-NIAID) Contract No. HHSN272201000005I. Additional M-line snails 
(when required) infected with the same strain (PR-1) of S. mansoni were kindly provided 
by Nuha Mansour/Quintin Bickle from the London School of Hygiene and Tropical 
Medicine (LSHTM, UK).  
Snails were maintained in 1.5 l transparent plastic containers from ‘Really Useful Box’ 
until patency, approximately 35 days post-infection. Snails from the BRI were kept ~50 
per box with approximately 1 l of tap water filtered through a Brimark carbon filtration unit 
(Silverline UK; Devon, UK), and fed with dried round lettuce and fish food (Tetramin) 
twice a week. Snails from LSHTM were kept in approximately 1 litre of distilled water with 
1 ml added salts (100 g calcium carbonate, 10 g magnesium carbonate, 10 g sodium 
chloride, 2 g potassium chloride dissolved in 3 litres of distilled water)5 and fed also with 
dried round lettuce and fish food twice a week. 
All snail boxes were thoroughly cleaned once a week although the water was changed 
twice weekly. Discarded water was carefully decanted into buckets containing 2 % Virkon 
(Thermo Fisher Scientific) and left for a minimum of 5 days before disposal. Dead snail 
shells were removed from the boxes daily to prevent any potential bacterial infection 
spreading to the remaining population. Under normal conditions, the boxes containing 
infected snails were kept in an LMS incubator at 26°C under constant light. During 
patency, snails were kept in the dark by placing the boxes into larger, black, plastic boxes 
as from the Really Useful Box Company.  
2.4 Adult Schistosomes 
Adult worms were supplied by Bioglab (c/o Professor Mike Doenhoff, University of 
Nottingham, UK). Upon receipt, worms were transferred to a Petri dish and equilibrated 
in RPMI medium containing antibiotics/antimycotics (x4) for 1 - 2 h at 37°C/5% CO2 prior 
to use. 
2.5 Isolation of Cercariae and Mechanical Transformation into Somules 
Patent snails were transferred from their boxes into a 100 ml glass beaker containing 50 
ml of filtered water and were left under direct light from a fluorescent table lamp for 
between 60 - 120 min. After this time, snails were returned to fresh boxes, fed and placed 
back in the dark for the next shed (a minimum of three days later). By keeping the beaker 
                                                          
5 Salt recipe kindly provided by Nuha Mansour at LSHTM 
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under light, cercariae emerged and swam to the top of the beaker and were therefore 
easier to transfer by sterile pipette into three 15 ml screw cap Falcon tubes (Thermo 
Fisher Scientific). The tubes containing the cercariae were incubated on ice for no more 
than 30 min while two 20 ml volumes of BME with antibiotic/antimycotic were placed at 
37°C. The tubes were then centrifuged (Eppendorf - 5702) for 10 min at 0.5 x g (rcf), and 
the supernatant removed down to 3 ml. 3 ml of warmed BME was then added to provide 
a total of 6 ml. Following this, the tubes were vortexed (Vortex Genie 2) for approximately 
10 min to mechanically transform the cercariae, then 1 ml of HBSS was added. Tubes 
were returned to ice for a further 7 min then centrifuged again, this time for 2 min at 0.5 
x g to separate the cercarial heads from the tails. The supernatant was removed down 
to 3 ml. Somules were re-suspended by briefly vortexing the tubes and the contents were 
poured into a high-sided Petri dish. Under a microscope, the dish was gently swirled to 
form a clump of somules in the centre. These were transferred to a new 15 ml tube. This 
process was repeated until as many somules as possible had been collected, then the 
volume was made up to the next nearest ml with BME. To count the somules, the tube 
was vortexed and taking from the middle of the tube, three aliquots of 1 µl each were 
transferred into a small glass dish, making sure to vortex between each sample. The 
somules contained in each aliquot were enumerated and the mean calculated. (total no. 
somules = (mean somule count x 1000) x total volume (ml) collected).  
The transformed somules were then placed in an incubator at 37°C, 5%CO2 for 18 - 24 
h before use in experiments. 
2.6 Exposure of Parasites to Host Molecules or Kinase Inhibitors 
Stimulation and inhibition experiments were performed on cercariae, somules and adult 
worms. The treatments included human serum, insulin, L-arginine, linoleic acid (LA) and 
SC79 as potential stimulants, and Akt Inhibitor X, Herbimycin A, GSK2334470 and 
LY294002 as inhibitors.  
Samples of freshly shed cercariae were collected using a 1 ml pipette and transferred 
into wells of a 48 well tissue culture plate. During collection, the beaker was kept under 
light to promote concentration of cercariae at the water surface, allowing for easier and 
more consistent collection to try to achieve similar numbers of cercariae per well. 
Cercariae were then exposed to either 100 μM L-arginine (0-45 min) or 10 μM Akt 
Inhibitor X (0-60 min) by adding each compound directly to each well for the desired time. 
To expose cercariae to LA, a 48 well plate was pre-coated with this fatty acid; 500 μl of 
26.6 μg/ml LA in methanol was placed in each well and allowed to evaporate over 72 h 
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at 4 °C. 1 ml cercariae suspension was then added for increasing durations (0-45 min). 
Cercariae treatments were performed at room temperature to mimic natural conditions. 
At the appropriate duration, cercariae were transferred to pre-chilled 1.5 ml microfuge 
tubes and placed on ice for 5 min. Samples were then processed for western blotting, 
immunohistochemistry or immunoprecipitation.  
Approximately 1000 somules cultured overnight for ~18 h in 1 ml BME per well in a 48 
well tissue culture plate (Nunc) were exposed to 10 % human serum (0 - 30 min), 1 μM 
bovine/human insulin (0 - 30 min), 100 μM L-arginine (0 – 30 min), 26.6 μg/ml LA (0 – 
45 min), 1 - 100 μM Akt Inhibitor X (0 - 60 min), 12 μM herbimycin (60 - 120 min), 1 – 50 
μM LY294003 (1 h) or 1 – 50 μM GSK2334470 (2 h). Treatments were halted by 
transferring the somules into pre-chilled microfuge tubes and placing on ice for 5 min. 
An additional wash in 1 ml ice-cold PBS was performed when somules treated with 
serum. During exposures, somules were incubated at 37°C/5 % CO2. Samples were then 
processed for western blotting, immunohistochemistry or immunoprecipitation. 
Adult worms were exposed to compounds either as individual sexes or in pairs, which 
was determined by the experiment. After receipt, adult worms were placed in a Petri dish 
at 37°C for 1 h to equilibrate. Worms were then gently transferred to microfuge tubes 
using flat-ended tweezers and exposed to 1 μM insulin (10 - 30 min), 1 μM L-arginine 
(30 - 45 min), 1 – 100 μM Akt Inhibitor X (60 min) or 12 μM Herbimycin (60 - 120 min). 
To end treatment, tubes were placed directly in ice for 5 min. Samples were then 
processed for western blotting, immunohistochemistry or immunoprecipitation. 
2.6.1 Sample preparation for western blotting 
After 5 min incubation on ice, the somules or cercariae were centrifuged at full speed 
(12,045 x g; Eppendorf minispin) for 45 s and the supernatant removed, leaving ~20μl 
with the pellet. Parasites were then solubilised in 1 x LDS-PAGE sample buffer, and 1 x 
sample reducing agent was added. Samples were then heated to 95°C for 5 min on a 
thermomixer compact (Eppendorf) and sonicated (Fisherbrand) for ~1 min. At this stage, 
samples were either loaded directly onto a gel for electrophoresis, or frozen at -20°C with 
the addition of 1 x protease and phosphatase inhibitors. 
After 5 min incubation on ice, worms were transferred to new pre-chilled tubes containing 
RIPA buffer (20 μl/worm pair) and homogenised on ice using a motorised pestle (VWR). 
Worms were then centrifuged at full speed for 45 s and the supernatants collected in 
new microfuge tubes. 1 x LDS PAGE sample buffer and 1 x sample reducing agent were 
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next added. Samples were then heated to 95°C for 5 min and sonicated for ~1 min. At 
this stage, samples were either loaded directly onto a gel for western blotting, or frozen 
at -80°C with the addition of 1 x protease and phosphatase inhibitors. 
In some cases, protein estimations (on samples in RIPA buffer) were performed on the 
extracted proteins using the Bradford microassay and using the manufacturer’s 
instructions with BSA (0 – 1.5 mg/ml) as the protein standard. 
2.6.2 Sample preparation for immunohistochemistry 
After treatment and incubation on ice for 5 min in microfuge tubes, the water, BME or 
RPMI medium was removed from cercariae, somules or adult worms respectively, 
leaving ~100 μl, and replaced with 300 μl 4% paraformaldehyde (approximately 75%). 
Parasite were incubated at 4°C for 1 – 2 h then the paraformaldehyde was washed out 
and parasites stored in PBS. 
2.6.3 Sample preparation for immunoprecipitation with kinase assay 
Somules (24 h, ~10,000 per sample) were placed in a microfuge tube in 200 μl BME. 
Somules were treated with 10% human serum for 10 min then placed on ice for 5 min. 
Somules were washed twice with 500 μl ice-cold PBS and twice with 500 μl cell lysis 
buffer, centrifuging at full speed (12,045 x g; Eppendorf minispin) for 30 s between each 
wash. After the final spin, the supernatant was collected in a new microfuge tube and 
protease and phosphatase inhibitors added (1:100). Samples were stored at -80°C.  
Adult worm pairs (~20) were placed in a microfuge tube containing 500 μl RPMI medium. 
Worms were treated with 10% human serum for 10 min then placed on ice for 5 min. 
Worms were washed twice in ice-cold PBS, then suspended in 500 μl cell lysis buffer 
and homogenised on ice using a motorised pestle. Parasites were centrifuged at full 
speed for 3 min in a pre-chilled rotor (Eppendorf minispin) and the supernatant collected 
in a new tube. The pellet was re-suspended in 200 μl cell lysis buffer and the 
homogenising and centrifuging repeated, adding the supernatant to the previously 
collected sample. Protease and phosphatase inhibitors were added (1:100) and the 
samples were stored at -80°C.  
2.6.4 Sample preparation for cross-linked immunoprecipitation 
Typically, two microfuge tubes were prepared per assay, each containing ~10,000 18 h 
somules in 200 μl BME; somules were then treated with 1 μM insulin for 10 min before 
placing on ice for 5 min. Samples were then centrifuged at 1000 rpm (Eppendorf 
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minispin) for 5 min, supernatants discarded, and washed once in 1 ml PBS re-
centrifuged. 500 μl ice-cold IP lysis/wash buffer containing 1:100 protease and 
phosphatase inhibitors was added to each pellet and somules resuspended. After 5 min 
incubation on ice, samples were centrifuged at full speed for 10 min and supernatants 
collected. Protease and phosphatase inhibitors were re-added and samples stored at -
80 °C. 
2.7 Tegument Stripping 
Adult worm pairs (10 – 20) were placed in a microfuge tube with 500 μl RPMI medium. 
Human insulin (1 μM) was added (or not, control) and worms were incubated for 10 min 
before being transferred into tubes containing 100 μl ice-cold PBS and placed on ice for 
5 min. Ensuring the lids were firmly closed, the tubes were immersed in liquid nitrogen 
for 15 min. After removing from the liquid nitrogen, parasites were thawed initially at room 
temperature until almost defrosted (approximately 8 min) then put on ice until fully 
thawed. Worms were washed in ice cold PBS (1 ml) and incubated on ice for a further 5 
min. The tubes were then vortexed (20 x 1 s pulses). Once worms had settled to the 
bottom of the tubes, the supernatant was collected and kept on ice. The supernatants 
were then centrifuged at 16,000 x g for 30 min at 4°C (Hettich Zentrifugen EBA12R). The 
supernatant was removed but retained, and the pellet resuspended in RIPA buffer (40 μl 
per 10 worms). An aliquot of the pellet was taken for protein estimation and the remaining 
sample was prepared for western blotting. A portion of the supernatant (i.e. non-
particulate fraction) was also prepared for western blotting. 
2.8 Proteome Profiler Assay 
After parasites were subjected to the desired treatment(s) (without further processing) in 
microfuge tubes, they were washed in 1 ml PBS, leaving as little PBS as possible in each 
tube. The buffers detailed below are as specified in the kit. Parasites were suspended in 
lysis buffer 6 (10 µl/per worm pair or 1000 somules). Adult worms were homogenised on 
ice using the motorised pestle, centrifuged at full speed (12,045 x g; Eppendorf minispin) 
for 2 min, then the supernatant was transferred to a clean microfuge tube on ice. For 
somules, ~2000 were treated (or not, control) then placed on ice for 5 min. Samples were 
then centrifuged at full speed for 30 s and the supernatants discarded. The pellet was 
washed in 1 ml ice-cold PBS and re-centrifuged. The pellet was then re-suspended in 40 
μl lysis buffer 6, protease and phosphatase inhibitors were added (1:100), and the 
samples sonicated for ~20 s. A small portion (5 μl) of each sample was taken for a protein 
estimation. 5 - 50 µg of total protein, as determined by protein estimation, was diluted in 
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Array Buffer 1. The lysate could not exceed 20% of the final reaction volume. Once 
diluted, 50 - 100 µl lysate was added to each well of the 96 well assay plate. The plate 
was covered with parafilm and incubated overnight (~ 18h) at 4°C on a horizontal orbital 
microplate shaker (Eppendorf, Stevenage, UK) set at approximately 500 rpm. After 
incubation, as much lysate as possible was removed and each well was washed four 
times with 400 µl wash buffer. After the final wash, the plate was inverted on tissue to 
wick the remaining buffer. Reconstitution of the detection antibody cocktail was done in 
100 µl distilled water. Per pair of wells, 1.67 µl of this cocktail was made up to 100 µl in 
Array Buffer 2. 50 µl of diluted detection antibody cocktail was then added to each well, 
the parafilm was replaced and the plate incubated for 1 h at room temperature on the 
microplate shaker. The washing procedure was repeated. Streptavadin-HRP was next 
diluted according to instructions, 50 µl was added to each well and samples incubated 
for 30 min at room temperature on the microplate shaker. Washing was repeated a final 
time, 50 µl of mixed Substrate Solution was added to each well and incubated for at least 
30 s prior to imaging. A Syngene Gbox imaging system (Syngene, UK) and associated 
software were used to image the plate. The iris and focus settings were tested before 
imaging using the template on the mousemat provided.  
2.9 Western Blotting 
Samples from storage at -20°C were placed on a hot block at 95°C for 5 min, allowed to 
cool to room temperature and centrifuged on a short pulse (10 s) to remove any liquid in 
the lids of the microfuge tubes. Meanwhile, running buffer (1x Bolt running buffer, diluted 
in distilled water) was poured into the electrophoresis cell and the Bolt Bis-Tris SDS-
PAGE gel (10 or 15 well; 10% or 4 – 12% gradient gel) inserted and clamped. Using a 
graduated Hamilton syringe, wells were carefully loaded with pre-stained molecular 
weight marker and the samples. Gels were run at 165v and 280mA using a Hoefer 
powerpack until the marker reached the bottom of the gel.  
Blotting paper and Protran nitrocellulose membrane were next prepared. Wearing 
gloves, 4 pieces of blotting paper per gel and one piece of membrane were cut into 7.5 
x 9 cm rectangles. These were placed in blotting buffer (3 g tris, 15 g glycine and 200 ml 
MeOH, made up to 1 l with distilled water). Gels were carefully removed from their 
cassettes, and placed in the blotting buffer to equilibrate for 5 min. The semi-dry transfer 
apparatus was then set up: blotting paper (x2), nitrocellulose membrane, gel, and two 
further pieces of blotting paper. A roller was used to lightly roll over the stack, removing 
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any residual bubbles. Excess buffer was mopped up from around the stack and a semi-
dry electrotransfer performed for 90 min at 15 v and 280 mA.  
After transfer, the gel and membrane were removed together from the stack and excess 
membrane cut away around the gel. The gel was removed and discarded, and the 
membrane washed once in distilled water before being incubated in Ponceau S stain for 
1 min to check for homogeneous transfer. The membrane was washed with distilled 
water three times to remove excess Ponceau S, until clear bands were visible. Any 
membrane trimming/cutting was done at this stage while lanes were visible, using a 
scalpel. Membranes were then washed three times for 5 min each in 1 x TTBS in a plastic 
tub. Membranes were then blocked for a minimum of 1 h in ~5 ml 1 % BSA blocking 
buffer at room temperature with gentle agitation. A 1:1000 dilution (5 μl) of appropriate 
primary antibody was added directly into the blocking solution and left to rock at 4°C 
overnight followed by a further 1 h at room temperature. The washing procedure was 
repeated (3 x 5 min with TTBS) then the membrane was transferred to a solution (1:3000 
dilution) of appropriate secondary antibody in TTBS, and incubated for 120 min at room 
temperature with gentle agitation. Washing was repeated then the membrane was rinsed 
briefly in distilled water ready to be visualised. 
Equal amounts of the Supersignal West Pico chemiluminescent substrate components 
were mixed; to cover a membrane, approximately a 1 ml was required. One membrane 
at a time was laid on the imaging tray of the CCD GeneGnome chemiluminescence 
imaging system (Syngene, Cambridge, UK) and the substrate was added, ensuring total 
coverage and no air bubbles. Membranes were imaged and typically 10 images were 
captured with 30 s between exposures. Images were saved as Syngene files and also 
as .tiff files to allow import into Microsoft Office. When imaging for actin, five images were 
typically captured as the signal was strong. Bands were quantified for analysis using 
associated GeneTools software with appropriate background correction. 
2.10 Lambda Phosphatase Treatment 
Post electrophoretic transfer, membranes were washed briefly twice in distilled water 
then blocked for 1 h in 5 ml TTBS with 1 % BSA at room temperature. After blocking, 2 
mM MnCl2 and, where de-phosphorylation was required, 400 U/ml λ-phosphatase was 
added and incubated overnight at 4°C with constant agitation. The membranes were 
then washed in TTBS for 5 min and rinsed in distilled water 5 times before continuing 
with the western blot protocol.  
 Chapter 2 – Materials and Methods       36 
 
2.11 Immunoprecipitation (IP) – Kinase Assay 
Samples were retrieved from -80°C storage, defrosted and kept on ice. Tubes were 
centrifuged in a pre-chilled rotor for 3 min at full speed (12,045 x g; Eppendorf minispin). 
The volume of each sample was determined before splitting the sample equally between 
two 2ml screw-cap tubes. 10% of each sample was removed and retained as the 10% 
of I.P. input (control). A 1:50 dilution of anti-phospho Akt (XP) antibodies was added to 
one tube with the second acting as the no antibody control. All samples were then placed 
on the rocker at 4°C for overnight incubation.  
The contents of each screw-cap tube were transferred into microfuge tubes and placed 
on ice (samples were transferred at this stage before the addition of agarose beads). 
Protein A agarose beads were mixed and a volume (10 % of the total sample volume) 
added to both the negative control and the I.P. tube. All samples were incubated at 4°C 
for 1 h. Samples were pulse centrifuged in a pre-chilled rotor at full speed for 30 s and 
the supernatant removed and discarded, being careful not to disturb the pellet. The pellet 
was washed twice in 500 µl of ice-cold cell lysis buffer and then a further two times in 
500 µl ice-cold kinase buffer. Tubes were kept on ice at all times. Each pellet was re-
suspended in 50 µl of kinase buffer, then 1 µl of 10 mM ATP and 1 µg of kinase substrate 
(GSK-3 α/β fusion protein) was added. In the 10% input tube, double the quantity of 
assay components were added. All three sample tubes were placed in a Eppendorf 
thermomixer at 30°C at 700 rpm for 1 h. After this time, 12.5 µl of 5x sample buffer was 
added to the negative control and IP tubes and 20 µl to the 10% input tube. Tubes were 
vortexed for 10 s each, pulse centrifuged at full speed for 30 s then heated at 95°C for 5 
min. The samples were then subjected to western blotting (section 2.4) with the following 
modifications: 
• After transfer, membranes were blocked in 5% non-fat dried milk in TTBS then 
washed and placed in a 5% BSA solution containing the primary anti-phospho 
GSK-3α/β (Ser21/9) antibody at 1:1000 dilution.  
• The secondary antibody was diluted in 5% non-fat dried milk instead of TTBS 
and incubated with the membrane for 1 h.  
• To visualise bands, 0.5 ml of each LumiGLO substrate component was mixed 
into 9 ml of distilled water and incubated with the membrane for 1 min at room 
temperature with gentle agitation before exposing as normal on the GeneGnome 
imaging system.  
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2.12 Crosslink Immunoprecipitation 
The crosslinked IP was performed using the Pierce Crosslink Immunoprecipitation Kit 
following the manufacturers recommendations.  
To bind the anti-phospho Akt (Thr308) antibodies to the agarose beads, 20 μl of evenly 
suspended Pierce Protein A/G Plus Agarose was added to a Pierce Spin Column. The 
column was centrifuged at 1000 rpm (Eppendorf minispin) for 1 min and the flow-through 
discarded. The resin was washed twice with 200 μl 1x coupling buffer, re-centrifuged and 
the flow-through discarded. After removing any excess liquid from the bottom of the 
column, the plug was inserted. To each tube of washed resin, 10 μl of antibody, 5 μl of 
20x coupling buffer and 85 μl of distilled water was added. These columns were 
incubated for 60 min at room temperature on a rocker to ensure continued suspension. 
The plugs were removed and the columns centrifuged at 1000 rpm for 1 min. The resin 
was washed once with 100 μl 1x coupling buffer, then twice with 300 μl 1x coupling buffer 
before re-inserting the plugs. To each tube, 2.5 μl 20x coupling buffer, 9 μl 2.5 mM 
disuccinimidyl suberate (DSS) and 38.5 μl distilled water was added. This solution was 
incubated for 60 min at room temperature on a rocker. The plug was then removed and 
the column centrifuged; 50 μl elution buffer was added to the resin and re-centrifuged. 
Two washes were completed with 100 μl elution buffer and two with 200 μl IP lysis/wash 
buffer, centrifuging at 1000 rpm for 1 min after each wash.  
The sample lysate was pre-cleared using control agarose beads. 80 μl control agarose 
resin slurry was transferred to a spin column and centrifuged, then washed with 100 μl 
1x coupling buffer, centrifuged and the flow-through discarded. The previously prepared 
500 μl lysate was added to the column and incubated on a rocker for 60 min at 4 °C. The 
column was then centrifuged and the flow-through collected to be added to the cross-
linked antibody.  
Pre-cleared lysate (300–600 μl) was added to the column containing the antibody-
crosslinked resin. The column was incubated overnight at 4°C on a rocker. The plug and 
cap were removed and the column centrifuged at 1000 rpm for 1 min. The spin column 
was placed in a fresh collection tube and the resin washed three times with 200 μl IP 
lysis/wash buffer, and once with 100 μl 1x conditioning buffer, centrifuging after each 
wash. The column was then placed in a fresh collection tube and centrifuged with 10 μl 
elution buffer. A further 50 μl elution buffer was added and incubated for 5 min at room 
temperature. The column was then centrifuged a final time at 1000 rpm for 1 min and the 
flow-through collected for analysis by western blot analysis (section 2.9).  
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2.13 Fractioning samples 
Each 24 h somule sample (~20,000; treated/untreated) was lysed in 250 μl cell lysis 
buffer (Cell Signalling Technology) with protease and phosphatase inhibitors in a 
microfuge tube. Samples were left on ice for 5 min before centrifuging at full speed 
(12,045 x g; Eppendorf minipsin) for 1 min and the supernatants collected. This lysis step 
was repeated with each pellet to extract as much protein as possible and supernatants 
combined for each sample. 500 μl was then transferred to a Vivaspin 500 column and 
each column was centrifuged at 15,000 rpm, 15°C for 10 min in a Hettich Zentrifugen 
(EBA12R). The flow-through was retained and the upper fraction transferred from the 
column to another microfuge tube, making up the upper fraction a similar volume to the 
lower fraction with cell lysis buffer. Each sample was then divided into two, antibody 
added to one, with the other as a control. Samples were placed at 4°C overnight with 
constant agitation. From this point, the protocol for IP (section 2.11) was followed. 
2.14 RNAi  
2.14.1 Designing small interfering RNA 
Small interfering RNAs (siRNAs) were designed using the IDT online design tool 
(https://www.idtdna.com/site/order/designtool/index/DSIRNA_CUSTOM). Initially, the 
Akt FASTA sequence was input and a basic local alignment search tool (blast) was used 
against human. Two of the resulting siRNAs were chosen based on their position in the 
gene; each within a single exon rather than spanning two. The two resulting target 
sequences were: SmAkt siRNA1 5’-ATTGTTGGATAAAGATGGTCATATA-3’ which 
spans bp 1119 – 1143 of the SmAkt coding region, and SmAkt siRNA2 5’-
AAGTGATCATGAAGTCTTATTTGAG-3’ which spans bp 1332 – 1356. The design tool 
was used specifically to create a 25-mer siRNA product that spanned close to the Thr308 
phosphorylation motif (bp 1188 – 1218). The siRNA target sequences were blasted 
against the S. mansoni genome and no matches were found other than those for Akt. A 
control siRNA was also obtained which shares no similarity with any part of the S. 
mansoni genome, DS Scrambled Negative Control, with the sequence siRNA 5’-
CTTCCTCTCTTTCTCTCCCTTGTGA-3’.Of the six available designs, two were chosen.  
2.14.2 Performing RNAi 
Adult worms were carefully transferred directly into an electroporation cuvette containing 
100 μl Optim-MEM using flat-ended tweezers. 2.5 μg of each siRNA was added to each 
cuvette. 2.5 μg of scrambled control was added to the negative control samples. 
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Parasites were electroporated at 120V for 20 ms before being transferred into individual 
wells of a clean 48 well plate. To avoid risk of contamination, separate plates were used 
for samples that were to be processed on different days. Wells were made up to 1 ml 
containing approx. 930 μl Opti-MEM, 20 μl antibiotic/antimycotic and 50 μl FBS. 
Parasites were maintained at 37°C, 5% CO2 for 3 - 7 days. Knockdown was then 
measured by western blot.  
2.15 Immunohistochemistry 
Parasites were transferred to wells of a 24 well tissue culture plate, PBS was removed 
and parasites incubated in 1% glycine solution for 10 min. Next, the glycine solution was 
replaced with 0.3% Triton X-100 in PBS and incubated for 1 h. Parasites were then 
washed in PBS three times each for 10 min, each time removing as much PBS as 
possible. The parasites were next blocked in 10% normal goat serum for 2 h, (300 µl per 
well). The washing procedure was repeated and the parasites incubated with the primary 
antibody (1:50 dilution in 1% BSA) with constant agitation for 3 days at 4°C. The parasites 
were then washed in PBS three times for 30 min each. Following the final wash, parasites 
were re-suspended in 1 ml PBS, Alexafluor 488 secondary antibody (1:500 in PBS) and 
rhodamine phalloidin (5 μM/ml) was added and parasites left to incubate for 2 days in 
the dark at 4°C. Following this, parasites were washed three times for 30 min each. After 
the last wash, as much PBS as possible was removed and the remaining PBS was 
carefully pipetted with the parasites (cercariae or somules) onto a silane prepared slide. 
For cercariae and somules, slides were checked under the microscope to ensure a 
sufficient and even distribution of parasites, before placing them on a hot plate at 60°C 
for approximately 30 min or until the liquid had evaporated. For adult worms, 100 μl PBS 
was pipetted directly onto an untreated glass slide, then worms were carefully placed in 
the droplet using flat-ended tweezers. Once dry, 1-2 drops of Vectashield mounting 
medium was placed over the adherent parasites and a coverslip gently placed on top, 
ensuring no air bubbles. The cover slip was sealed around the edges with transparent 
nail polish and left flat in the fridge overnight to dry in a slide magazine.  
Specimens were visualised on a Leica TCS SP2 AOBS confocal laser scanning 
microscope using 20x dry, 40x or 63x oil immersion objectives and images captured. 
Laser levels were maintained within experiments between negative control and stained 
samples.  
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2.16 Bioinformatics  
2.16.1 Gene alignment 
Akt gene sequences from H. sapiens, D. melanogaster, C. elegans and S. mansoni were 
aligned using Multiple Sequence Comparison by Log-Expectation (MUSCLE) software, 
available at: http://www.ebi.ac.uk/Tools/msa/muscle/. The sequences were entered in 
FASTA format, retrieved from NCBI or GeneDB for the S. mansoni gene. Output format 
ClustalW was selected and the results were copied into Microsoft Powerpoint, where 
colours were added to indicate the level of homology between the four species; white to 
black for increasing homology. 
2.16.2 STRINGdb  
The identifier for Akt (Smp_073930.2) was entered into STRINGdb (http://string-db.org/) 
(December, 2015). The parameters at the bottom of the page were altered to give either 
medium confidence (≥0.40) or high confidence (≥0.70), and to produce a maximum of 
500 results; the option, ‘Disable Structure Previews inside Network Bubbles’ was 
selected. An image of the medium confidence map was saved (Save > Image (Low Res)) 
but the nodes on the high confidence map were moved so that all Smp numbers were 
visible.  
2.16.3 Blast2GO 
Blast2GO Pro was downloaded as a local trial copy. The Smp identifier data obtained 
through STRING was downloaded as a Fasta file, then imported to Blast2GO. A 
Cloudblast (blastp) was conducted to identify potentially homologous sequences from 
public protein databases. The settings for blast were: Number of blast hits – 20, Blast 
expectation value – 1.0E-3, HSP length cut off – 33. Next, the mapping function was 
employed to match the sequence IDs obtained in the blast step against the Gene 
Ontology (GO) annotation database. The data was then annotated, evaluating the 
information from the previous two steps and assigning the most reliable GO terms to 
each sequence. The parameters for running the annotation were: Annotation cut off – 
55, GO weight – 5, Filter by GO taxonomy – Nematodes, Hit filter – 500.   
To begin analysing the data, charts were created (Charts > Make Statistics > 
Annotation). All options in the ‘Annotation Statistics’ window were selected, GO 
distribution by level was set to three and maximum number of terms to display in Direct 
 Chapter 2 – Materials and Methods       41 
 
GO Count for Biological processes, Molecular function and Cellular component was set 
to 20.  
To create pie charts of the GO data, a combined graph was made (Graphs > Make 
Combined Graph > Run). All GO categories were automatically included. In the charts 
section of the side toolbar for each graph, ‘Make level pie chart’ was selected and level 
3 chosen. Pie charts for Biological process, Molecular function and Cellular component 
at level 3 were made in this way.  
2.16.4 Kinasephos phosphorylation site prediction 
To identify potential phosphorylation sites within Akt interacting proteins, the entire list of 
high confidence STRING predicted functional Akt partners was transferred into Microsoft 
Excel. Using the interactive list at STRINGdb, the amino acid sequence for each protein 
(FASTA format), was submitted to kinasephos (http://kinasephos.mbc.nctu.edu.tw/). 
Using the drop down menu, protein kinase B was selected, the prediction specificity was 
set to 95%, and the box for tyrosine residue prediction was unselected. If results were 
retrieved, details from the first four columns (Locations, Phosphorylated Sites, HMM Bit 
Score and E-value) were pasted the into the Excel spreadsheet. This process was 
repeated individually for each of the proteins. 
(http://metazoa.ensembl.org/biomart/martview) 
2.17 Histology 
Adult worms were placed in plastic histology cassettes, fixed in approximately 50 ml 10% 
neutral buffered formalin for 2 h in 120 ml plastic tubs (Sigma), then stored in 70% 
industrial methylated spirits (IMS) in clean tubs. The processing was done manually due 
to the small size of the parasites. Watch-glasses with lids were used to hold the parasites 
for dehydration. Worms were transferred from the IMS storage containers into the watch-
glasses using flat-ended forceps. Two washes of 90% ethanol, each for 1 h were 
performed, during which time 3 drops of eosin was used to pre-stain the worms. Two 
further washes in 100% ethanol were carried out before two washes in HistoChoice 
clearing agent. Meanwhile, Histoplast PE paraffin wax was melted at 57°C in 300 ml 
glass containers, one for each sample. Worms were transferred into histology cassettes, 
one for each sample, and submerged in the wax for 1 h, twice. One at a time, worms 
were encased in wax blocks using a HistoStar wax block maker. Blocks were left to cool 
for 1 h on the cold plate, removed from the moulds, and then stored in the fridge 
overnight.  
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A microtome (Leica, RM2235) was used to slice the worms into 5 μm sections, which 
were then expanded using a water bath at 45°C and mounted on polysine slides. The 
slides were left upright in a slide holder for approximately 10 min to remove excess water 
then placed on a slide drying bench for up to 4 h at 40°C. Slides were placed horizontally 
in an oven set at 40°C overnight to dry completely before staining.  
Slides were placed in a slide holder and immersed in two baths of Histochoice for 5 min 
each to de-wax the slides. Slides were hydrated through 90% IMS, 70% IMS and distilled 
water, each for 2 min. Haematoxylin stain was used for 15 min then slides were rinsed 
in distilled water and immersed in alkaline tap water for 2 min to ‘blue’ the slides. Slides 
were placed in 70% IMS for 2 min, dropped in eosin and immediately transferred to 90% 
IMS. Longer incubation in eosin was not required due to the pre-staining during tissue 
processing. Slides were moved to 100% ethanol for 5 min then Histochoice for a final 
clearing before being mounted using DPX and 20 x 60mm cover slips. Finished slides 
were dried overnight in the oven at 40°C then stored in a slide magazine at room 
temperature. 
2.18 Measurement and Analysis of Tegument Tubercles 
2.18.1 Tubercle analysis of Akt Inhibitor X treated worms 
Adult male worms were placed (five/well) in a 48 well tissue culture plate, containing 1 
ml RPMI medium. Worms were treated with 0.1, 1 or 10 μM Akt Inhibitor X or not (control) 
and incubated for five days at 37°C/5% CO2. Images were captured daily of worm 
tubercles using a LEICA microscope/tablet image capture system using a x 10 objective 
lens. As much as possible images were captured of the dorsal surface to maintain 
consistency between worms. To analyse, images were imported into Image J, the area 
of tubercles (n > 40) was determined using the measurement function and means 
calculated.  
2.18.2 Tubercle analysis of histology worms 
After histological preparation, slides were viewed using a Nikon microscope (Eclipse Ni) 
imaging system. Images were captured at x 40 magnification of tubercles on the dorsal 
surface of worms. Using the Nikon software, the diameter of ~50 tubercles per treatment 
was measured and the means calculated.  
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2.19 SGTP4 Expression at the Somule Tegument During Transformation 
To determine the effect of Akt inhibition on the expression of SGTP4 in somules during 
transformation from cercariae, pre-incubation was required with Akt Inhibitor X at the 
cercarial stage. Snails were shed and approximately 1 ml of cercariae suspension (in 
water) was collected using a Pasteur pipette and transferred to a microfuge tube. Control 
and inhibitor-treated parasites were investigated for each time point studied. 10 μM of 
Akt Inhibitor X (or not, control) was incubated with cercariae for 1 h at room temperature. 
Following this, tubes were vortexed for 2 min on a platform attachment (Vortex Genie 2) 
to induce transformation of the cercariae into somules, then parasites were cooled on 
ice for 5 min. The parasites were then centrifuged at full speed (12,045 x g; Eppendorf 
minispin) for 45 s and the supernatant removed to leave approximately 20 μl parasite 
suspension; 1 ml of RPMI medium containing 10 μM of Akt inhibitor X (or not, control) 
were added and parasites incubated at 37 °C in 5% CO2 for 30, 60 or 120 min. At each 
time point, parasites were processed for western blotting or 
immunohistochemistry/confocal laser scanning microscopy with anti-Akt or anti-SGTP4 
antibodies as detailed in sections 2.5.1 and 2.5.2. 
For microscopy, at each time point, a single confocal Z-scan through the centre of a 
parasite was captured (30 somules, 15 each treated and non-treated). Post capture, 
images were analysed using Leica confocal quantification software. Two digital lines 
were drawn across each somule, one anterior and one posterior approximately ¼ and ¾ 
through the parasite, respectively. Effort was made to keep the lines perpendicular 
through the somules and to extend past the somule by equal distance at each end. 
Graphs were generated by the software displaying the signal intensity along the lines. 
The peak fluorescence intensity at the two intersections of the lines with the tegument 
were recorded. Settings were altered to show only the green channel of each line on the 
graphs, and an example image from each time point was captured. 
2.20 Glucose Uptake Assay – Promega Glucose uptake Glo Assay 
All kit components were thawed at room temperature. Once thawed, the luciferase 
reagent, stop buffer and neutralization buffer were kept at room temperature, while all 
other reagents were placed on ice. Prior to use, thawed components were mixed to 
ensure homogenous solutions. The 2DG6P detection reagent (Table 2.1) was prepared 
1 h before use to minimize assay background. The 2DG6P detection reagent had to be 
made fresh and used on the day of preparation. 
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Component   Per Reaction   Per 10 ml  
Luciferase Reagent   100 μl   10 ml  
NADP+   1 μl   100 μl  
G6PDH   2.5 μl   250 μl  
Reductase   0.5 μl   50 μl  
Reductase Substrate   0.0625 μl   6.25 μl  
 
 
Somules were treated (or not, control) with Akt Inhibitor X as detailed in Section 2.6; a 
blank well was set up with only 1 ml RPMI medium to act as a background control. For 
the assay, somules were then washed twice in pre-warmed PBS (37°C) then 
resuspended in 50 μl PBS with 10 μM Akt Inhibitor X. This wash removed any 
components in the PRMI that may have interfered with the assay. The blank well was 
treated in the same way. Parasites were then transferred into a clean, white, 96 well 
plate (Nunc). For adult worms, parasites were washed in 100 μl warmed PBS then 
transferred to fresh wells containing 50 μl PBS. A 10 mM solution of 2DG was prepared 
from the 100 mM stock solution accounting for the number of reactions needed (5 μl per 
reaction). 5 μl 2DG was added to each well, mixed briefly and the plate incubated at 
room temperature for 20 min. After 20 min, 25 μl of stop buffer was added and the plate 
manually shaken for 30 s to kill the parasites and lyse the surface cells (the parasites 
appeared intact under the dissecting microscope). After a further 5 min at room 
temperature the plate was shaken again for 30 s. Immediately after adding the 
neutralization buffer, 100 μl of 2DG6P was added to each well, the plate shaken for a 
further 30 s and incubated for 30 min at room temperature before taking the initial 
reading. Luminescence was measured using a 0.5 – 1 s integration on a BMG Fluorstar 
Optima plate reader. A second luminescence reading was taken after 1 h incubation with 
the 2DG6P. The signal of the blank well was subtracted from all other wells to account 
for any background reading. 
2.21 Cercarial Video Analysis 
Freshly shed cercariae were transferred by pipette in a 100 μl drop into the bottom of a 
48 well tissue culture plate. Treatments of 1 μM L-arginine, 100 μM LA or 10 μM Akt 
Inhibitor X were added via 1 μl of appropriately diluted reagent. Movies were captured 
using a Canon DSLR camera attached to a Leica stereo dissecting light microscope. The 
focus was set to the bottom of the well plate and the zoom adjusted so the majority of 
the droplet was in focus. Treatments were performed in a staggered manner to allow 
Table 2.1 Reagents and volumes required to make up the 2DG6P detection reagent as 
detailed in the Promega Glucose uptake Glo assay protocol. 
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enough videoing time between treatments. For 0 min captures, the well was placed under 
the camera and the recording initiated immediately after the 1 μl reagent was added; 30 
s movies were captured at 0, 1, 5, 10, 20, 30 and 45 min for each treatment.  
For analysis, 30 individual cercariae were randomly chosen from each video and the 
number of seconds each swam was measured. Contracting movements were not 
counted as active swimming.  
In addition to the above analysis, movies captured for cercariae treated with 10 μM Akt 
Inhibitor X were also analysed for the number of parasites swimming at certain time 
points. The camera was focused on the bottom of the plate therefore any settled, non-
swimming cercariae were clearly visible and these were enumerated at 0, 10, 30 and 45 
min. At 45 min, no cercariae were swimming at all, so the number counted for this time 
point was taken as the total. Movies were paused for enumeration at the start of each 30 
s clip for consistency.   
2.22 Statistical Analysis 
Where appropriate, statistical differences between means were tested for by ANOVA 
using Fisher’s multiple comparison post-hoc test with Minitab 16. All data is expressed 
as mean ± standard deviation (SD) with the values p ≤ 0.001, 0.1 or 0.5 to indicate 
statistical significance. 





Results 1 – Characterisation of 
functionally active Akt in S. mansoni     
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Exploring cell signalling in the human-infective/resident life stages of schistosomes may 
eventually result in the identification of a much-needed novel drug target against the 
parasite. Research in this area also provides valuable knowledge of the host-parasite 
relationship on a molecular level. Although several signalling pathways have been 
studied in S. mansoni, our overall understanding of molecular communication in 
schistosomes remains poor. Recent studies have identified roles for several protein 
kinases in S. mansoni, such as TK6, PKC and PKA (Table 1.1). Akt has also been 
studied in schistosomes (Morel et al., 2014a) although only from the perspective of 
parasite control, and not functional biology. Furthermore, a novel insulin-like peptide has 
been recently characterised in S. japonicum (Du et al., 2017), which could have important 
applications for future work on schistosome Akt. This chapter concerns the validation 
and application of commercially available antibodies and pharmacological Akt inhibitors 
and activators for use in S. mansoni. RNAi of Akt was also performed and 
phosphorylated Akt was functionally mapped in various schistosome life stages to 
demonstrate the in situ localisation of the activated kinase. A proteome profiler kit was 
trialled in early work to assess the viability of this approach for screening selected S. 
mansoni kinase activities.  
3.1 Proteome Profiler 96 Kit 
Initial experiments were performed using a Proteome Profiler kit (Human Phospho-
Kinase Array 1) to ascertain whether schistosome extracts could be screened for multiple 
phosphorylated (activated) kinases simultaneously. The chosen array contained targets 
associated with MAPK and Akt signalling. Such pre-designed arrays have been used 
successfully in human cancer research (Bordinhão et al., 2016; Wang et al., 2016). 
Although such arrays are commercially available only for mammalian species, given the 
generally good interspecies conservation of phosphorylation motifs, this array was 
trialled with the rationale that the employed antibodies might react suitably with the S. 
mansoni kinases. The Profiler kit is a two-site sandwich ELISA-based kinase array. The 
specific capture antibodies spotted in each well bind to the protein kinases in the 
homogenate. An HRP-conjugated detection antibody is then added, which binds to a 
different (phosphorylated) motif on each kinase, allowing measurement of the 
phosphorylated proteins by chemiluminescence. The targets of the assay and their 
phosphorylation sites are illustrated in Figure 3.1.  
 
The aim was to monitor the activities of the different kinases in parallel, and ascertain 
their responses to various stimulants. Adult worms were exposed to three different 
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treatments (anisomycin, EGF, or PMA) before total proteins were extracted and 50 μg 
protein applied to each array. Anisomycin is a known activator of p70S6K, p38 MAPK and 
ERK1 (Cano et al., 1994; Kardalinou et al., 1994), EGF is a commonly known stimulant 
of multiple signalling pathways including ERK1/2 (Adamson and Rees, 1981), and PMA 
activates protein kinases such as PKC (Castagna et al., 1982). Not all antibodies on the 
array reacted with the schistosome extracts (Figure 3.2). In all cases phosphorylated 
(activated) ERK was detected and, in all but one experiment (Figure 3.2 B), p70S6K was 
also activated after stimulation. However, phosphorylated -Akt, -JNK, and -Src were not 
detected in adult worm extracts irrespective of treatment (Figure 3.2 A-C). To ascertain 
if protein quantity affected detection, 25 μg and 100 μg total protein from PMA-treated 
adults were applied to each array (Figure 3.2 C). Increased levels of phosphorylated 
GSK-3β and p70S6K were detected with 100 µg protein, however -Akt, -JNK, and -Src 
remained unreactive (Figure 3.2 C). Finally, the array was screened using somule protein 
extracts to ascertain whether a different S. mansoni life stage would demonstrate greater 
immunoreactivity. Although phosphorylated Src was detected (Figure 3.2 D), this spot 
also presented in the non-treated control. There was little observable difference between 
treatments and the results were consistent across replicate experiments, with one 
exception (Figure 3.2 B). Overall, results from the Profiler kit were inconclusive, likely 
due to the incompatibility of the anti-human total kinase (capture) and/or phospho-kinase 
(detection) antibodies with the S. mansoni proteins. As a result, a different approach was 
taken, aiming to focus on Akt signalling in S. mansoni using different methodologies.  
Figure 3.1 Composition of the Proteome Profiler kit (Human Phospho-Kinase Array 1). 
A. The phosphorylation sites for each kinase target represented on the array. B. Layout of the 
pre-spotted capture antibodies on the base of each well in the 96 well plate. A cocktail of 
antibodies directed against the phosphorylated target proteins was used to detect the active 
kinases. 




3.2 Initial Detection of Phosphorylated Akt in S. mansoni   
Prior to screening commercially available anti-Akt antibodies against S. mansoni protein 
extracts, a multiple pair-wise alignment of the predicted S. mansoni Akt protein against 
Akt proteins from H. sapiens, D. melanogaster and C. elegans was created using 
MUSCLE.  Human Akt1 was chosen to facilitate selection of appropriate antibodies for 
testing based on sequence similarity between species; D. melanogaster and C. elegans 
Akt were selected as comparator proteins due to the status of these species as 
invertebrate model organisms and because each species possesses an Akt homologue 
with a pleckstrin homology (PH) domain (Vanhaesebroeck and Alessi, 2000). The protein 
sequences for alignment were sourced from NCBI with the exception of the S. mansoni 
Akt sequence, which was retrieved from Ensembl Metazoa. SmAkt possesses 79% 
homology with both human Akt1 and D. melanogaster Akt1A sequences, and 80% 
homology with C. elegans Akt. Figure 3.3 outlines the three key protein domains; the PH, 
Figure 3.2 Multiple phosphorylated S. mansoni kinases are captured and detected by 
the Human Phospho-Kinase Array 1. A. Adult S. mansoni were treated with anisomycin (20 
μM) for 30 min, EGF (15 nM) for 5 min, PMA (10 μM) for 30 min, or left untreated (control). 
Worm protein extracts (50 μg) were incubated in wells of the plate overnight at 4°C. B. 
Replicate experiment performed as in A, but with samples incubated for 5 h at room 
temperature. C. Adult worms treated with PMA, but with different protein amounts used. D. 24 
h somules incubated with 10% human serum for 10 min, or not (control).  
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kinase, and regulatory domains. Also highlighted are the residues that are 
phosphorylated in human, D. melanogaster and C. elegans Akt that may be conserved 
for Akt activation in S. mansoni. Notably, the S. mansoni Akt gene contains a long leader 
sequence at the N-terminus, a feature not shared by the human, D. melanogaster or C. 
elegans homologues.  
The PH domain, a motif approximately 100 amino acids (aa) long, was first identified 
over two decades ago (Haslam et al., 1993). This region appears in number of signalling 
proteins, many of them protein kinases. The PH domain in Akt has been implicated in 
binding to PIP2 and PIP3 in the context of Akt membrane localisation (Lietzke et al., 2000; 
Vanhaesebroeck and Alessi, 2000). S. mansoni and human Akt share 57.5% homology 
in the PH domain (Figure 3.3).  
The Akt catalytic kinase domain generally ranges from 250 – 300 amino acids in length 
(depending on species) and can be further separated into several major sub-domains 
(Hanks et al., 1988). In S. mansoni Akt, the kinase domain is 264 amino acids long. The 
human Akt kinase domain is conserved with those of PKA and PKC, 65% and 75% 
respectively (Coffer and Woodgett, 1991; Alessi et al., 1996b), hence why Akt is also 
known as PKB. Additionally, the kinase domain contains the Asp-Phe-Gly (DFG) motif. 
This motif marks the start of the activation loop, which is 20-30 amino acids long and is 
commonly involved in kinase activation (Hanada et al., 2004). The S. mansoni Akt kinase 
domain shares 73.1%, 71.9% and 69.6% similarity with human, D. melanogaster and C. 
elegans kinase domains, respectively (Figure 3.3).  
The regulatory domain is located at the carboxyl terminal end of the protein and contains 
the crucially important hydrophobic motif. The hydrophobic motif consists of F-X-X-F/Y-
S/T-Y/F, where X is any amino acid, and is found in all proteins of the AGC superfamily 
(Peterson and Schreiber, 1999). Phosphorylation of the serine/threonine residue in this 
motif is critical for protein activation (Alessi et al., 1996a). 
 Chapter 3 – Results 1         51 
 
 
Figure 3.3 Full multiple pair-wise alignment of S. mansoni Akt with Akt proteins from three 
other organisms. S. mansoni (Smp_073930), H. sapiens (NP_00104432.1), D. melanogaster 
(AHN57352.1) and C. elegans (O18178.4) alignment created using MUSCLE. The pleckstrin 
homology (PH) domain is indicated in green, the kinase domain in red, and the regulatory domain 
in blue. The black dots indicate important conserved residues for phosphorylation of Akt, the DFG 
motif of the ATP binding site, Sm (Thr401) and Sm (Ser565). The colours range from light grey to 
black showing least conserved to most conserved amino acids, respectively, as determined by 
MUSCLE.  
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As discussed in Chapter 1 (Section 1.2), for activation, Akt must be phosphorylated not 
only on the Thr308 residue in the activation loop, but also the Ser473 residue in the 
hydrophobic motif (human numbering) (Alessi et al., 1996a), as is also the case for D. 
melanogaster (Sarbassov et al., 2005) and C. elegans (Paradis et al., 1999) Akt. 
However, western blotting with anti-phospho Akt (Ser473) antibodies raised against a 
phosphorylated peptide surrounding this residue failed to reveal any immunoreactive 
bands in S. mansoni extracts (data not shown). This is likely due to the low level of amino 
acid similarity surrounding Ser473 between the S. mansoni and human protein, as 
revealed by bioinformatic analysis (Figure 3.4). By comparison, the residues surrounding 
Thr308 and Tyr315 (human numbering) showed almost complete conservation. Initial 
western blots performed with monoclonal anti-phospho Akt (Thr308) antibodies that 
recognise exclusively the phosphorylated (activated) form of human Akt, revealed an 
immunoreactive protein of approximately ~52 kDa in extracts from in vitro cultured S. 
mansoni somules and a weaker immunoreactive protein of ~70 kDa (Figure 3.5A). This 
antibody recognises the sequence: 5’-GATMKTFCGTP-3’ (Figure 3.4). Tyr315 is thought 
to be phosphorylated prior to phosphorylation of Thr308 and Ser473 (Chen et al., 2001) 
and is also important to Akt catalytic activation. The anti-phospho Akt (Tyr315) antibodies 
recognise the highly conserved sequence 5’-CGTPEYLAPEV-3’; these antibodies also 
detected the ~52 kDa in extracts from S. mansoni somules (Figure 3.5A). λ-phosphatase 
treatment was employed to release phosphate groups from proteins on the blot; the lack 
of antibody binding following treatment (Figure 3.5A) demonstrates that the anti-phospho 
Akt (Thr308) and (Tyr315) antibodies specifically recognise the phosphorylated Akt-like 
protein. 
During multiple initial experiments using these anti-phospho antibodies in somules, it 
was noted that the stronger and more consistently immunoreactive band for Akt was that 
of ~52 kDa. The current S. mansoni genome (Protasio et al., 2012) predicts Akt to be 68 
kDa and does not indicate that there may be different isoforms, as occurs in other 
organisms such as C. elegans. (Paradis and Ruvkun, 1998; Manning and Cantley, 2007). 
Thus, an important aim became to determine the identity of this ~52 kDa Akt-like protein.  
In addition to the two anti-phospho antibodies, a ‘total’ Akt (anti-Akt1/2/3) antibody was 
tested which detects all Akt protein present, regardless of phosphorylation status (Figure 
3.5 B). This anti-Akt antibody recognises the ‘PEYLA’ region in the amino acid sequence, 
therefore overlapping the Tyr315 site (Figure 3.4). In somules, this antibody recognised a 
band at 50 kDa and at 70 kDa, with the latter being stronger than when detected with the 
anti-phospho Akt (Thr308) and (Tyr315) antibodies. This supports the possibility that there 
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are two forms of Akt in S. mansoni, with one (50 kDa) having a greater basal level of 








Figure 3.4 Partial pair-wise alignment of S. mansoni Akt and Akt from three other 
organisms shows homology of important phosphorylation motifs. Predicted S. mansoni 
(Sm) Akt sequence and the comparative alignment of relevant Akt sequences from human (Hu), 
D. melanogaster (Dr) and C. elegans (Ce). The amino acid sequences shown span the anti-
phospho antibody recognition sites for the antibodies that bind Thr308, Tyr315 and Ser473 residues 
(human numbering). These antibodies only recognise the phosphorylated kinase and typically 
identify a total of 10-12 residues around the phosphorylated amino acid (green, orange and blue 
boxes). The recognition site around the Ser473 residue shows poor conservation between the Sm 
and Hu sequences. Three dots signify the DGF motif of the ATP binding site. This alignment was 
created using MUSCLE with sequences imported from NCBI and Ensembl Metazoa.  




Having characterised two anti-phospho Akt antibodies and a total Akt antibody using 
somule extracts, cercariae and adult worm protein extracts were also screened. Each 
antibody recognised a band of similar molecular weight (~52 kDa) across the three life 
stages, indicating that all antibodies were recognising a similar protein (Figure 3.6). This 
was expected based on the sequence alignment (Figure 3.4). The anti-Akt antibody also 
sometimes revealed a weakly immunoreactive band above the putative Akt band in 
cercariae and adult worms. This was attributed to non-specific background binding as it 
was not seen consistently across experiments. 
 
 
Figure 3.5 Detection of an Akt-like protein in S. mansoni. Somules (~1000 per lane) were 
processed 18 h post transformation. A. The blot was cut into four pieces, two of which were 
treated with MnCl2/λ-phosphatase overnight (+). Western blotting using anti-phospho Akt (Thr308) 
and anti-phospho Akt (Tyr315) antibodies was then performed on all blots. Blots were also probed 
with anti-actin antibodies to reveal the presence of protein in all lanes. B. The membrane was 
probed with ‘total’ anti-Akt antibodies that recognise Akt irrespective of its phosphorylation status. 
The positions of the relevant molecular weight markers are indicated. The blots shown are 
representative of those obtained in at least two independent experiments.  
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3.3 Immunoprecipitation of SmAkt and Activity Assay 
Immunoprecipitation (IP) and Akt activity experiments were performed with adult worm 
and somule extracts to ascertain whether the putative phosphorylated Akt protein 
detected by western blotting possessed Akt activity. To conduct these experiments, an 
Akt activity assay kit was used, which included a GSK-3α/β kinase substrate peptide 
known to be specifically phosphorylated by human Akt. This assay was selected due to 
the good conservation between human and S. mansoni GSK-3 proteins (Chapter 4, 
section 4.4.3). The assay kit employs the ‘classical’ method of IP whereby the antibody 
is incubated directly with the sample containing the target protein to form an antigen-
antibody complex. Post complex formation, protein A agarose beads are added to ‘pull 
down’ the target protein by binding to the Fc region of the IP antibody (Kaboord and Perr, 
2008). This method results in both the antigen of interest and the antibody being released 
from the beads during the elution stage. Phosphorylated GSK-3α/β fusion protein is then 
detected by western blotting after kinase assay. 
Anti-phospho Akt XP (Thr308) antibodies were able to precipitate protein from serum-
treated somules and adults, that phosphorylated the GSK-3α/β fusion protein substrate 
(Figure 3.7). There was minimal immunoreactivity in the negative control (no antibody) 
lanes against phosphorylated GSK-3α/β, demonstrating that the immunoprecipitations 
were reasonably specific and that the immunoprecipitated protein possesses Akt-like 
activity.  
 
Figure 3.6 Different S. mansoni life stages show similar banding profiles when blotted with 
antibodies against Akt. Cercariae (C) (~1000), somule (S) (~1000) and adult worm (A) (~ 1 pair) 
proteins were processed for western blotting with anti-phospho Akt or anti-Akt antibodies as 
indicated. Blots were also stripped and re-probed with anti-actin antibodies. Blots are 
representative of results obtained in two independent experiments. 
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Given the successful IP, the anti-phospho Akt (Thr308) XP antibody was used to attempt 
to isolate enough protein for sequencing. An alternative to the classical IP method was 
used, the oriented affinity method (Kaboord and Perr, 2008), because the Akt-like protein 
shared a similar molecular weight (~50 kDa) to the antibody heavy chain. The oriented 
affinity method employs DSS to covalently crosslink the antibody to the agarose beads, 
thereby preventing it from eluting with the antigen and interfering with analysis. After gel 
staining, three potential bands were cut from the gel run with the IP eluates and sent for 
sequencing at Nottingham University. However, the results were negative, presumably 
due to low protein abundance. Nevertheless, the oriented IP protocol was used for 
reciprocal IPs of the Akt antibodies used (Figure 3.8). Three antibodies (anti-phospho 
Akt (Thr308) XP, anti-phospho-Akt (Thr308) and anti-Akt) were used as the IP antibody in 
separate experiments and the resulting immunocomplexes were processed for western 
blotting with reciprocal antibodies (Figure 3.8). In all cases the same molecular weight 
band was observed, further supporting that each antibody is recognising the same target 
protein. 
Finally, 50 kDa spin columns (Vivaspin 500) were used to isolate proteins of ~50 kDa or 
less from the somule protein homogenate prior to IP and kinase assay. This was done 
to ensure that Akt kinase activity (Figure 3.7) was due to a ~50 kDa Akt rather than larger 
(~70 kDa) Akt form(s) that might have been immunoprecipitated although not detected 
by blotting (Figure 3.8). After immunoprecipitation and kinase assay, the 0-50 kDa 
Figure 3.7 Phosphorylation of the GSK-3 substrate by an immunoprecipitated S. 
mansoni Akt-like protein. Somules (~20,000) or adult worm pairs (~20) were homogenised, 
separated into equal amounts and subjected to immunoprecipitation using monoclonal anti-
phospho Akt (Thr308) XP antibodies (+Ab) or not (control, -Ab). Immunocomplexes were then 
subjected to an Akt assay, with GSK-3α/β fusion protein as the Akt substrate. 
Phosphorylation of GSK-3α/β by Akt was then detected by western blotting using anti-
phospho GSK-3α/β (ser9/21) antibodies. Results are representative of three independent 
experiments.  
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fraction demonstrated phosphorylation of the GSK-3α/β substrate which could only have 
been achieved by an Akt-like protein (Figure 3.9). 
 
3.4 RNAi Knockdown 
To provide further evidence that the detected Akt-like protein results from the annotated 
S. mansoni Akt gene, RNA interference (RNAi) was performed. RNAi by electroporation 
has become a routine tool for the suppression of protein expression in S. mansoni 
(Beckmann et al., 2010; Kasinathan et al., 2014; Morel et al., 2016). The siRNAs were 
designed and sourced from IDT using their online custom design tool. Protein knockdown 
was measured by western blotting after 5 days culture of worms in Opti-MEM. The 
Figure 3.8 Reciprocal immunoprecipitation (IP) of S. mansoni Akt.  24 h somules (~10,000 
per IP)  were homogenised, pre-cleared and immunoprecipitated with one of three antibodies; 
anti-phospho Akt (Thr308) XP, (Thr308), and Akt antibodies (Ab). Subsequent western blotting of 
the pulled down protein was performed with anti-Akt, anti-phospho Akt (Tyr315), and (Thr308) Ab.  
Figure 3.9 Fractionation columns reveal Akt-like activity in 0 - ~50 kDa fraction of S. 
mansoni homogenates. Somules (~20,000) were homogenised and the homogenate was 
processed through a Vivaspin 500 column with a 50 kDa cut-off. The flow through was separated 
into equal amounts and subjected to immunoprecipitation using monoclonal anti-phospho Akt 
(Thr308) XP antibodies (+Ab) or not (control, -Ab). Immunocomplexes were then subjected to an 
Akt assay, with GSK-3α/β fusion protein as the Akt substrate. Phosphorylation of GSK-3α/β by 
Akt was then detected by western blotting using anti-phospho GSK-3α/β (ser9/21) antibodies. 
Results are representative of three independent experiments.  
 
 Chapter 3 – Results 1         58 
 
validated anti-total Akt antibodies facilitated detection of total expressed Akt before and 
after RNAi, and the anti-phospho (Thr308) antibodies allowed for the estimation of 
remaining activated Akt. From three independent experiments, a significant 83% 
(p≤0.001) reduction in total Akt expression was observed after RNAi compared to control 
worms (Figure 3.10), demonstrating that the detected Akt protein is derived from the 
annotated Akt gene. Although significant, there was only a reduction of 26% (p≤0.05) in 
the phosphorylated protein levels, suggesting that the remaining Akt might be 













3.5 Immunolocalisation of Akt and Activated Akt in S. mansoni  
Previous work in our laboratory has employed anti-phospho antibodies and confocal 
laser scanning microscopy to localise phosphorylated (activated) protein kinases in intact 
S. mansoni (de Saram et al., 2013; Hirst et al, 2016). Having established that the anti-
phospho Akt and total Akt antibodies recognise S. mansoni Akt, experiments were 
undertaken to map Akt and functionally activated Akt in the parasite. Cercariae, somules 
and adult worms, were stained with antibodies and mounted for microscopy, without 
treatment, to visualise the basal localisation of both phosphorylated and non-
phosphorylated Akt, and to evaluate any differences between the two. Negative control 
Figure 3.10 Knockdown of Akt expression in adult S. mansoni. A. Adult worms (5 pairs) were 
electroporated with either 2.5 μg SmAkt siRNA or 2.5 μg scrambled control siRNA. After culture 
for 5 days, worms were prepared for western blotting and the resulting membranes were probed 
with anti-Akt antibodies, then stripped and re-probed with anti-phospho Akt (Thr308) antibodies; 
blots were also probed with anti-actin antibodies to assess protein loading between lanes. B. The 
mean (+/- S.D., n=3) relative change in band intensity following treatment was determined 
(GeneTools) over three independent experiments when compared with controls (indicated by the 
dotted line). *p≤0.05 and ***p≤0.001 (ANOVA). 
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parasites labelled only with the secondary Alexafluor 488 antibodies and rhodamine 
phalloidin, which stains the actin filaments revealed that non-specific binding did not 
occur (Figure 3.11). 
 
3.5.1 Immunohistochemistry of Akt in cercariae 
Freshly shed, actively swimming cercariae were immediately fixed and processed for 
immunohistochemistry. Activated Akt was particularly found in the nervous system of the 
head region and could also be seen localised to distinctive punctate regions along the 
tail (Figure 3.12 a-c). In individual ‘z’ sections, these latter spots of activation appeared 
in pairs, progressing towards the tail furcae as demonstrated in adjacent z-sections 
(Chapter 6, section 6.1). This activated Akt could signify the presence of sensory 
receptors in the tail, possibly important in host invasion and/or cercarial locomotion. The 
presence of Akt in the nervous system of the cercariae again indicates a possible 
sensory function. In several cases, the tail/head junction of the cercariae displayed 
activated Akt, as did the oral tip. Anti-Akt antibodies used to label total Akt expression 
Figure 3.11 Negative control parasites display little non-specific binding of the secondary 
antibody. The red channel (a, c, e) is visible as rhodamine phalloidin binds directly to actin, 
whereas the Alexafluor 488 secondary antibodies (green) bind to the primary antibody only. There 
is no background non-specific binding of this antibody to either parasite life stage (b, d, f). Laser 
levels for all subsequent confocal microscopy were set according to those employed for negative 
control scans. Bars: 50 μm except e-f, 200 μm. 
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(Figure 3.12 d-f), revealed additional expression, particularly at the oral tip which 
presented as six individual structures, shaped in a circle around the tip; Akt here is not 
active as the structures were not seen with anti-phospho Akt antibodies.  
3.5.2 Immunohistochemistry of Akt in somules 
When stained with anti-phospho Akt (Thr308) antibodies, 24 h in vitro cultured somules 
showed activated Akt at the tegument and underlying musculature, and more general 
staining of the pre-acetabular glands within the parasite (Figure 3.12 g-i). Interestingly, 
24 h ‘somules’ retaining tails that had not detached (Figure 3.12 g), showed less Akt 
activation in the tails when compared to cercariae, indicating a potential importance of 
Akt in swimming/host location. Somules stained with the anti-Akt antibodies (Figure 3.12 
j-l) showed a similar general Akt localisation profile at the parasite surface and 
musculature, with additional signal noted particularly associated with the pre-acetabular 
glands (Figure 3.12 k-l) and concentrated sub-tegumental regions, identified possibly as 
cytons (Figure 3.12 j). Cytons are cell bodies that lie within the parenchyma and are 
connected to the tegument by cytoplasmic tubules (Skelly and Shoemaker, 2000).  
3.5.3 Immunohistochemistry of Akt in adult worms 
Adult worms were processed with all three antibodies, anti-phospho Akt (Thr308) (Figure 
3.13), anti-phospho Akt (Tyr315) (Figure 3.14) and anti-Akt (Figure 3.15). Staining with 
the anti-phospho Akt (Thr308) antibodies resulted in highly detailed adult worm images, 
with phosphorylated Akt present primarily in the tegument, gynaecophoric canal, 
oesophageal sphincter, and in some cases, the oral sucker. The adult males displayed 
greater activated Akt levels than female worms, which in turn showed little activated Akt 
except in the oesophageal sphincter (Figure 3.13 c). Deep scanning of the female worms 
also revealed no phosphorylated Akt signal at laser levels appropriate for Akt detection 
in male worms. Immunolocalisation using anti-phospho-Akt (Tyr315) or anti-Akt antibodies 
revealed a similar overall distribution to the anti-phospho-Akt (Thr308) antibodies, 
although the anti phospho-Akt (Tyr315) antibodies produced a generally weaker signal. 
When stained with anti-Akt antibodies, there were no additional locations of Akt 
compared with the two anti-phospho antibodies, suggesting that the Akt is predominantly 
located in these areas in adult worms regardless of phosphorylation status. 




Figure 3.12 Immunolocalisation of Akt and phosphorylated Akt in cercariae and somules. 
(a-c) Anti-phospho Akt (Thr308) antibodies (Ab) reveal phosphorylated Akt (p-Akt) throughout the 
nervous system, head-tail junction and at the parasite surface of the oral tip. ‘Spotting’ along the 
length of the tail could indicate sensory receptors. (d-f) Total Akt staining with anti-Akt Ab in 
cercariae reveals the same pattern of Akt localisation in the tail and additionally shows brightly 
stained structures at the oral tip, not seen with phospho-Akt Ab. (g-i) Somules stained with anti-
phospho Akt (Thr308) Ab reveal a relatively high presence of p-Akt at the parasite surface and 
underlying musculature compared to cercariae. (j-l) Total Akt staining of somules with anti-Akt 
Ab reveals non-phosphorylated Akt in the pre-acetabular glands and in the tegument in the form 
of spots, possibly cytons. Rhodamine phalloidin was used to stain filamentous actin (red), all 
images are maximum projections with the exception of (b) and (l). Scale bars = 25 μm.  
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Figure 3.13 In situ immunolocalization of phosphorylated (activated) Akt in intact S. 
mansoni adults. Adult worm pairs were fixed and incubated with anti-phospho Akt (Thr308) (a-e) 
followed by Alexa Fluor 488 secondary Ab (green); specimens were also stained with rhodamine 
phalloidin to reveal actin filaments (red). All images are of z-axis projections displayed in 
maximum pixel brightness mode except (d) which is derived from a single surface scan. (a) Whole 
male and female worms in copula; (b-e) detailed scanning of activated Akt and total Akt in worms. 
Bar: 200 μm, except d = 20 μm. 
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Figure 3.14 In situ immunolocalization of phosphorylated (activated) Akt in intact S. 
mansoni adults. Adult worm pairs were fixed and incubated with anti-phospho Akt (Tyr315) (a-e) 
primary antibodies (Ab) followed by Alexa Fluor 488 secondary Ab (green); specimens were also 
stained with rhodamine phalloidin to reveal actin filaments (red). All images are of z-axis 
projections displayed in maximum pixel brightness mode. (a) Whole male and female worms in 
copula; (b-e) detailed scanning of activated Akt and total Akt in worms. Bar: 300 μm. 
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Figure 3.15 In situ immunolocalization of total Akt in intact S. mansoni adults. Adult worm 
pairs were fixed and incubated with anti-Akt primary antibodies (Ab) (a-g) followed by Alexa Fluor 
488 secondary Ab (green); specimens were also stained with rhodamine phalloidin to reveal actin 
filaments (red). All images are of z-axis projections displayed in maximum pixel brightness mode. 
(a) Whole male and female worms in copula; (b-g) detailed scanning of total Akt in worms. Bar: 
200 μm. 
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3.6 Effect of Human Host Factors and Other Agents on S. mansoni Akt 
Phosphorylation  
When S. mansoni enters the skin of the human host it will encounter for the first time in 
its life cycle blood factors and other molecules that might stimulate Akt signalling in the 
parasite. Somules were therefore transformed mechanically and cultured overnight in 
BME only. They were then exposed to serum, insulin, or L-arginine for increasing 
durations, or the chemical compound SC-79. Proteins were extracted and processed for 
western blotting to ascertain whether these components stimulated Akt phosphorylation 
(activation) in the somules.   
3.6.1 Effect of serum on S. mansoni Akt phosphorylation 
Treatment of somules with human serum was investigated with the rationale that Akt 
phosphorylation may increase upon exposure. Initial results showed that serum 
treatment resulted in increased Akt phosphorylation (activation) at 5 and 10 min declining 
to below basal levels at 30 min (Figure 3.16). However, subsequent experiments with 
serum revealed that in many cases, the anti-phospho Akt (Thr308) antibody bound to a 
human serum component resulting in a double-band effect making interpretation difficult; 
human serum alone also reacted with anti-phospho Akt (Thr308) antibodies (data not 




Figure 3.16 Serum treatment induces Akt activation in S. mansoni somules at 5-10 min.    
24 h somules (~1000) were treated with 10% human serum at 37 °C, 5% CO2 for the times 
indicated. Protein samples were processed for western blotting with anti-phospho Akt (Thr308) 
antibodies, then stripped and re-probed with anti-actin antibodies to determine protein loading 
between lanes. Above blot is representative of 5 blots.  
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3.6.2 Effect of insulin on S. mansoni Akt phosphorylation 
Given that insulin receptors exist in S. mansoni (Kayath et al., 2007; Vanderstraete et 
al., 2013) and that in humans Akt is modulated by insulin signalling (Alessi et al., 1996a), 
the effect of insulin on Akt activation in S. mansoni somules was explored. In vitro 
transformed somules were treated with insulin (bovine; 1 μM) and somule extracts 
blotted with anti-phospho Akt (Thr308) antibodies. Although somewhat variable between 
individual experiments, analysis of blots revealed that over several replicates, 10 min 
insulin treatment increased Akt phosphorylation by 43% (p≤0.001) when compared to 0 
Figure 3.17 Exogenous insulin activates Akt in intact S. mansoni. A. Somules (~1000) were 
treated with 1 μM recombinant bovine insulin for the indicated durations and protein samples 
processed for western blotting with anti-phospho Akt (Thr308) antibodies. Blots were then stripped 
and re-probed with anti-actin antibodies to determine protein loading in each lane. 
Immunoreactive bands from seven independent experiments were analysed for mean intensity 
(±S.D.; n=5) using GeneTools and the change in phosphorylation calculated relative to 
phosphorylation levels of controls (0) that were assigned a value of 1 (also shown as dotted line). 
*p≤0.05, and ***p≤0.001 (ANOVA). B. Somules (~1000) were treated with 1 μM human insulin 
for 10 min and protein samples processed for western blotting with anti-phospho Akt (Thr308) 
antibodies. Blots were then stripped and re-probed with anti-actin antibodies to determine protein 
loading in each lane. The blot in B is representative of those from four independent experiments.  
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min controls (Figure 3.17 A). Across four blots, similar results (47% increase) were 
obtained for human insulin at the same concentration (Figure 3.17 B).  
3.6.3 Effects of L-arginine on S. mansoni Akt phosphorylation 
Skin lipids have long been known to stimulate the penetration of host skin by cercariae 
(Stirewalt, 1971) with the amino acid L-arginine being specifically recognised as a factor 
by Granzer and Haas (1986). More recently, L-arginine has been shown to stimulate 
SmVKRs expressed in Xenopus oocytes (Gouignard et al., 2012). Thus to investigate if 
L-arginine modulated Akt activation in S. mansoni, somules were exposed to this amino 
acid at the same concentration (100 μM) as used by Gouignard et al. (2012) for 
increasing durations similar to those for insulin (Figure 3.18). L-arginine exposure 
resulted in an increase in somule Akt phosphorylation, culminating with a significant 1.84 
fold increase compared to the control at 30 min (p≤0.001). Over several experiments, L-
arginine produced a stronger and more reproducible stimulation than insulin. 
Consequently, for further experiments, insulin and L-arginine were used concurrently, 
Figure 3.18 L-arginine activates Akt in S. mansoni somules.  A. Somules (~1000) were 
treated with 100 μM L-arginine for increasing durations and samples were processed for western 
blotting with anti-phospho Akt (Thr308) antibodies. Membranes were stripped and re-probed with 
anti-actin antibodies to determine protein loading. B. Immunoreactive bands from three 
independent experiments were analysed for mean intensity (±S.D.; n=7) using GeneTools and 
the change in phosphorylation calculated relative to phosphorylation levels of controls (0) that 
were assigned a value of 1 (also shown as dotted line). ***p≤0.001 (ANOVA).  
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with the nature of the experiment dictating the preferred stimulator. For example, L-
arginine, being a skin surface component, was more appropriate in experiments involving 
cercariae (Chapter 6) whereas insulin was preferentially used in somule and adult worm 
studies.  
3.6.4 Effect of alternative Akt pathway stimulators on S. mansoni Akt 
As well as serum, insulin and L-arginine, a relatively new Akt stimulator, SC79, was 
tested, with little effect seen on Akt phosphorylation (Figure 3.19). SC79 was first 
reported as a specific Akt stimulant by Jo et al. (2012). Originally screening for Akt 
inhibitors, Jo et al. discovered that while SC79 suppresses Akt plasma membrane 
translocation, it also simultaneously enhances cytosolic Akt phosphorylation. 
Phosphorylation of both the Thr308 and Ser473 residues was increased and activation was 
demonstrated in cells both with and without serum treatment, indicating a strong level of 
stimulation (Jo et al., 2012). However, as shown in Figure 3.19, there was no evidence 
of increased Akt phosphorylation in S. mansoni somules until used at 100 μM, but this 
was found to be non-reproducible in subsequent experiments.  
 
3.7 The Effects of Akt Pathway Inhibitors on S. mansoni Akt Phosphorylation 
3.7.1 The effect of LY294002 on S. mansoni Akt phosphorylation 
In total, four inhibitors of the Akt pathway were tested: LY294002, GSK2334470, Akt 
Inhibitor X and Herbimycin A. LY294002 is a specific phosphatidylinositol 3-kinase (PI3K) 
inhibitor, reported to prevent PI3K activity with an IC50 value of 1.4 μM in human and 
rabbit cells (Vlahos et al., 1994). During in vitro experiments with live somules, LY294002 
Figure 3.19 SC79 does not consistently stimulate S. mansoni Akt. 24 h somules (~1000) 
were treated for 2 h with SC79 (1μM, 10 μM and 100 μM) or DMSO (vehicle, control) at 37 °C, 
5% CO2. Samples were processed for western blotting with anti-phospho Akt (Thr308) antibodies, 
then membranes were stripped and re-probed with anti-actin antibodies to confirm similar protein 
loading between lanes. 
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did not consistently block phosphorylation of Akt at the concentrations used (1 μM, 10 
μM and 50 μM) after 3 h pre-incubation (Figure 3.20). After actin equalisation, no 
significant change in Akt phosphorylation (activation) could be determined. This 
experiment was conducted prior to the discontinuation of serum as a stimulator, hence 










3.7.2 The effect of GSK2334470 on S. mansoni Akt phosphorylation 
GSK2334470 is a specific PDK1 inhibitor (Najafov et al., 2011). PDK1 activates Akt by 
phosphorylating the Thr308 residue in the activation loop, in keeping with 22 other AGC 
kinases, which are also phosphorylated on a serine/threonine residue in the activation 
loop (Mora et al., 2004). GSK2334470 was incubated with somules at three 
concentrations, initially for 1 h. When this yielded no inhibition, incubation was increased 
to 2 h. Although there was variability between experiments, analysis of blots revealed 
that over three experiments, a significant decrease (p≤0.05) in Akt phosphorylation 





Figure 3.20 LY294002 shows inconsistent inhibition of S. mansoni Akt. Somules (~1000) 
were incubated for 180 min at 37°C with 1 μM, 10 μM or 50 μM LY294002 then exposed to 10% 
human serum for 10 min. Somules were processed for western blotting with anti-phospho Akt 
(Thr308) monoclonal antibodies. Membranes were stripped and re-probed with anti-actin 
antibodies to determine protein loading differences between lanes. 
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3.7.3 The effect of Akt Inhibitor X on S. mansoni Akt phosphorylation 
Despite the decreased Akt phosphorylation achieved with GSK2334470, trials with this 
inhibitor were halted when greater efficiency and consistency of inhibition was found with 
Akt Inhibitor X. In contrast to LY294002 and GSK2334470, which inhibit kinases 
upstream of Akt, Akt Inhibitor X directly inhibits the Akt protein. Akt Inhibitor X was first 
used in S. mansoni by Morel et al. (2014a) who showed that, among other inhibitors, Akt 
Inhibitor X reduced the pairing and egg laying capabilities of adult worms in vitro. Morel 
et al. also demonstrated a 100% reduction of germinal vesicle breakdown (GVBD) in 
constitutively active mutant SmAkt L150R expressing Xenopus oocytes after treatment 
with 5 μM Akt inhibitor X for 15 h.  
As no data was available regarding the efficacy of Akt inhibitor X towards S. mansoni Akt 
in intact parasites, a dose response was performed. Live somules were treated with 
increasing concentrations (1 μM - 50 μM) of Akt Inhibitor X for 1 h then treated for 10 min 
with 1 μM human insulin. Blots were probed with both anti-phospho Akt (Thr308) and 
(Tyr315) antibodies. Incubation of somules with 50 µM Akt Inhibitor X for 1 h significantly 
reduced the phosphorylation of Akt following insulin stimulation (p≤0.01), although 
clearer inhibition was observed at 10 μM over multiple experiments when probed with 
anti-phospho Akt (Tyr315) antibodies (Figure 3.22). At 50 µM, Akt inhibitor X reduced 
mean Akt phosphorylation by 34% and 46% when detected with anti-phospho Akt 
(Thr308) and (Tyr315) antibodies, respectively. The subtle difference in mean levels of 
inhibition detected by the two antibodies is possibly due to the different routes by which 
Figure 3.21 GSK2334470 shows moderate inhibition of S. mansoni Akt. A. Somules (~1000) 
were incubated for 120 min at 37°C with 10 μM, 20 μM or 50 μM GSK2334470, DMSO (vehicle), 
or not (-) then stimulated for 10 min with 1 μM human insulin. Parasites were processed for 
western blotting with anti-phospho Akt (Thr308) antibodies. Membranes were stripped and re-
probed with anti-actin antibodies to determine protein loading. B. Immunoreactive bands were 
analysed and mean intensity (±S.D.; n=3) determined using GeneTools and the change in 
phosphorylation calculated relative to phosphorylation levels of controls (-) that were assigned a 
value of 1 (also shown as dotted line). *p≤0.05 (ANOVA). 
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each antibody target residue is phosphorylated; Tyr315 being activated by Src (Chen et 
al., 2001) compared with the Thr308 residue which is activated by PDK1 (Alessi et al., 
1997). 
  
3.7.4 Effect of Herbimycin A on S. mansoni Akt phosphorylation 
Herbimycin A is a selective Src inhibitor. Given that Src phosphorylates the Tyr315 residue 
in human Akt, herbimycin was employed to assess its effects on S. mansoni Akt 
activation using anti-phospho Akt (Tyr315) antibodies. This inhibitor was previously used 
Figure 3.22 Akt Inhibitor X blocks Akt activation in S. mansoni somules. A. Somules (~1000) 
were incubated for 1 h at 37°C with Akt Inhibitor X at four different concentrations, then for 10 
min with 1 μM human insulin. Parasites were processed for western blotting with anti-phospho 
Akt (Thr308) or (Tyr315) antibodies. Blots were then stripped and re-probed with anti-actin 
antibodies to determine protein loading. B. Immunoreactive bands were analysed for mean 
intensity (±S.D.; n≥3) using GeneTools and the change in phosphorylation calculated relative to 
phosphorylation levels of controls (0) that were assigned a value of 1 (also shown as dotted line). 
*p≤0.05, **p≤0.01 (ANOVA). 
 
 Chapter 3 – Results 1         72 
 
in schistosomes to suppress mitotic activity in adult female worms (Knobloch et al., 
2006).  
Herbimycin A was used at 12 μM as this is its IC50 value (Knobloch et al., 2006). Somules 
were incubated for increasing durations (30 - to 120 min) with the inhibitor, then 
stimulated for 10 min with human insulin. Similar to Akt Inhibitor X, herbimycin A 
significantly decreased phosphorylation of Akt following stimulation with human insulin 
(Figure 3.23). After 120 min, mean phosphorylation levels were reduced by 27% 
compared to the control samples (p ≤ 0.01) (Figure 3.23). This implicates Src as the 




Figure 3.23 Herbimycin A inhibits Tyr315 phosphorylation in S. mansoni somules, 
implicating Src as an upstream kinase. A. Somules (~1000) were incubated for 30 min, 60 
min, or 120 min at 37°C with 12 μM herbimycin A, then 10 min with human insulin. Parasites were 
processed for western blotting with anti-phospho Akt (Tyr315) antibodies. Membranes were 
stripped and re-probed with anti-actin antibodies to determine protein loading. B. Immunoreactive 
bands were analysed for mean intensity (±S.D.; n=3) using GeneTools and the change in 
phosphorylation calculated relative to phosphorylation levels of controls (0) that were assigned a 
value of 1 (also shown as dotted line). **p≤0.01 (ANOVA). 
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Summary  
This chapter reports the validation of three antibodies for studying Akt in S. mansoni. 
Anti-phospho Akt (Thr308) and (Tyr315) antibodies and the anti-Akt antibodies all recognise 
the same molecular weight S. mansoni Akt-like protein at ~52 kDa, across cercariae, 
somules and adult worms. Reciprocal immunoprecipitation experiments confirmed that 
each of the antibodies was binding the same protein target at ~52 kDa and Akt activity 
assays revealed that the immunoprecipitated protein possessed Akt-like activity. RNAi 
(employing siRNA) of the predicted S. mansoni gene was successfully performed and 
western blotting with anti-Akt antibodies revealed an 84% Akt knockdown in adult worms. 
Immunolocalisation studies across the different S. mansoni life-stages revealed where 
Akt is present in the parasite and where it is activated. Phosphorylated (activated) Akt 
was predominantly present in the tegument and tubercles of the adult worms but also in 
the tegument of somules. Other notable areas of phosphorylated Akt were the cercariae 
nervous system and oral tip, the preacetabular glands and cytons in somules, and the 
gynaecophoric canal and oesophageal sphincter in adult worms.  
Studies employing host molecules that S. mansoni could interact with during infection 
revealed that insulin and L-arginine stimulated Akt in somules, with maximal activation 
occurring at 10 min and 30 min, respectively. By far the most effective inhibitor tested 
was Akt Inhibitor X, which caused a 35% and 42% decrease in Akt phosphorylation when 
probed with anti p-Akt (Thr308) and anti p-Akt (Tyr315) antibodies, respectively. Herbimycin 
A also proved to be an efficient inhibitor of Akt activation in somules. 
This chapter confirms the presence of an evolutionarily conserved Akt protein in S. 
mansoni, which can be stimulated and inhibited with known mammalian Akt pathway 
effectors. The level of conservation between S. mansoni, C. elegans, D. melanogaster 
and human sequences indicates a functionally conserved role for Akt in the parasite, and 
the response to insulin stimulation raises further possibilities about as yet unknown 
functions of the protein. 
 





Results 2 – Downstream Akt Signalling 
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Having demonstrated the presence of activated Akt in various S. mansoni life stages 
(Chapter 3) an investigation into putative downstream Akt interacting proteins and 
substrates was undertaken in an attempt to better understand the biology of the parasite. 
As discussed in previous chapters, minimal data is available on Akt signalling in S. 
mansoni; this is particularly the case for Akt substrates. Conversely, substrates of Akt in 
humans have been well characterised and these are involved in diverse cellular 
processes from metabolism and cell proliferation, to glucose uptake (Manning and 
Cantley, 2007). By employing Akt substrate antibodies and bioinformatic approaches this 
chapter aims to map global substrate activity and illuminate putative Akt interactions 
within the parasite.  
4.1 Akt Substrate Localisation in S. mansoni  
4.1.1 Akt substrate immunoblotting in three life stages 
Akt exclusively phosphorylates substrates at Ser/Thr residues and has substrate 
specificity to proteins that possess an arginine residue at the -5 and -3 positions relative 
to the Ser/Thr phosphorylation site (i.e. RXRXXS*/T*) (Alessi et al., 1996b). The anti-
phospho Akt substrate antibodies used here have preference for Ser/Thr residues 
preceded by Arg at the -5 and -3 positions, but may also detect motifs containing Arg at 
only the -3 site; the Ser/Thr residue must also be phosphorylated for detection6.   
To compare the overall profile of Akt substrates in cercariae, somules and adult worms, 
a western blot was done with samples from all three life-stages, including adult male and 
female worms individually, as well as an adult pair (Figure 4.1). With the exception of the 
female worm lane, all other samples contained comparable levels of protein (based on 
actin immunoreactivity), facilitating comparison between samples. The results indicate 
that as the parasite develops and matures in the definite host, more putative Akt 
substrates become phosphorylated (excepting female worms), suggesting that Akt 
becomes more active in cellular processes. Cercariae displayed less substrate 
phosphorylation by western blot compared to somules, which in turn had a reduced 
global phosphorylation when compared with adult worms. Although weaker in total 
signal, the female worms showed a similar banding pattern to the male worms, with only 
a few bands absent, notably at ~15 kDa, ~20 kDa and ~45 kDa (Figure 4.1). Additionally, 
adult worm pairs were treated with increasing concentrations of Akt Inhibitor X for 1 h to 
monitor the effect of Akt inhibition on the substrate phosphorylation profile (Figure 4.2). 
                                                          
6 www.cellsignal.com [Accessed: January 13th 2016] 
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As the concentration of inhibitor increased, many of the substrates displayed weaker 
phosphorylation despite similar protein levels (based on actin immunoreactivity). This 
demonstrates that the detectable proteins are sensitive to Akt Inhibitor X, thus supporting 
that they are Akt substrates.  
4.1.2 Immunolocalisation of Akt substrates in cercariae, somules and adult worms 
Figure 4.1 Akt phosphorylates more cellular substrates as S. mansoni matures. 
Western blotting of the human-infective/resident life stages of S. mansoni using anti-Akt 
substrate antibodies. Lanes contain from left to right; ~1000 cercariae, ~1000 somules, 1 adult 
male worm, 2 adult female worms and 1 pair of adult worms. The membrane was stripped 
and re-probed with anti-actin antibodies to determine protein loading. 
76 
Figure 4.2 Akt-directed phosphorylation of putative Akt substrates is reduced by Akt 
Inhibitor X. Western blotting of S. mansoni adult worms (1 pair per lane) using anti-Akt 
substrate antibodies. Worms 24 h post-perfusion were treated for 1 h with 10, 25 or 50 μM Akt 
Inhibitor X at 37 °C, 5% CO2. The membrane was stripped and re-probed with anti-actin 
antibodies to determine protein loading. 
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In order to map Akt substrates within the parasite, confocal microscopy was conducted 
on freshly shed cercariae, in vitro cultured (~24 h) somules and adult worms that were 
processed for immunohistochemistry with anti-phospho Akt substrate antibodies. In 
cercariae (Figures 4.3 a-c) the nervous system in the head displayed strong 
immunoreactivity and the pattern of staining observed was similar to that seen with 
cercariae stained for phosphorylated (activated) Akt (Figure 3.12), with the cephalic 
ganglia and ventral nerve cords particularly evident. Detailed analysis of individual z-
sections revealed that the nervous system of the tail contained phosphorylated Akt 
substrates and that regions of substrate phosphorylation were also evident towards the 
tail surface (Figure 4.3 c); such localisation raises the possibility that Akt, and its 
substrates, are implicated in cercarial movement and possibly host penetration. 
Unlike cercariae, the distribution of phosphorylated Akt substrates in somules was more 
heterogenous when compared to that of phosphorylated Akt (Figure 4.4 c.f. Figure 3.12). 
The phosphorylated substrates in somules appeared to be primarily localised internally 
and the distribution was quite general throughout the parasite (Figure 4.4 a-c). However, 
deep scanning (Figure 4.4 b) revealed a layer of punctate sub-tegumental staining in 
addition to a halo of immunoreactivity surrounding the tegument surface. The single ‘z’ 
Figure 4.3 Cercariae display phosphorylated Akt substrates in the nervous system and 
other anatomical regions. Freshly shed cercariae were fixed and stained with anti-phospho Akt 
substrate antibodies (green) and rhodamine phalloidin (red) to reveal filamentous actin and were 
imaged by confocal microscopy. (a) Whole cercariae showing phosphorylated Akt substrates 
throughout the parasite but particularly at the oral tip, nervous system and tail surface. (b) Close-
up projection of the head reiterates the substrate phosphorylation in the nervous system, clearly 
seen in the cephalic ganglia/longitudinal nerve cords. (c) A deep tissue scan (single z-section) 
of the cercaria tail reveals highly specific staining of the tail nerve cords. a, b = maximum 
projections; bar: 100 μm.  
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scan (Figure 4.4 c) revealed the preacetabular gland in the centre of the parasite with 
slightly greater Akt substrate phosphorylation than the surrounding tissue.  
 
As with cercariae, the overall distribution of phosphorylated Akt substrates in adult worms 
revealed using anti-phospho Akt substrate antibodies was comparable to that achieved 
with anti-phospho Akt antibodies. Substrate staining was seen in the tegument tubercles, 
oral and ventral suckers, and the gynaecophoric canal (Figure 4.5 a-d). The tegument 
tubercles did not appear to be stained as intensely as with the anti-phospho Akt 
antibodies (Figures 3.13 and 3.14) although as the two sets of images were captured on 
different occasions, using different antibodies and with different laser settings, direct 
comparisons cannot be drawn. One observation that can be made however is the lack 
of substrate phosphorylation in the presumed oesophageal sphincter (Figure 4.5 c.f. 
Figure 4.4 Somules display considerable internal signal for phosphorylated Akt 
substrates. 24 h somules were fixed and stained with anti-phospho Akt substrate antibodies 
(green) and rhodamine phalloidin (red) to reveal filamentous actin, then imaged by confocal 
microscopy. (a) Maximum projection displaying general localisation of phosphorylated Akt 
substrates within the somule. (b) Deep tissue scan of the central portion of a somule illustrating 
the general localisation of substrate phosphorylation. (c) A single z-section through the somule 
centre showing only the phosphorylated Akt substrates (no actin). Bar: 50 μm.  
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Figure 3.13). The female worm displayed phosphorylated Akt substrates in the head 
region from the ventral sucker upwards towards the tip of the oral sucker (Figure 4.5 a, 
c). Detailed observations could not be easily made on other features of the female worm 
as she resided within the male. However, deep scans of the pair revealed little to no 
Figure 4.5 Adult worms display phosphorylated Akt substrates in the tegument. 
Approximately 24 h post-perfusion, adult worms were fixed and stained with anti-phospho Akt 
substrate antibodies (green) and rhodamine phalloidin (red) to reveal filamentous actin, then 
imaged by confocal microscopy. (a) Tiled maximum projection of an adult worm pair showed 
substrate activity in the tegument and oral suckers of both male and female worms. (b) Deep 
tissue scanning of the male dorsal region revealed phosphorylated Akt substrates localised at 
the gynaecophoric canal surface and in the tegument tubercles. (c) A higher magnification 
maximum projection of the male and female heads shows in greater detail the substrates in 
the oral suckers and the ‘halo’ of substrate phosphorylation at the worm teguments. (d) A 
maximum projection of the male dorsal region revealed specific localisation of phosphorylated 
Akt substrates to the tegument tubercles. This activity increased towards the tail tip where the 
tubercles are greater in density. Bars: 150 μm.  
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internal substrate staining other than the surface of the gynaecophoric canal (Figure 4.5 
b). 
4.2 Akt in the S. mansoni Genome 
When the first version of the S. mansoni genome was published (Berriman et al., 2009), 
the predicted Akt was annotated as being 776 amino acids (aa) long. The current 
prediction, 586 aa, excludes a sequence encoding gluterodoxin 5 (190 aa) which had 
been incorrectly included in the original protein prediction (Figure 4.6). The original 
predicted protein identifier, Smp_073930 was changed to Smp_073930.1 for Akt and 
Smp_073930.2 for the larger protein that also contained gluterodoxin 57. For 
approximately 18 months, Akt was removed from GeneDB and NCBI. When relisted, it 
had a new identifier, Smp_243630. The functional protein association network analysis 
tool, STRING, was used to predict interactions between Akt and other S. mansoni 
proteins. However, at the time of analysis (Spring 2016) and writing (Summer 2017) the 
STRING database only contained the larger Smp_073930.2. Therefore, any proteins 
identified in the STRING interaction map that were exclusively interacting with 
gluterodoxin 5 were manually removed; only two proteins were predicted to be 
interactors with gluterodoxin 5, Smp_012050 and Smp_139630.  
4.3 Protein Interactions with Akt in S. mansoni 
In any organism, the variety and volume of protein interactions is astonishing. In order to 
further understand the role of Akt in S. mansoni, it is necessary to study the specific 
connections between Akt and other proteins of the parasite, and what purpose they might 
serve. To begin to unravel the complexity of potential Akt protein-protein interactions, 
                                                          
7 http://www.genedb.org [Accessed February 22nd, 2016] 
Figure 4.6 Corrections have been made to the originally annotated Akt gene product.  
Historically (Berriman et al., 2009), Akt was annotated in the genome as being 776aa. Revision 
of the genome (Protasio et al., 2012) resulted in a revised annotation (Smp_073930.2), which 
includes a 190aa Gluterodoxin 5 protein.  
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STRING (Szklarczyk et al., 2011) was used with Smp_073930.2 as input sequence. 
STRING associations are largely derived from predictions or from transferring 
associations/interactions between organisms (‘interlog transfer’); nevertheless STRING 
provides a snapshot of possible interactions with probabilistic confidence scores. The 
maps created with STRING provide a visual perspective of the putative protein network 
and can provide a large amount of data in a relatively short space of time. Initially, a map 
of medium confidence (≥0.40) interactions was constructed with a maximum limit of 500 
proteins (Figure 4.7). The density of interactions shown in the medium confidence map 
indicates the likely importance of Akt  
Figure 4.7 Medium confidence putative protein interaction map for S. mansoni Akt. A 
map was created in STRINGdb (evidence mode) using Smp_073930.2 as input and 
parameters set to maximum 500 interactions at medium confidence (STRING Global Score  ≥ 
0.40). Smp_073930.2, coloured red, appears towards the network centre. The colour code 
indicates the sources for the predicted interactions.  
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Figure 4.8 High confidence putative protein interaction map for S. mansoni Akt 
classified in 12 categories. A. Map in ‘evidence mode’ created in STRINGdb using 
Smp_073930.2 as input and parameters set to maximum 500 interactions at high confidence 
(STRING Global Score ≥ 0.70). B. A view of the same interaction map but with 12 interaction 
clusters (each with a different colour) defined using the KMEANS algorithm; inter-cluster 
edges are shown with dashed lines, interacting proteins with high Global Scores appear in the 
same cluster (colour). Smp_073930.2, coloured green, appears towards the network centre. 
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in many biological processes in S. mansoni. The confidence parameter was then raised 
from ≥0.40 (medium) to ≥0.70 (high). The resulting output table (Appendix 2) comprising 
mapped proteins was saved for further analysis in which putative phosphorylation sites 
were investigated (Section 4.4.1). The high confidence map is clearer to interrogate but 
still reveals a 158 potential Akt protein-protein connections (Figure 4.8 A). 
To begin to understand better the putative protein-protein interactions, an interaction 
map was created categorising the proteins into 12 clusters using the K-Means algorithm 
within STRING (Figure 4.8 B). K-Means analysis aims to determine groups within a data 
set based on the features of each data point without any prior parameters being set8. 
Each colour on the K-Means map represents a different grouping, with the majority of 
proteins being grouped together as green. The STRING software provides no further 
information on the defined groupings but the exercise does provide a useful basic visual 
reference prior to Gene Ontology (GO) analysis.  
4.4 Gene Ontology with High Confidence Akt-Interacting Protein Sequences  
Gene Ontology is a method to meaningfully annotate genes and their products from any 
organism (Ashburner et al., 2000). The three key non-overlapping domains which form 
the basis of GO are present in all organisms and thus make suitable categories: 
‘biological process’, ‘cellular component’ and ‘molecular function’. Biological process is 
defined as a biological objective contributed to by a gene or gene product. A biological 
process often results in a chemical or physical change, requiring a series of molecular 
functions. Examples of biological process terms range from ‘cell growth and 
maintenance’ at high level, to ‘cAMP biosynthesis’ at specific low-level classification. 
Molecular function is described as a gene product’s biochemical activity, or potential 
activity, and details only the function itself, not the location or method of the function. 
Terms including ‘transporter’, ‘enzyme’ or ‘Toll receptor ligand’ would be found in a list 
of molecular functions. Finally, cellular component refers to the location of the gene 
product activity within a cell. Examples include ‘nuclear membrane’, ‘ribosome’ and 
‘Golgi apparatus’. The terms within this domain are representative of eukaryotic cell 
structure knowledge and not all terms can be applied to every organism (The Gene 
Ontology Consortium, 2000).  GO annotation is a highly useful tool for determining 
                                                          
8 https://www.datascience.com/blog/introduction-to-k-means-clustering-algorithm-learn-data-science-
tutorials [Accessed August 3rd 2017]. 
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biological significance within large data sets or to aid in sorting data from novel genomes 
(The Gene Ontology Consortium, 2006).  
To begin GO of the high confidence putative Akt interacting proteins, a list of the high 
confidence Smp numbers retrieved from STRING was imported into Ensembl Metazoa 
and an output table of gene ontology created. The table listed every “GO term name” 
allocated to each Smp number, resulting often in many output terms per protein; from a 
list of 158 high confidence proteins, 940 output terms were received with only six proteins 
not recognised. The basic GO domain data was used to visualise the distribution 
between the three Level 1 GO categories: biological process, cellular component and 
molecular function. The chart reveals that over half of all protein classifications within the 
list of high confidence putative Akt interacting proteins fall under the molecular function 





Figure 4.9 Over half the putative Akt interacting proteins are categorised under the 
GO term ‘molecular function’. The initial categorisation using Ensembl Metazoa, of 158 
high confidence Akt interacting proteins taken from STRINGdb into the three GO parent 
domains; biological process (32%), cellular component (14%) and molecular function (54%).  
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4.4.1 Blast2GO analysis 
The high confidence putative Akt interacting protein list derived from STRING was also 
imported into Blast2GO9, a platform which provides GO data in several forms and allows 
for statistical analysis. Figure 4.10 displays the number of GO terms assigned to each 
protein sequence. The majority of proteins (82%) were assigned 10 GO terms or less, 
contrasting with only 6% which received 20 or more GO terms.  
Blast2GO also produces data regarding the number of annotations per GO level (Figure 
4.10). GO is represented in a direct acyclic graph (DAG) and shows the parent-child 
relationships between terms. Each child term is more specific than its parent term 
although a child term can have more than one parent. These ‘generations’ of terms form 
Levels, so that a data set GO can be studied as whole or cut at a specific level. This 
allows for detailed analysis to be made efficiently. Analysis of levels revealed that Level 
3 was the most suitable for further GO annotation as this level had the highest number 
of annotations across all three domains together (Figure 4.11).  
                                                          
9 https://www.blast2go.com/blast2go-pro [Accessed August 3rd 2017]. 
Figure 4.10 82% of putative Akt interacting sequences have 10 or less GO annotations. 
The distribution of GO terms across the imported high confidence sequences suggests that 
many proteins within the data set have specific functions as opposed to being implicated in 
several areas of cell biology. Chart derived using Blast2GO; Charts > Make Statistics > 
Annotation. 
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Before investigating GO at a specific level, overview graphs of each domain were 
created. Direct GO count graphs display the most commonly annotated terms, 
regardless of GO hierarchy. The top term descending from the biological process root 
was ‘cellular protein modification process’ with 61 sequences annotated (Figure 4.12). 
This term is defined as “The covalent alteration of one or more amino acids occurring in 
proteins, peptides and nascent polypeptides (co-translational, post-translational 
modifications) occurring at the level of an individual cell. This also includes the 
modification of charged tRNAs that are destined to occur in a protein (pre-translation 
modification)” and has 63 potential child terms (EMBL-EBI, 2017). In this data set, this 
term is found at Level 6 (Appendix 3). The most annotated molecular function term (81 
sequences) was ‘ion binding’ (Figure 4.13), defined as “Interacting selectively and non-
covalently with ions, charged atoms or groups of atoms.” (EMBL-EBI, 2017). This term 
is found at Level 3 in the data set and has no child terms (Appendix 4). Finally, the top 
term for cellular component was ‘protein complex’ (Figure 4.14) - “A stable 
macromolecular complex composed (only) of two or more polypeptide subunits along 
with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-
protein prosthetic groups (such as nucleotides or metal ions)” (EMBL-EBI, 2017) (34 
sequences). In this data set, this term features at Level 3 and has no child terms 
(Appendix 5). 
Figure 4.11 GO Level 3 contains the greatest number of annotations across the three 
domains at once. Within the ‘Make Statistics’ function of Blast2GO, data was retrieved on 
the number of annotations per GO level. Biological processes (P) dominate the lower levels 
while cellular component (C) terms are those remaining at high levels; molecular function (F) 
appear more normally distributed. Level 3 was chosen as the most useful for further analysis. 
Chart derived using Blast2GO; Charts > Make Statistics > Annotation. 




Figure 4.12 Direct GO count for the high confidence Akt interacting proteins within the 
biological process (BP) domain. The top 20 most annotated terms across the entire BP 
domain are displayed, regardless of GO hierarchy. Created in Blast2GO; Charts > Make 
Statistics > Annotation. 
Figure 4.13 Direct GO count for the high confidence Akt interacting proteins within the 
molecular function (MF) domain. The top 20 most annotated terms across the entire MF 
domain are displayed, regardless of GO hierarchy. Created in Blast2GO; Charts > Make 
Statistics > Annotation. 
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At Level 3, the top 20 terms for each of the three root domains are represented in Figure 
4.15. This gives a cross-sectional overview of the GO and provides detail on the 
specificity of the terms at this level. The most annotated term at Level 3 in the biological 
process domain, with 87 sequences, is ‘cellular metabolic process’ (GO:0044237: “The 
chemical reactions and pathways by which individual cells transform chemical 
substances.” (Blast2GO, 2017)). At Level 3, this term is a parent to several more specific 
terms, in this case; ‘heterocycle metabolic process’, ‘cellular aromatic compound 
metabolic process’, ‘cellular nitrogen metabolic process’ and ‘cellular macromolecule 
metabolic process’ (Appendix 3). In the molecular function domain, the most annotated 
term (53.3% of sequences) is ‘ion binding’ (GO:0043167:, “Interacting selectively and 
non-covalently with ions, charged atoms or groups of atoms.” (Blast2GO)). Here, this 
term does not have any child terms (Appendix 4). The localisation term which received 
the most annotations in Level 3 of the cellular components domain was ‘intracellular’ 
(GO:0005622: “The living contents of a cell; the matter contained within (but not 
including) the plasma membrane, usually taken to exclude large vacuoles and masses 
of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm.” 
(Blast2GO, 2017)). Of the 32 possible child terms linked with this term, this data set 
Figure 4.14 Direct GO count for the high confidence Akt interacting proteins within the 
cellular component (CC) domain. The top 20 most annotated terms across the entire CC 
domain are displayed, regardless of GO hierarchy. Created in Blast2GO; Charts > Make 
Statistics > Annotation. 
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contained 3; ‘intracellular organelle’, ‘intracellular part’ and ‘intracellular nonmembrane 
bound organelle’ (Appendix 5).  
Next, pie charts were created from combined graphs (Appendix 3-5), which are designed 
to allow the combined annotation of a group of sequences to be visualised together. The 
pie charts show the number of sequences per GO node at a specific level from the 
combined graph of each domain; biological process (Figure 4.16), molecular function 
(Figure 4.17) and cellular component (Figure 4.18), representing similar information as 




Figure 4.15 The biological process domain contains the most terms at Level 3 for the 
high confidence Akt interacting proteins. A GO distribution by level graph created through 
the annotation statistics feature of Blast2GO. A maximum term number of 20 was set.  






Figure 4.16 Level 3 biological processes domain contains 19 nodes. Level 3 pie chart 
created from a combined graph with the parameters; Sequence filter – 13, Nodescore filter – 
0.00, Nodescore alpha – 0.60. A total of 19 nodes each with a minimum of 13 sequences 
annotated. The nodescore is calculated as the sum of sequences associated to a GO term, 
directly or indirectly, each weighted by the distance of the term to the term of direct association.  
Created in Blast2GO 
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4.4.2 Gene Ontology with medium confidence Akt protein interactions 
In addition to GO analysis of the high confidence putative protein connections with Akt, 
analysis was repeated with the additional proteins generated using STRING Global 
Score ≥ 0.40 (medium confidence). Addition of these proteins did not alter the general 
distribution of basic GO terms; biological process, cellular component and molecular 
Figure 4.18 Level 3 cellular components domain contains 10 nodes. Level 3 pie chart 
created from a combined graph with the parameters; Sequence filter – 11, Nodescore filter – 
0.00, Nodescore alpha – 0.60. A total of 10 nodes each with a minimum of 11 sequences 
annotated. Created in Blast2GO 
 
Figure 4.17 Level 3 molecular function domain contains 6 nodes. Level 3 pie chart 
created from a combined graph with the parameters; Sequence filter – 15, Nodescore filter – 
0.00, Nodescore alpha – 0.60. A total of 6 nodes each with a minimum of 15 sequences 
annotated, although in this case each term had at least 25 annotated sequences. Created in 
Blast2GO 
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function (data not shown) as seen in Figure 4.8. However, interrogation of the interacting 
protein list with regard to Akt signalling highlighted some interesting findings. At 0.694 
confidence are listed three putative glucose transporter proteins. One of these 
(Smp_105410) is listed in GeneDB10 as GTP4. Also in the list are members of the Ras 
superfmily, Rab, Rac and Rho. These proteins are known to play a role in vesicle 
trafficking, amongst other things (reviewed by Bustelo et al., 2007).  
4.5 Analysis of Downstream Substrate Proteins 
4.5.1 Bioinformatic analysis of putative substrates 
The list of high confidence (STRING Global Score ≥ 0.70) Akt interacting proteins was 
used to determine which proteins might be actively involved in Akt signalling as 
substrates based on potential Akt phosphorylation sites present within each. In total, 
three phosphorylation prediction platforms were used: KinasePhos, ScanSite3 and 
HRPD (Appendix 3). For each protein, the full (predicted) aa sequence was queried for 
the presence of motifs that comply with Akt phosphorylation requirements; a Ser or Thr 
residue with Arg at -3 and -5 positions (RXRXXS/T). Potential phosphorylation sites were 
tabulated and compared between the prediction platforms. Table 4.1 lists 32 proteins, 
which generated 48 putative Akt phosphorylation sites common across at least two of 
the three databases. The protein with the most putative phosphorylation motifs was 











                                                          
10 http://www.genedb.org/Homepage/Smansoni [Accessed September 10th 2017].  
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Table 4.1 





Smp_053130 40S ribosomal protein S6 (248 aa)* 235 SRSHSLRES 
Smp_099930 F-box and wd40 domain protein, putative (863 aa) 289 SRTQSIPFS 
Smp_064010 Camp-response element binding protein-related (825 aa) 210 RRSSTLAPP 
  614 QRRRSVFTA 
Rac  Rac gtpase, putative (188 aa) 71 LRPLSYPQT 
Smp_039490.1_
mRNA 
Expressed protein (954 aa) 832 KRRYSKTDS 
  887 RRSSSNRPS 
  929 RRSRSFNQR 
  938 HRSRSTDRR 
  947 DRSSSNRYR 
Smp_156680 
Fyve finger-containing phosphoinositide kinase, fyv1, 
putative (2289 aa)* 
591 MRDCSLESL 
  995 SRVKSLNKM 
  1756 ARTHSNSIS 
Smp_104030.3_
mRNA 
Scribble complex protein (Cell polarity protein) (1456 aa) 74 IRLLTLSDN 
  848 ARIQSKTAD 
Smp_105910 CREB-binding protein 1 (SmCBP1) (2093 aa) 1499 RRISTMHRG 
Cdc42 
Cell polarity protein (Regulator of photoreceptor cell 




Arginine/serine-rich splicing factor, putative (371 aa) 189 SRSGSYRSR 
  233 QRSESGNDS 
  304 SRSRSISHS 
  316 SRSRSVESR 
  337 SRSRSMSHR 
  339 SRSMSHRSE 
Smp_062950 Growth factor receptor-bound protein, putative (234 aa) 155 NRLLTLVDL 
Smp_150430 
Forkhead protein/ forkhead protein domain, putative 
(504 aa) 
181 RRTNSLQRS 
Smp_017900 Serine/threonine kinase (806 aa)* 794 VRAKSILTN 
Smp_136750 Serine/threonine kinase (1767 aa)* 423 SRRRSGISS 
  697 KRLISAASE 
Smp_082030 Family C56 non-peptidase homologue (C56 family) (184 aa) 123 KRLTSYPGF 
Smp_072110.1_
mRNA 
Programmed cell death, putative (534 aa) 520 KRFISETDS 
Smp_035390 Protein tyrosine phosphatase n11 (Shp2), putative (708 aa) 708 PRTKS**** 
Smp_139400 Tensin, putative (1704 aa) 1121 GRAFSGSPT 
Smp_196030 GTPase activating protein,putative (745 aa) 503 NRSNSFSES 
Smp_131050 
Camp-dependent protein kinase type II regulatory subunit, 
putative (301 aa) 
254 PRAASAYAV 
Smp_021590 Rac gtpase activating protein, putative (610 aa) 181 GRASSVSHT 
Smp_050830 Synaptojanin, putative (526 aa) 468 HRKNSVSSA 
Smp_065840 DNA topoisomerase 2 (1599 aa) 1482 GRQFSAPPK 
Smp_141540 Thymidine kinase, putative (945 aa) 54 QRRWSVPFQ 
Smp_183460_m
RNA 
Map/microtubule affinity-regulating kinase 2,4, putative 
(108 aa) 
95 RRRSSLDTS 
Smp_016920 Putative uncharacterized protein (203 aa) 153 RRTRSIGPS 
  162 RRSNSMNIF 
Smp_148430 Expressed protein (738 aa) 570 SRSSSLCYN 
Smp_148420 Expressed protein (974 aa) 597 KRLDSLTDE 
  766 RKTISMPPN 
Smp_166200 Axis inhibition protein, axin, putative (1142 aa) 635 SRSYSMAEH 
Smp_085740 Abl-binding protein-related (583 aa) 288 SRKSSGSSG 
Smp_149150 
Acyl-CoA-binding protein (Acbp) (Diazepam binding 
inhibitor) (Dbi) (343 aa) 
125 DRGFSLSKV 
Smp_161230 




Table 4.1 Several putative Akt interacting proteins possess one or more potential Akt 
phosphorylation sites. An exert taken from appendix 3 showing those phosphorylation sites 
of high confidence proteins (>0.70) which were in accordance across at least two of the three 
phosphorylation site prediction platforms, KinasePhos, ScanSite3 and HRPD.  
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4.5.2 S. mansoni homologues of human Akt substrates –Glycogen Synthase Kinase -3 
Akt has many known substrates in humans (Figure 1.7). To begin to assess if any of 
those substrates have S. mansoni homologues, experiments were designed to study 
glycogen synthase kinase-3 α/β (GSK-3α/β) within the parasite. 
Figure 4.19 Multiple pairwise alignment of Schistosoma mansoni (Sm)GSK-3 with 
human (Hs)GSK-3α/β proteins. Alignment of the GSK-3 protein to compare S. mansoni 
(CCD75971.1), H. sapiens GSK-3α (NP_063937.2) and H. sapiens GSK-3β 
(NP_001139628.1). The alignment was created using MUSCLE. The Kinase domain is shown 
in red and the black dots indicate important conserved residues for phosphorylation of GSK-
3; Hs(Ser9/21) and Hs(Tyr216/279). The colours range from light grey to black showing least 
conserved to most conserved residues, respectively, as determined by the MUSCLE software. 
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GSK-3 is involved in the regulation of many signalling pathways including those 
implicated in glucose metabolism, cell cycle regulation, and innate and adaptive 
immunity (Beurel et al., 2010; Giambelluca et al., 2013). GSK-3 lies downstream of Akt 
and is present as two distinct isoforms in humans, GSK-3α and GSK-3β (Zhao et al., 
2013). Unusually, GSK-3 is constitutively active until phosphorylated in response to 
external signals; for example, inactivation by Akt occurs when stimulated by insulin 
(Cross et al., 1995). GSK-3α and GSK-3β are phosphorylated at Ser21 and Ser9 
respectively (Dajani et al., 2001). In addition to GSK-3α/β in humans, several GSK-3 
proteins have been identified in other organisms, such as in Saccharomyces cerevisiae 
and D. melanogaster (Osolodkin et al., 2011). Bioinformatic analysis of GSK-3β across 
parasites performed by Osolodkin et al. (2011), revealed that S. mansoni GSK-3 
possesses 88% kinase domain similarity to human GSK-3β. Figure 4.19 shows a multiple 
pair-wise alignment between SmGSK-3, HsGSK-3α and HsGSK-3β. As the alignment 
demonstrates, the currently annotated/predicted S. mansoni protein is shorter than its 
human counterparts at the N-terminus. Within these additional human residues is Ser9/21, 
which HsGSK-3α/β requires be phosphorylated to inactivate the protein. With this 
residue missing from the annotated SmGSK-3, it is unsurprising that the antibody against 
Figure 4.20 Detection of GSK-3α/β in S. mansoni. ~1000 untreated, 24 h somules were 
processed for western blotting with either anti phospho-GSK-3α/β (Ser9/21) or anti phospho-
GSK-3α/β (Tyr216/279) antibodies. Membranes were then stripped and re-probed with anti-actin 
antibodies to determine protein loading. Relevant molecular weight markers are indicated. 
Blots are representative of two experiments.  
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Ser9/21 (human) was unsuccessful when tested with S. mansoni parasite material (Figure 
4.20). However, antibodies against phosphorylated GSK-3α/β (Tyr216/279) successfully 
detected a GSK-like protein at the predicted molecular weight (53 kDa) in S. mansoni 
somules (Figure 4.19). Further troubleshooting using the anti- GSK-3α/β (Ser9/21) was 
therefore not undertaken. 
Using anti-phospho GSK-3α/β (Tyr216/279) antibodies, western blotting confirmed that, as 
in humans, S. mansoni GSK-3 is inversely activated by Akt. When somules were 
incubated in the stimulants insulin and L-arginine, GSK-3 signal was no more apparent 
than in the control samples (Figure 4.21). However, when treated with Akt Inhibitor X, 









Figure 4.21 S. mansoni GSK-3α/β phosphorylation (activation) is increased when Akt is 
inhibited. 24 h somules (~1000) were treated with 1 μM insulin (10 min), 100 μM L-arginine 
(30 min) or 10 μM Akt Inhibitor X (60 min). Samples were processed for western blotting with 
anti-phospho GSK-3α/β (Tyr216/279) antibodies. Membranes were then stripped and re-probed 
with anti-actin antibodies to determine protein loading between lanes. The blot is 
representative of results obtained in three experiments. 
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Summary: 
This chapter has reported the global distribution of Akt substrates in S. mansoni human-
infective/resident life stages and has considered the identity of putative Akt interacting 
proteins via bioinformatic analysis.  
Western blotting with anti-phospho Akt substrate antibodies revealed approximately 
twelve Akt-like substrates detectable in cercariae, somules and adult male and female 
worms. These substrates were then mapped within each parasite stage, and the 
phosphorylated Akt substrate distribution broadly mirrored that of activated Akt, with the 
exception of somules, which displayed a more general substrate phosphorylation 
throughout the parasite.  
Given the potential for a large Akt signalling network being present in S. mansoni, as is 
the case in mammals, a bioinformatic analysis was performed to help unravel the nature 
of signalling downstream of Akt in schistosomes. Initially, STRING analysis defined 158 
putative Akt interacting proteins at a high confidence (STRING Global Score ≥ 0.70). 
Gene ontology of those proteins highlighted the wide range of cellular processes that 
SmAkt is potentially involved in.  
Analysis of potential phosphorylation sites within the putative high confidence Akt 
interactors revealed 32 sequences that possessed one or more specific motif 
requirements for Akt phosphorylation.  
Finally, a known substrate of human Akt, GSK-3α/β, was tested for in S. mansoni 
somules. Conservation of the two species genes was high at 88% and immunoblotting 
supported that Akt in S. mansoni blocks GSK-3 activity as it does in humans.  
This chapter has highlighted the central position of Akt within S. mansoni cell signalling 
and has opened potentially important avenues for future research. 
 





Results 3 – Akt in the tegument: A role 
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As discovered during the immunolocalisation work (Chapter 3), activated Akt localises to 
the tegument of somules and adult worms. Numerous studies have been dedicated to 
researching the schistosome tegument as it is the point of contact with the mammalian 
host blood and therefore has the potential to possess novel drug targets (van Balkom et 
al., 2005; Braschi et al., 2006b; Braschi and Wilson, 2006; Loukas et al., 2007; Castro-
Borges et al., 2011; Collins et al., 2016). Given the possibility of targeting Akt in 
schistosomes for parasite control, this chapter focused on investigations into the role of 
Akt in this parasite host-interactive layer.  
Having validated Akt Inhibitor X for use in schistosomes to supress Akt activation, initial 
experiments focused on evaluating the possible effects of this inhibitor on tegument 
structure/morphology, particularly given that the tegument is known to turn over rapidly 
in vitro and in vivo (Van Hellemond et al., 2006). Subsequently, a functional application 
for Akt in the tegumental layer was identified via experiments exploring the connection 
between Akt and the facilitated glucose transporter protein, SGTP4.  
5.1 Activation of Akt in the Tegument of S. mansoni  
In Chapter 3, activated Akt had been identified in the tegument via immunolocalisation. 
Thus, tegument stripping was performed to demonstrate the presence of Akt in this 
structure by western blotting; the effect of human insulin on phosphorylation of 
tegumental Akt was also determined. Stripping the tegument from adult worms involved 
snap-freezing them in liquid nitrogen and vortexing to remove the outer layer of the 
worms (Roberts et al., 1983); samples were then centrifuged to isolate the particulate 
membranous fraction. Male and female adult worms were treated with or without human 
insulin and their teguments stripped and processed for western blotting with anti-
phospho Akt (Thr308) antibodies. Phosphorylated Akt was detected in both the 
membranous particulate fraction and the cytoplasmic fraction, and the total pool of 
phosphorylated Akt increased approximately 2.1 fold and 1.5 fold (p≤0.01), respectively 
when worms were treated with human insulin compared with the controls (Figure 5.1).  
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5.2 Inhibition of Adult S. mansoni Akt by Akt Inhibitor X   
5.2.1 The role of Akt in S. mansoni tegument morphology 
To ascertain the effects of Akt inhibition on the gross phenotype of the parasite, an 
observational study of adult worms incubated with 10 μM Akt Inhibitor X was conducted 
over five days with daily inhibitor replenishment. Observations under high-power light 
microscopy revealed that the tubercles on the tegument of male worms appeared larger 
after 48 h. Their appearance was swollen and less uniform in comparison to those on 
the control worms, which were small, neat and close together. Also ‘blebbing’ was 
observed at the tegument surface from day three, a phenomenon previously noted in the 
literature in response to drug treatments (Becker et al., 1980; Manneck et al., 2010). 
Other observations made included the longitudinal uncurling of male worms in the 
presence of the inhibitor. Rather than being curled around in their normal shape, the 
Figure 5.1 Akt is present in the tegument of adult S. mansoni and can be activated by 
human insulin. A. Mixed populations of male and female worms (10 worms/treatment) were 
treated with human insulin (1 μM) for 10 min or not and their teguments stripped and the 
membranous particulate fraction isolated. The fractions containing the particulate and 
cytoplasmic samples were western blotted with anti-phospho Akt (Thr308) antibodies. Blots were 
also stripped and re-probed with anti-actin antibodies to ascertain protein loading levels. B. Blots 
from 3 independent experiments were analysed using GeneTools and the mean relative increase 
in Akt phosphorylation (±S.D.) in response to insulin calculated with respect to actin. **p≤0.01, 
when compared with control levels (represented by the dotted line)  
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worms flattened and appeared ribbon-like. After 24 h in 10 μM Akt Inhibitor X, the male 
worms were also seen to be more active, displaying a greater frequency of twisting, 
turning and whip-like movements. This was not seen with the lower doses of the inhibitor. 
Also after ~24 h, worms became increasingly opaque the longer they remained in the 
inhibitor, a phenomenon thought to indicate pending parasite death, although some 
worms were observed for several days in this state. Finally, Akt Inhibitor X seemed to 
induce shrivelling of the oral and ventral suckers, and initially was thought to affect the 
worm’s ability to adhere to the culture plate surface, but this observation was not seen 
consistently.  
An experiment was thus designed to quantify the response of the tubercles to Akt 
Inhibitor X by capturing photomicrographs and analysing them with ImageJ to measure 
the area of the tegument protrusions with and without treatment. Representative images 
from control and 10 μM Akt Inhibitor X treated worms are displayed in Figure 5.2 A. The 
outcomes of this experiment were not striking but an upward trend in the size of the 
tubercles was apparent after treatment with 10 μM Akt Inhibitor X (Figure 5.2 B). 
Additionally, there was a marked decrease in the mean tubercle area over the five days 





















Figure 5.2 Incubation of adult worms in Akt Inhibitor X promotes increased tubercle size 
over 5 days. Male adult worms (5 per well) were maintained in RPMI and increasing 
concentrations of Akt Inhibitor X or not (control) for up to 5 days. A. Worms were photographed 
daily using LEICA microscope/tablet image capture system (x10 objective). The light intensity 
was adjusted to view the tubercles clearly but was maintained constant for each day. B. The 
mean tubercle area (±S.D., n ≥ 45) was then calculated by analysing micrographs using ImageJ.* 
p≤0.05, *** p≤0.001.  
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5.2.2 The effect of Akt inhibition on worm phenotype by histological analysis  
In an attempt to better analyse the tubercle size following treatment, worms were 
processed for histology so that the tegument tubercles could be observed in cross 
section. Based on the previous observations (Figure 5.2), male worms were treated with 
1 μM or 10 μM Akt Inhibitor X and incubated for four days with daily media/inhibitor 
replenishment. Worms were fixed, sectioned, and processed for histology, sections 
visualised under a Nikon Ni-E microscope and images captured for analysis. Images of 
tubercles only on the anterior dorsal surface of the males were captured to control for 
possible regional differences between individual worms. Nikon NIS-Elements BR 
software was used to measure the diameter in μm across the base of tubercles in each 
image. This approach was chosen because measuring the height of the tubercles was 
impractical given there is no clear starting point from which to measure. The analysis 
revealed that there was an upward trend in mean diameter size following treatment with 
Figure 5.3 Male adult worm tubercle morphology is affected by treatment with Akt Inhibitor 
X. A. Male adult worms (5 per well) were incubated for 4 days in RPMI and increasing 
concentrations of Akt Inhibitor X or not (control), replenished daily. Worms were fixed in 10% 
neutral buffered formalin and processed for histology. Images were captured at x40 magnification 
and tubercle diameter was measured using Nikon software. B. The mean tubercle diameter 
(±S.D., n ≥ 40) was calculated. ***p≤0.001, when compared with control levels. 
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1 μM and 10 μM Akt Inhibitor X increasing tubercle diameter by 14.9 % and 23.5 % 
respectively (p≤ 0.001) (Figure 5.3). Figure 5.3 A shows representative images for each 
treatment and it is apparent that the tubercles of worms treated with 10 μM Akt Inhibitor 
X protrude further from the tegument surface. 
5.3 A Role for Akt in Glucose Transport in S. mansoni 
It is well documented that schistosomes rely on a supply of blood glucose to survive 
(Rogers and Beuding, 1975; Uglem and Read, 1975). Each adult worm metabolises its 
dry weight in glucose every ~5 h, sourced from the host blood (Bueding, 1950). Glucose 
transporter proteins (GTPs) exist in almost all organisms, with the exception of anaerobic 
bacteria, to carry essential glucose across the hydrophobic membrane into cells for 
metabolism. In schistosomes, four glucose transporters have been identified in the 
genome, SGTP1, 2, 3 and 4, with SGTP1 and SGTP4 being the focus of studies as the 
only two displaying functional glucose transport activity (Skelly et al., 1994). SGTP1 is 
found in the majority of schistosome life stages, whereas SGTP4 is specifically present 
in the definitive host resident life stages (somules to adult worms) (Skelly and 
Shoemaker, 1996). Whilst both transporters are found in the tegument of somules and 
adult worms and their distribution appears consistent along the length of male and female 
adult worms, there is a crucial difference in their specific localisation within these life 
stages. SGTP1 is located at the basal tegument membrane and within the parasite body, 
whereas SGTP4 is found specifically at the apical tegument membrane, indicating that 
SGTP4 interacts initially with host glucose at the parasite surface to facilitate diffusion 
into the worm (Skelly and Shoemaker, 1996).  
5.3.1 SGTP4 in the apical tegument membrane 
Close examination of overlay images showing SGTP4 and filamentous actin confirm that 
in S. mansoni somules and adult worms, SGTP4 is expressed exclusively in the apical 
membrane (Figure 5.4) as reported by Skelly and Shoemaker (1996). At 1 h post-
transformation, SGTP4 was observed in discontinuous patches around the apical 
membrane of somules. During this stage of SGTP4 evolution at the parasite surface, 
areas could be identified where the glucose transporter was erupting from sub-
tegumental cytons (Figure 5.4 (inset)).  
In adult worms, SGTP4 expression at the apical membrane is well established and single 
z scans of the male and female tegument reveal a narrow space between SGTP4 
localisation and the sub-tegumental muscle layer, indicating that no SGTP4 is present in 
the basal tegument membrane adjacent to the muscle.  
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Having demonstrated that Akt in S. mansoni host-resident life stages is primarily 
localised within the parasite tegument and is activated by host insulin (Chapter 3), the 
possibility that Akt is linked to the expression of SGTP4 and schistosome glucose uptake 
was explored. This hypothesis was further supported by evidence of the immediate 
evolution of SGTP4 at the somule surface after transformation (Skelly and Shoemaker, 
1996), and the fact that human Akt is already known to play a role in glucose uptake 
(Schultze et al., 2012).  
5.3.2 Akt regulates the surface expression of SGTP4 in somules 
As reported by Skelly and Shoemaker (1996), SGTP4 expression begins after cercariae 
have started to transform into somules with SGTP4 evolving at the surface of the parasite 
within hours. Hence, to establish whether or not Akt influences SGTP4 expression, 
freshly-shed cercariae were incubated in water at room temperature with Akt Inhibitor X 
for 60 min to enable the inhibitor to penetrate the cercaria prior to transformation. 
Following tail detachment, somules were suspended in RPMI and Akt Inhibitor X, 
incubated at 37 °C, and samples at 30, 60 and 120 min post-transformation processed 
for western blotting with anti-SGTP4 and anti-phospho Akt (Thr308) antibodies. The 
Figure 5.4 SGTP4 is expressed exclusively in the apical tegument membrane of S. mansoni 
somules and adult worms. Single z scans of a somule, male and female adult worms stained 
with anti-SGTP4 antibodies (green) and filamentous actin (red).  
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temperatures used aimed to replicate the conditions the parasite would experience 
during host location/infection. At 30 min, there was a relatively low level of SGTP4 
expression in the absence of the inhibitor, which increased substantially after 60 min. 
However, treatment of somules with 10 μM Akt Inhibitor X, which reduced Akt activation, 
resulted in a striking suppression of SGTP4 expression 60 min and 120 min post 
transformation (Figure 5.5), when compared to those not exposed to the inhibitor. These 
results provided the first indication of a link between Akt and SGTP4 expression in the 
developing parasite.  
 
5.3.3 Inhibition of Akt blunts SGTP4 expression at the somule surface 
To determine the effect of Akt inhibition on the localisation of SGTP4 in somules 
immunohistochemistry and confocal laser scanning microscopy were employed. Over 
the three times points studied (30, 60 and 120 min), in the control samples SGTP4 
expression was seen to evolve across the somules in an anterior to posterior direction, 
after which it appeared to migrate from the sub-tegumental cyton network to the 
tegument surface (Figure 5.6). This was concurrent with previous research by Skelly and 
Shoemaker (1996). In contrast, the parasites treated with 10 μM Akt Inhibitor X showed 
little to no SGTP4 expression until 120 min, where low levels of SGTP4 appeared to 
remain in the sub-tegumental cyton network (Figure 5.6). Thus Akt inhibition appears to 
Figure 5.5 Inhibition of Akt reduces SGTP4 expression in S. mansoni somules.  Cercariae 
were treated for 1 h with Akt Inhibitor X (10 μM) (or not, control) at room temperature immediately 
after being shed from snails. The cercariae were then subject to mechanical transformation and 
were placed in RPMI along with 10 μM Akt Inhibitor X or not. The samples were then incubated 
at 37°C, 5% CO2, for increasing durations. Somule proteins were then processed for western 
blotting with anti-phospho Akt (Thr308) antibodies before re-probing with anti-SGTP4 antibodies; 
Blots were also probed with ant-actin antibodies to confirm similar protein loading between 
samples. The blot shown is representative of four experiments. 
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supress not only the expression of SGTP4 but its transport to the parasite surface over 
120 min.   
To quantify the development of SGTP4 at the tegument of somules, individual z-sections 
were captured through 30 somules at each time point (15 control/15 inhibited) and Leica 
image analysis software used to determine the intensity of the signal from the SGTP4 
staining at the tegument. To illustrate the overall variability in SGTP4 staining pattern 
between treatments, at each duration, a montage of all z-sections was constructed for 
comparison (Figure 5.7). For quantification, lines were drawn through the anterior and 
posterior quarters of each somule and the fluorescence intensity recorded (Figure 5.8 
A); the charts under each image (Figure 5.8 A) represent the signal intensity measured 
across each line, with peaks at both ends indicating the increase in signal at the 
intersection with the tegument. Analysis of the fluorescence intensity data (Figure 5.8 B), 
Figure 5.6 Inhibition of Akt supresses the expression of SGTP4 at the S. mansoni somule 
surface during transformation. Cercariae were treated for 1 h with Akt Inhibitor X (10 μM) or 
not (control), at room temperature immediately after being shed from snails. The cercariae were 
then subject to mechanical transformation and were placed in RPMI containing 10 μM Akt 
Inhibitor X or not. The samples were then incubated at 37°C, 5% CO2, for increasing durations. 
Somules were fixed in 4% paraformaldehyde and processed for immunohistochemistry with anti-
SGTP4 antibodies (green); rhodamine phalloidin was also used to stain filamentous actin (red). 
Maximum projection images were captured for somules at each time point and for each treatment. 
Laser setting were maintained the same throughout. Bar: 25 μm.  
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revealed that Akt Inhibitor X significantly reduced SGTP4 expression at the somule 
tegument (p≤0.001) at both anterior and posterior ends (by 75% and 88%, respectively 
at 120 min), with the exception of the 30 min time point where the posterior of the somule 
showed minimal SGTP4 signal in the control.  
Figure 5.7SGTP4 localisation is consistent across all 15 individual S. mansoni somules. 
Displaying only the green laser channel, z-section images were captured through 30 anti-STGP4 
stained (green) somules per time point (15 control/15 treated). Tiling of images demonstrates the 
consistency of SGTP4 expression with and without inhibition. Bar: 25 μm.  
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Figure 5.8 Akt Inhibitor X attenuates SGTP4 expression in S. mansoni somules.                      
A. Immunohistochemistry and expression analysis of SGTP4 at the tegument towards the anterior 
(lines ♯1 - ♯2) and posterior (lines ♯3 - ♯4) of the transforming somules, images are single z-
sections through the centre of somules. B. Mean fluorescence intensity of SGTP4 expression at 
the tegument was calculated over time (graph; mean ±S.D., n=30 per treatment); ***p≤0.001 
(ANOVA). 
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5.3.4 Glucose Assay in Somules 
Having established that the developmental expression of SGTP4 in somules could be 
impeded by treatment with Akt Inhibitor X, a glucose assay was used to monitor glucose 
uptake, with and without inhibitor treatment. A plate-based Glucose Uptake-Glo 
bioluminescence assay was used to measure the ability of the parasites to import 
glucose based on the detection of 2-deoxyglucose-6-phosphate (2DG6P); 2DG6P is 
processed by mammalian cells in the same manner as glucose (Yoshiyama et al., 1995).  
Here, somules were treated as for the immunohistochemistry experiments although only 
60 min and 120 min time points were done. Over three independent assays, Akt inhibitor 
X treatment supressed mean relative glucose uptake by 56% and 74% at 60 min and 




5.4 The Role of SGTP4 in Adult S. mansoni 
Figure 5.9 Akt Inhibitor X reduces glucose uptake over time in S. mansoni somules. 
Cercariae (1000 per treatment) were treated for 1 h with Akt Inhibitor X (10 μM) or not (control), 
at room temperature immediately after being shed from snails. The cercariae were then subject 
to mechanical transformation and were placed in RPMI containing 10 μM Akt Inhibitor X or not. 
The samples were then incubated at 37°C, 5% CO2, for 60 min or 120 min, washed in PBS and 
subjected to glucose uptake assay in the presence of Akt Inhibitor X. Luminescence readings 
were taken at 1h. Mean relative glucose uptake was calculated from three independent 
experiments (±S.D.); *** p≤0.001 (ANOVA). 
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5.4.1 RNAi of Akt attenuates SGTP4 expression in adult worms  
To definitively show that Akt signalling is linked to SGTP4 expression, RNAi of Akt was 
performed. Male and female adult worms were separately electroporated with siRNAs 
targeting Akt (see section 3.4) and were then maintained in Opti-MEM for five days. In 
both sexes, knockdown of Akt protein expression was successful (Figure 5.10). 
Furthermore, knockdown of Akt resulted in a marked reduction in SGTP4 expression 
(Figure 5.10) - 59% and 47% in male and female worms, respectively based on duplicate 
experiments. This demonstrates that SGTP4 expression is influenced by signalling via 
the Akt pathway.  
 
5.4.2 SGTP4 in adult S. mansoni is affected by Akt inhibition 
Experiments next aimed to determine whether Akt plays a role in glucose uptake in adult 
worms by affecting the overall expression of SGTP4 and its maintenance at the parasite 
surface. Male and female worms were separated and treated overnight (20 h) with 10 
μM Akt Inhibitor X. Because of the tegumental turnover that exists in adult schistosomes, 
it was hypothesised that existing SGTP4 would be shed from the parasite surface, and 
that new de novo expression of SGTP4 would be supressed by this longer-term Akt 
inhibition. Inhibition of SGTP4 expression was more apparent in the adult female worms 
compared to the males despite Akt not being completely inhibited (Figure 5.11). The 
Figure 5.10 SGTP4 expression is reduced in adult S. mansoni by the knockdown of Akt. 
Adult male and female worms were processed separately for RNAi. Worms were electroporated 
with SiRNA targeting Akt and after 5 days, worms were processed for western blotting with anti-
Akt antibodies before stripping the membranes and re-probing with anti-SGTP4 and subsequently 
anti-actin antibodies, with anti-actin used as a loading control. The blot is representative of results 
obtained in two independent experiments.  
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reduced inhibition of Akt is likely due to the low basal level of Akt present in female 
worms. In male worms, an apparent decrease in both phosphorylated Akt and SGTP4 
expression was observed over two experiments.  
As with the somules, the next experiments aimed to evaluate the effects of Akt inhibition 
on the localisation of SGTP4 at the parasite surface. Male and female worms were 
incubated for 20 h in Akt Inhibitor X then fixed and processed for immunohistochemistry 
using anti-SGTP4 antibodies. Confocal laser scanning microscopy revealed that in both 
sexes, SGTP4 was observed primarily in the tegument (Figure 5.12). Akt Inhibitor X-
treated worms displayed a weaker signal although SGTP4 expression at the parasite 
surface was not completely supressed. This mirrors the outcomes of the expression 
analysis by western blotting (Figure 5.11). Thus, the residual SGTP4 expression 
observed could be due to partial Akt inhibition or sustained presence of SGTP4 at the 




Figure 5.11 SGTP4 expression is inhibited in adult S. mansoni by Akt Inhibitor X. Adult male 
and female worms were separated approximately 24 h post perfusion. 10 worms were treated (or 
not) with 10 μM Akt Inhibitor X in RPMI overnight (20 h) and incubated at 37°C, 5 % CO2. Worms 
were washed, homogenised and processed for western blotting with anti-phospho Akt (Thr308) 
antibodies before stripping and re-probing with anti-SGTP4, and anti-actin antibodies to confirm 
that similar amounts of protein were loaded from each sample. The blot shown is representative 
of those obtained in two independent experiments. 











Figure 5.12 Akt Inhibitor X reduces SGTP4 expression at the surface of adult S. mansoni. Adult 
male and female worms were treated separately for 20 h in RPMI supplemented with 10 μM Akt Inhibitor 
X. Worms were fixed and processed for immunohistochemistry with anti-SGTP4 antibodies (green). 
Rhodamine phalloidin was used to stain filamentous actin (red). Bar: 75 μm. 
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5.4.3 Glucose Assay in Adult Worms 
The Glucose Uptake-Glo bioluminescence assay was next used with adult worms to 
measure glucose uptake in both sexes when subjected to Akt inhibition. Worms were 
incubated for 20 h with Akt Inhibitor X then assayed (1 male or 3 females per well). A 
significant decrease in glucose uptake of 38 % (p≤0.01) and 37 % (p≤0.01) was observed 
in male and female worms, respectively (Figure 5.13). To determine protein levels 
between male and female worms in the assay, the same worms were processed for 
western blotting with anti-actin antibodies, and the glucose uptake assay results were 







Figure 5.13 Glucose uptake in adult S. mansoni is reduced by Akt Inhibitor X treatment. Males 
and female worms were incubated separately overnight (20 h) in 10μM Akt Inhibitor X or not 
(control), at 37°C, 5% CO2. Worms were then subjected to a glucose uptake assay in the presence 
of Akt Inhibitor X or not. Luminescence readings were taken at 30 min and mean relative glucose 
uptake was calculated compared to the controls (±S.D.; n=4 for males, n=5 for females). **p≤0.01, 
***p≤0.001 (ANOVA).  
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Summary: 
This chapter has encompassed novel research conducted on the schistosome tegument. 
Initial observations revealed that in somules and adult worms, phosphorylated Akt is 
localised primarily in the tegument (Chapter 3, section 3.4). This discovery prompted 
further investigation into the role that Akt might be playing in this host-interactive layer.  
Initially, western blotting of adult worm tegument membrane fractions confirmed the 
presence of Akt in this layer and demonstrated that insulin significantly increased 
tegumental Akt phosphorylation. Following this, observational studies using light 
microscopy revealed that the tegument surface is disrupted following treatment with 
increasing concentrations of Akt Inhibitor X. Specifically, the tubercles in worms exposed 
to 10 μM inhibitor appeared larger and less uniform than their untreated counterparts.  
Next a possible link between Akt activation in the tegument and schistosome glucose 
transporter expression was evaluated. In somules, SGTP4 expression at the tegument 
surface was significantly supressed following Akt inhibition, as observed using 
immunolocalisation/confocal microscopy and western blotting. Further analysis 
confirmed that the intensity of SGTP4 expression at both anterior and posterior ends of 
the somules was substantially attenuated by incubation in Akt inhibitor X. Furthermore, 
glucose uptake assays revealed that Akt Inhibitor X treatment reduced glucose transport 
in somules with 74% less glucose imported into the parasite after a 2 h incubation with 
the inhibitor.  
In adult worms, RNAi established a definitive link between the activated Akt kinase and 
expression of the facilitated glucose transporter, SGTP4. SiRNA-mediated knockdown 
of female and male worm Akt resulted in reduced expression of the transporter protein 
(47% and 59% respectively). Western blotting demonstrated inhibition of SGPT4 
expression after treatment with Akt Inhibitor X and immunohistochemistry demonstrated 
the apparent reduction in SGTP4 at the tegument surface. As with somules, glucose 
uptake in adults was reduced significantly, by 38% and 37% in male and female worms 
respectively, following Akt inhibitor X treatment. 
Collectively these results demonstrate a novel role for Akt in S. mansoni glucose import 
processes, which significantly advances our understanding of schistosome biology, 
particularly in relation to host-parasite interactions.  





Results 4 – A putative role for Akt in S. 
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Of all the schistosome life cycle stages, cercariae have possibly the most challenging 
task – to infect a mammalian definitive host, especially given that this larval stage is 
viable for up to 72 h (Gryseels et al., 2006). How the parasite finds and enters the host 
was unknown until three decades ago, when studies began characterising the chemical 
and environmental signals, including various host skin elements, sensed by cercariae 
(Granzer and Haas, 1986; Ressurreição et al., 2015). Among the chemical skin 
elements, cercariae behaviour is influenced by L-arginine and fatty acids such as linoleic 
acid (LA) (Haas et al., 2002; Ressurreição et al., 2015). Also known to be a key factor in 
host penetration is the cercarial tail, serving a purely motor-functional role (Walker, 
2011). Given that L-arginine has been demonstrated to be an effective stimulator of Akt 
activation (Chapter 3), and that activated Akt/phosphorylated Akt substrates (Chapter 4) 
have been shown to be present in the tail, the possible link between Akt activation status 
and cercarial movement/host sensing was explored.  
6.1 S. mansoni Cercariae Display Distinct Phosphorylated Akt Localisation 
Patterns 
During immunohistochemical analysis of cercariae (Chapter 3), single z scans through 
the parasite revealed distinct spots of phosphorylated Akt close to the surface of the 
parasite that appeared in pairs. Two pairs of spots were consistently seen in the head 
region, with the anterior pair somewhat larger than the posterior pair (Figure 6.1 A1 c.f. 
A2). Given previous work on the structure of schistosome life stages (Senft et al., 1961; 
Bahia et al., 2006), these spots were presumed to be flame cells. Flame cells are ciliated 
cells, localised in the basal membrane, forming part of the protonephridial system (Sato 
et al. 2002). The protonephridium functions as a means of excreting waste products 
(Valverde-Islas et al., 2011) and the flame cells are the cellular termini, producing 
excretory vesicles (Sato et al. 2002). Knowledge of this excretory system is limited due 
to lack of techniques to study excretion (Valverde-Islas et al., 2011).  
Along the length of the cercaria tail, a number of ‘hotspots’ of phosphorylated Akt were 
also observed, with approximately six pairs seen in all samples visualised. A pair was 
also noted close to the head-tail junction, although this was seen less consistently. Given 
that phosphorylated Akt was also observed in the tail nervous system (Chapter 3) the 
possibility remains that the identified punctate regions of intense Akt activation (Figure 
6.1 B) could be due to the presence of sensory receptors indicating that the tail may also 
participate in host localisation in response to certain cues.  
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6.2 Exposure of Cercariae to Host Factors 
6.2.1 The effects of L-arginine on Akt phosphorylation in cercariae 
As a mammalian skin component, L-arginine has been reported to play an important role 
in the location and penetration of suitable hosts by cercariae (Granzer and Haas, 1986; 
Haas et al. 2002). In previous assays using L-arginine, the optimum time point for 
Figure 6.1 Akt activation near the surface of cercariae occurs in multiple distinct punctate 
regions. Freshly shed cercariae were processed for immunohistochemistry with anti-phospho 
Akt (Thr308) primary and Alexa Fluor 488 secondary antibodies (green). Rhodamine phalloidin 
was used to stain filamentous actin (red). A1. A pair of distinct punctate regions at the anterior 
of the head. A2. A second pair of punctate regions located posteriorly. B. Pairs of punctate Akt 
activity in the cercarial tail. The images are representative of the staining pattern observed across 
multiple specimens in several independent experiments. Bar: 50 μm.  
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stimulation of Akt in mechanically transformed 24 h somules when measured by western 
blotting was 30 min (Chapter 3, Section 3.5.3). To understand how cercariae might 
respond differently to somules, cercariae were exposed to L-arginine for increasing 
durations and processed for western blotting and immunohistochemistry. The results 
from immunohistochemical analysis indicated a minor increase in the phosphorylation of 
Akt from 1 – 10 min (Figure 6.2 A). The increased Akt activation occurred mainly in the 
tail although at 10 min, Akt in the head region also appeared more phosphorylated. From 
15 min onwards, levels of phosphorylated Akt appeared comparable to the control. In 
contrast, western blotting revealed that the phosphorylation of Akt increased at 5 min 
exposure and was sustained until 30 min, declining to basal levels thereafter (Figure 6.2 
B).  
6.2.2 The effects of linoleic acid on Akt phosphorylation in cercariae 
Linoleic acid (LA) is a polyunsaturated fatty acid component of human skin, which has 
been shown previously to stimulate signalling via more than one kinase pathway in S. 
mansoni (Ressurreição et al., 2015). Given that Akt had been located at the oral tip of 
cercariae (Chapter 3, section 3.4.1) it was hypothesised that Akt may be stimulated 
within cercariae upon contact with LA.  
As with L-arginine, the effect of LA on cercariae Akt activation was investigated using 
both western blotting and immunohistochemistry. Confocal laser scanning microscopy 
of stained cercariae revealed inconsistent localisation of phosphorylated Akt. There are 
noticeable increases in Akt activity at 5 min and 15 min compared to the control, with 
minimal Akt activation seen at the remaining time points (Figure 6.3 A), raising the 
possibility that Akt is activated in waves in response to L-arginine rather than 
continuously. The increase in Akt phosphorylation at 5 and 15 min was seen exclusively 
in the tail and at the oral tip of the cercariae, highlighting the possible importance of these 
areas in the series of events leading to host invasion. At 15 min, the structures at the 
oral tip are present as a ring of small nodules, clearly displaying phosphorylated Akt. 
Previously, these structures were only seen with anti-Akt antibodies (section 3.5). 
Western blot results showed only a moderate increase in Akt phosphorylation up to 30 
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Figure 6.2 L-arginine stimulates Akt phosphorylation in S. mansoni cercariae. Freshly 
shed cercariae were exposed to 100 μM L-arginine for increasing durations (1 – 45 min) or 
not (control). A. Cercariae were processed for immunohistochemistry with anti-phospho Akt 
(Thr308) primary and Alexa Fluor 488 secondary antibodies (Green). Rhodamine phalloidin 
was used to stain filamentous actin (red). All images are maximum projections, representative 
of ˃40 cercariae. Bars: 50 μm B. Cercariae were processed for western blotting with anti-
phospho Akt (Thr308) antibodies. Blots were then stripped and re-probed with anti-actin 
antibodies to determine protein loading levels between the lanes. Blot is representative of two 
experiments. A – acetabulum, CG – cephalic ganglia; FC – flame cell; H/T J – head-tail 
junction, LNC – longitudinal nerve cord; SP – sensory papillae; T – tegument; VNC – ventral 
nerve cord. 
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Figure 6.3 Linoleic acid treatment reveals inconsistent Akt phosphorylation in S. 
mansoni cercariae. Freshly shed cercariae were added to a well plate previously treated with 
linoleic acid for increasing times. A. Cercariae were processed for immunolocalisation with 
anti phospho-Akt (Thr308) antibodies. All images are maximum projections, bars: 50 μm. B. 
Cercariae were processed for western blotting with anti phospho-Akt (Thr308) antibodies. Blots 
were then stripped and re-probed with anti-actin antibodies to determine protein loading. Blot 
shown is representative of three experiments. A – acetabulum, H/T J – head-tail junction, NS 
– nervous system, SP – sensory papillae.  
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6.3 Akt Inhibitor X treatment 
Having evaluated the effects of mammalian skin components on the stimulation of 
cercarial Akt, next, the response to a previously validated inhibitor (Chapter 3) was 
explored. After exposure of cercariae to 10 μM Akt Inhibitor X for 1 h, phosphorylated 
Akt was considerably less evident in intact cercariae as determined by 
immunolocalisation; very little Akt activation remained in the tail and staining was no 
longer apparent in the head region (Figure 6.4 A). The discrepancy between the levels 
of Akt phosphorylation seen in the controls of the stimulation and inhibition experiments 
(Figures 6.2 - 6.4) are likely due to differences in staining performed on different days. 
However, the control and treated cercariae in each case were stained at the same time, 
allowing comparisons within, but not between, experiments; in all cases the laser settings 
remained constant for a specific experiment. Western blotting demonstrated similar 
Figure 6.4 Akt Inhibitor X treatment supresses Akt phosphorylation in S. mansoni 
cercariae. Freshly shed cercariae were treated with 10 μM Akt Inhibitor X for 1 h. A. Cercariae 
were processed for immunohistochemistry with anti phospho-Akt (Thr308) primary and Alexa 
Fluor 488 secondary antibodies (green). Rhodamine phalloidin was used to stain filamentous 
actin (red). Images are maximum projections. Bars: 50 μm. B. Cercariae were processed for 
western blotting with anti phospho-Akt (Thr308) antibodies. Blots were then stripped and re-
probed with anti-actin antibodies to determine protein loading between lanes. The blot shown 
is representative of those obtained in three experiments. A – acetabulum, H/T J – head-tail 
junction, NS – nervous system. 
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results to those seen with confocal microscopy; a reduction in Akt phosphorylation of ~61 
% was seen, measured over three experiments.  
6.4 The Effect of Akt Pathway Stimulation and Inhibition on Cercarial Swimming 
Given the localisation of phosphorylated Akt in cercariae and its response to skin 
components, it was hypothesised that Akt might influence the swimming behaviour of 
cercariae. Movies were therefore recorded of cercariae exposed to L-arginine, linoleic 
acid, or Akt Inhibitor X and various parameters analysed.  
The parasites were sampled from a beaker of freshly shed cercariae and a 100 μl droplet 
containing cercariae was pipetted onto the bottom of a Petri dish, to enable video capture 
of the entire droplet; treatments were delivered via a 1 μl drop of appropriately diluted 
stimulant or inhibitor. For each treatment, videos were taken at 1, 5, 10, 15, 30 and 45 
min.  
Thirty cercariae were analysed for each duration and the number of seconds each 
parasite demonstrated positive swimming action within a 30 s period was determined 
(Figure 6.5). Cercariae demonstrating contractile movements on the plate surface were 
not counted as swimming. The most effective treatments were L-arginine and Akt 
Inhibitor X, which had opposite effects on swim duration. The effect of L-arginine was 
rapidly apparent with the cercariae becoming highly agitated and swimming for 
significantly longer than the control parasites following exposure at 0 min (p≤0.001) 
(Figure 6.5). This lasted until approximately 20 min, after which the mean swim duration 
of treated cercariae dropped to control levels (Figure 6.5; Video 1).  
Conversely, after 5 min treatment with 10 μM Akt Inhibitor X cercariae sank to the base 
of the Petri dish. Muscular twitching and contractile movements were seen but very few 
cercariae swam (Figure 6.5; Video 3). This effect was sustained throughout the 45 min 
of the experiment. When L-arginine was added to cercariae that had already been 
treated for 1 h with Akt Inhibitor X, no change in the state of the parasites was observed. 
Cercariae remained relatively non-motile on the plate surface.  
Treatment with linoleic acid was performed separately and consequently a second 
control was done (Figure 6.5). Drops of water containing freshly shed cercariae were 
pipetted onto LA pre-coated glass cover slips, and movies captured in the same manner 
as before. Similarly to L-arginine, LA rapidly stimulated cercarial swimming and cercariae 
displayed an approximate 6-fold increase in swim duration after 1 min. However, this 
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activity decreased substantially from 5 min onwards, with a mean of 0.57 seconds swim 
time at 10 min, increasing slightly to 2.2 seconds at 30 min (Figure 6.5; Video 4).  
Another curious observation was in control and L-arginine treated cercariae, their tail 
furcae appeared curled upwards. This was consistent across all cercariae in these 
treatments. However, in Akt Inhibitor X cercariae tails were unaffected and extended.  
 
In addition, the number of swimming cercariae was also calculated at 0, 10, 30 and 45 
min (Figure 6.6). Non-swimming cercariae were clearly visible on the bottom of the plate 
and these were enumerated. At 45 min, no cercariae were left swimming, therefore the 
number counted was taken as the total amount of cercariae, and percentages were taken 
for the remaining time points. At 0 min, 81 % of cercariae were actively swimming. This 
Figure 6.5 Cercarial swim duration is affected by Akt Inhibitor X, L-arginine, and linoleic 
acid. Freshly-shed cercariae were pipetted into a Petri dish, treatments added, and movies 
were captured immediately (0 min) and after increasing durations. The number of seconds 
that a cercaria was swimming in a 30 s time frame was then enumerated and the mean swim 
duration compared with that for the control cercariae (Control 1 for L-arginine and Akt Inhibitor 
X, and Control 2 for linoleic acid). (±S.D.; n = 30). *p≤0.05, **p≤0.01, ***p≤0.001 (ANOVA). 
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decreased to 28 % after 10 min, and to 13 % after a further 20 min treatment, indicating 





Figure 6.6 Cercarial swimming drops 63 % in the first 10 min of treatment with 10 μM Akt 
Inhibitor X. The number of cercariae lying on the bottom of the plate in videos of 10 μM Akt 
Inhibitor X treatment from figure 6.5 were enumerated and calculated as a percentage of total 
cercariae.  
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Summary: 
Previously validated Akt stimulant and inhibitor, L-arginine, and Akt inhibitor, 
respectively, were used to determine the patterns of Akt phosphorylation in cercariae. 
LA was employed as a stimulant given its potential relevance to host finding and skin 
penetration. Western blotting of both L-arginine and LA treated cercariae revealed an 
increase in Akt phosphorylation of ~2.9 and 2.0-fold, respectively, at 30 min compared 
to the controls. Immunohistochemistry of treated cercariae showed a less dramatic 
increase in Akt phosphorylation although at 15 min LA induced phosphorylation of the 
sensory papillae on the cercariae head. Akt phosphorylation in the tail also appeared to 
be modulated in waves following LA treatment. Experiments with Akt inhibitor X showed 
a significant decrease in cercarial Akt phosphorylation using western blotting and 
immunohistochemistry techniques.  
To ascertain a functional role for Akt in S. mansoni cercariae, movies were recorded of 
cercariae swimming, after incubation with L-arginine, LA and Akt Inhibitor X for 
increasing durations. Both stimulants resulted in a striking increase in cercarial 
swimming. L-arginine treatment induced a level of cercarial swimming significantly above 
control levels (p≤0.5 – 0.001), until 45 min, whilst LA treated cercariae swimming times 
decreased to below control levels by 10 min, with a marginal increase again at 30 min. 
Akt Inhibitor X treatment caused a complete arrest in cercarial swimming after 45 min.  
These experiments have uncovered further functional roles for Akt signalling in S. 
mansoni, specifically in the cercarial stage and have furthered our knowledge into the 
molecular control of cercarial behaviour and host finding/penetration mechanisms.  
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Ranked the second most important neglected tropical disease (NTD) after malaria, 
water-borne schistosomiasis affects the lives of hundreds of millions of people in tropical 
developing countries. Research into cell signalling pathways of schistosomes provides 
not only valuable knowledge on the general biology of the parasite but may also reveal 
promising new avenues for drug development to enhance disease control. Insights 
gained during this project on the importance of Akt signalling to schistosome 
homeostasis highlight Akt as a worthy candidate for future drug targeting, particularly in 
the context of tegumental glucose transport. Figure 7.1 summarises the key findings from 
the research presented in this thesis.  
7.1 Determining the presence of an Akt in S. mansoni  
As a component of the PI3K signalling pathway, the protein kinase Akt is key to many 
fundamental processes in mammals including glucose uptake and metabolism, insulin 
signalling, cell-cycle progression and apoptosis (Brazil et al., 2004). As such, studying 
Akt in S. mansoni was deemed to be a valuable progression in deepening knowledge of 
signalling kinases of the parasite.  
7.1.1 Validating the ~52 kDa protein 
The first part of this research project focused on determining the identity of the ~52 kDa 
protein, detected with anti-phospho Akt (Thr308), anti-phospho Akt (Tyr315) and anti-Akt 
antibodies, which possessed Akt-like qualities. Whilst the currently published S. mansoni 
genome (Protasio et al. 2012) predicts Akt to be 68 kDa as confirmed by Morel et al. 
(2014), the ~52 kDa protein detected in this project across multiple S. mansoni life stages 
displayed convincing Akt activity. Three antibodies were validated, each recognising a 
similar protein band across three parasite life stages and reciprocal IPs verified that all 
antibodies bound the same protein. A fourth antibody tested, anti-phospho Akt (Ser473), 
did not react with S. mansoni total protein in several western blots. Protein sequence 
alignment to human Akt revealed a lack of sufficient conservation around the Ser473 
residue that would explain the lack or reactivity to S. mansoni protein. Within the stretch 
of 11 amino acids that are recognised by anti-phospho Akt (Ser473) antibodies, only 5 
residues (55%) were conserved between the two species, compared to 82% and 100% 
conservation across the epitope of the anti-phospho Akt (Thr308) and anti-phospho Akt 
(Tyr315) antibodies, respectively (Figure 3.4).  
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Experiments in Chapter 3 demonstrated that phosphorylation of the ~52 kDa Akt-like 
protein was increased by human host ligands and decreased by Akt pathway inhibitors. 
Furthermore, the protein immunoprecipitated using anti-phospho Akt (Thr308) XP 
antibodies possessed Akt activity, and RNAi of the Akt gene (Smp_243630) reduced the 
immunoreactivity to Akt antibodies by ~83%. This figure is comparable to results 
achieved after the knockdown of other S. mansoni proteins, 90% knockdown of SmILK 
expression (Gelmedin et al., 2017) and 83-85% reduction of SmIR1/2 expression (You 
et al., 2015). Quantification of the success of RNAi by western blotting is an established 
and accepted technique, and has been used in many studies (Xia et al., 2002; Seth et 
al., 2005; Wang et al. 2017), including in schistosomes (Patocka et al., 2014; You et al., 
2015; Han et al., 2017). Following RNAi, the levels of Akt protein and activated protein 
were measured using anti-Akt and anti-phospho Akt (Thr308) antibodies, respectively. In 
contrast to the ~83% reduction seen with the anti-Akt antibodies, the reduction in 
phosphorylated Akt signal was less stark. This was attributed to hyperactivation of the 
remaining Akt in the face of reduced overall expression of the protein through RNAi. 
Nevertheless, RNAi provided unequivocal evidence that the ~52 kDa protein is a bone 
fide Akt derived from the Akt gene Smp_243630.  
Furthermore, the effects of stimulators and inhibitors on Akt were investigated to provide 
a range of tools for studying functional roles for Akt in schistosomes. Although useful 
initially, serum was dismissed as a stimulatory agent due to the non-specific binding 
between serum and the anti-rabbit secondary antibody, often causing a double band 
effect. Human insulin and the amino acid L-arginine both provided robust and 
reproducible phosphorylation of Akt, with L-arginine being the more effective. Later, 
linoleic acid was found to be a stimulator of Akt in cercariae. All successfully trialled 
stimulants were exogenous factors that would be encountered by the parasite early-on 
during host invasion, revealing the potential for Akt to play a role in several processes, 
host localisation and penetration, parasite development and host-parasite 
communications. 
Several candidate molecules were tested to determine their ability to inhibit the 
phosphorylation (activation) of S. mansoni Akt in live somules: LY294002, GSK2334470, 
Akt Inhibitor X and Herbimycin A. Whilst the latter two compounds were found to robustly 
inhibit Akt phosphorylation and were chosen for further experiments, LY294002 and 
GSK2334470 were less effective. The original publication using LY294002 as a specific 
PI3K inhibitor (Vlahos et al., 1994), tested the effect of the compound on human 
neutrophils and rabbit smooth muscle cells at 100 μM, but determined an IC50 of just 1.40 
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μM. Vlahos et al. (1994) also reported a distinct lack of inhibition of protein kinase A 
(PKA) and protein kinase C (PKC), among other ATP-requiring enzymes, presumably 
due to their position not directly downstream of PI3K. In contrast to its protein kinase 
cousins, Akt (PKB) lies directly downstream of PI3K, hence the choice of LY294002 as 
an inhibitor. Results of the assays however, indicate a lack of conservation between 
HuPI3K and SmPI3K, in terms of its interaction with this inhibitor, therefore restricting its 
effect on downstream Akt phosphorylation, or insufficient penetration of the inhibitor 
within the intact live parasite. In contrast, Akt Inhibitor X, a phenoxazine, attenuates 
directly the Akt kinase (Thimmaiah et al., 2005). Thimmaiah et al. (2005) reported 
complete loss of Akt phosphorylation in human cancer cells after treatment of 1 h with 
2.5 μM Akt Inhibitor X, measured with anti-phospho Akt (Ser473) antibodies. Although the 
precise mechanism of protein interaction is unclear, it has been deduced that inhibition 
is independent of the PH domain, as upstream kinases which promote membrane 
localisation of Akt are unaffected by Akt Inhibitor X (Thimmaiah et al., 2005). 
7.1.2 A putative second Akt isoform 
In D. melanogaster, a single Akt gene (DAkt1) exists, which encodes two forms of the 
protein, one short (66 kDa) and one long (85 kDa) (Andjelkovic et al., 1995). The source 
of the two proteins is an alternative initiation codon, ACG, which precedes the usual start 
site, ATG (Andjelkovic et al., 1995), resulting in the longer protein. A third peptide of 120 
kDa was also discovered, derived from a distinct gene, which has a common epitope(s) 
to DAkt1 (Andjelkovic et al., 1995). Given the collective evidence acquired in this project, 
it is proposed that a similar mechanism is occurring in S. mansoni through alternative 
splicing at a region downstream from the published start codon. To achieve a resulting 
molecular weight of 52 kDa, a sequence of approximately 134 aa would need to be 
spliced from the currently annotated protein. In alignment with the human gene 
sequence, S. mansoni Akt possesses a leader sequence of 100 aa in addition to HuAkt1 
before the beginning of the PH domain, although the putative methionine start point sits 
at position 92. In addition to potential gene splicing, it is worth noting that proteins can 
migrate differently within different SDS-PAGE gel systems, possibly accounting for the 
remaining difference in molecular weight. A molecular characterisation of the S. mansoni 
Akt gene and its regulatory mechanisms is warranted to determine if and where the 
protein is being spliced. Alternatively, the protein could be post-translationally 
proteolytically cleaved. 
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Once it was clear that a second, smaller Akt isoform existed in S. mansoni, and 
antibodies to detect its presence and activation status were validated, work moved to 
mapping Akt within the three human infective/resident life-stages, cercariae, somules 
and adult worms. Across all slides of somules and adult worms visualised by confocal 
microscopy, phosphorylated/non-phosphorylated Akt, measured by anti-Akt antibodies, 
was located primarily in the tegument, and in adult males it also localised to the tubercles 
and the gynaecophoric canal. Possible regions demonstrating non-phosphorylated Akt 
could be localised through comparisons with images probed with anti-phospho Akt 
antibodies.  
Tubercles are exclusive to adult male schistosomes and present as tiny mound-like 
structures on the surface of the tegument (Hockley, 1973). When male adult worms were 
incubated in Akt Inhibitor X, the size of tubercles increased significantly over four to five 
days. A possible reason for this phenomenon could be an increase in surface area in an 
attempt to compensate for the reduction in SGTP4 expression also seen after adult worm 
treatment with this inhibitor. The swelling of the tubercles, whether or not intended to 
actively increase surface area, was possibly regulated by aquaporins. Aquaporins are 
ubiquitously expressed and are the most abundant transmembrane protein in the 
schistosome tegument (Castro-Borges et al., 2011). S. mansoni aquaporin (SmAQP) 
serves to transport water across the tegument (Da’dara et al., 2012) but has also been 
implicated in drug uptake and the excretion of lactate as a by-product of glucose 
metabolism (Faghiri and Skelly, 2009; Faghiri et al., 2010). Interestingly, Akt has been 
implicated in the translocation of mammalian aquaporin-2 via interaction with the Akt 
substrate AS160, a Rab GAP protein (Kim et al., 2011). Further evidence for the 
regulation of aquaporins by Akt has been obtained in chicken hepatocytes (Suh et al., 
2008). After the discovery that inhibition of Akt affects the morphology of adult worms at 
the tegument, several hypotheses for the localisation of Akt in this surface structure were 
considered, including Akt playing a role in vesicle trafficking and exocytosis, involvement 
in lipid raft trafficking/maintenance, male-female communication, and glucose uptake. 
Ultimately, experiments were designed to investigate the role of Akt in glucose transport 
across the tegument of S. mansoni (Chapter 4).  
7.1.3 Akt in S. mansoni cercariae 
In cercariae, activated and non-activated Akt, measured by anti-phospho Akt and anti-
Akt antibodies, localised particularly in the nervous system and punctate regions in the 
tail. This finding was exploited to study the possible importance of Akt to swimming and 
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recognition of the mammalian host (Chapter 6). Significant work has been done 
previously to define the chemical stimulants that attract cercariae to their definitive host 
(Shiff et al., 1972; Haas, 1992; Shiff and Graczyk, 1994; Haas et al., 1997; Brachs and 
Haas, 2008; Haas et al., 2008; Ressurreição et al., 2015). From these studies, it is known 
that L-arginine and LA promote attachment and skin penetration, respectively. 
Investigating these compounds from a signalling perspective revealed that both are 
capable of stimulating Akt phosphorylation in cercariae as determined by western 
blotting, although this change was less pronounced when visualised in intact parasites. 
Confocal microscopy images revealed only a modest increase in Akt phosphorylation in 
response to L-arginine not concurrent with the change seen by western blot. In some 
cases, Akt was detected in punctate regions in the anterior region of the head. These 
were seen inconsistently in un-treated cercariae and also in L-arginine stimulated 
parasites (Chapter 6; sections 6.1 - 6.2). It is hypothesised that these punctate regions 
of Akt activity are flame cells, which appear in pairs in the heads of cercariae (Senft et 
al., 1961; Skelly and Shoemaker, 2001). Flame cells contain cilia, the movement of which 
is thought to draw fluid into the protonephridial system from interstitial spaces, acting as 
a means of body fluid regulation, and also waste excretion (Valverde-Islas et al., 2011). 
The potential role of Akt in this mechanism is unclear and warrants further investigation.  
Another structure observed inconsistently in cercariae was a ring of punctate regions of 
Akt around the tip of the head, previously seen and named as sensory papillae 
(Ressurreição et al., 2015). Initially, these sensory papillae were only detected when 
parasites were stained with anti-Akt antibodies, demonstrating that the Akt present was 
not active. However, after stimulation with L-arginine and LA, phosphorylated Akt was 
localised to this region (Figures 6.2 – 6.3), albeit not in every specimen, but indicating 
that Akt is possibly functionally involved in the response to host factors in cercarial host 
localisation and penetration.  
Akt phosphorylation in cercariae was diminished by Akt Inhibitor X. Inhibitor treatment 
for 1 h significantly reduced Akt phosphorylation as measured by western blotting, and 
a decrease in global Akt phosphorylation when visualised by immunohistochemistry, with 
only punctate regions of activated Akt remaining in the tail. Clear staining of activated 
Akt of the peripheral nervous system in the tails of cercariae suggest that these regions 
of Akt activity are nerve ending or sensory receptors. They appear too abundant and 
irregularly spaced to be flame cells, which have never been reported in the tails of 
cercariae. This hypothesis provides a rationale for the tail being more than just a 
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locomotor organ; it may be stimulated by extracellular ligands to influence cercarial 
behaviour.  
As well as western blot and immunohistochemistry analysis, cercarial behaviour in 
response to LA, L-arginine and Akt Inhibitor X was monitored by video analysis. Movies 
were recorded in 30 s clips of cercariae after treatment at various time intervals. L-
arginine stimulated cercarial swimming immediately (Figure 6.5, Video 1), which was 
sustained before declining towards the end of the experiment. The sudden and drastic 
effect of L-arginine on the cercariae indicates a powerful response from sensory papillae 
in the head and potentially receptors in the tail. A similar response was observed with 
LA treatment, although the dramatic increase in swimming duration was not seen until 1 
min (Figure 6.5, Video 4). In this case however, swim time decreased to below control 
levels 20 min sooner than seen with L-arginine. This could be due to the different roles 
(cues) for each compound in the process of host skin penetration by cercariae. L-arginine 
promotes the initial skin attachment, meaning that cercariae can sense this chemical 
from a distance, causing them to locate the host. In contrast, LA stimulates the burrowing 
of cercariae into the skin itself. Video analysis showed many of the LA-treated cercariae 
lying the on bottom of the treated surface, presumably attempting to penetrate as they 
would do mammalian skin. LA has previously been shown to stimulate the 
phosphorylation of PKC and ERK in S. mansoni, and the release of acetabular gland 
contents (Ressurreição et al., 2015), a prerequisite for skin penetration. 
When cercariae were treated with 1 μM or 10 μM Akt Inhibitor X, the observed effect was 
in stark contrast to that seen with the Akt stimulants LA and L-arginine. More pronounced 
with 10 μM but just as clearly seen with 1 μM Akt Inhibitor X, treatment significantly 
attenuated the swimming of cercariae, with 63%, 87%, and 100% inhibition at 10, 20 and 
45 min respectively. As the locomotion organ of cercariae, these findings indicate that 
there are sensory receptors on the tails of cercariae and that Akt is in part responsible 
for motor function.  
7.2 Akt in the Bigger Picture of S. mansoni Signalling 
Every intracellular signalling pathway is composed of protein kinases which all possess 
connections with other proteins, forming a complex web of interactions (Natarajan et al., 
2006). The map of proteins, which are predicted to have a connection with Akt, created 
with STRINGdb began to reveal how many processes Akt may potentially be involved 
with in S. mansoni.  
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7.2.1 Glycogen synthase kinase 
Glycogen synthase kinase-3 was one of the first identified substrates of Akt in mammals 
(Lawlor and Alessi, 2001). The primary sites for phosphorylation of mammalian GSK-3 
are Ser21 for isoform α and Ser9 for isoform β. These sites are phosphorylated by Akt, 
which inactivates GSK-3, downregulating downstream processes (Fang et al., 2000). In 
addition to Akt, GSK-3α/β is also phosphorylated by cAMP-dependant PKA, 
independently of PI3K/Akt signalling (Fang et al. 2000). In S. mansoni, alignment of the 
GSK-3 gene with its human counterparts reveals that despite an 88% homology across 
the kinase domain (Osolodkin et al, 2011), the Ser9/21 residues are missing. This could 
be due to an error in annotation or, alternatively, the phosphorylated serine residue may 
appear elsewhere in the S. mansoni protein. However, given the specificity of Akt for 
substrate phosphorylation sites to have an Arg in the -3 and -5 positions, the latter 
possibility seems unlikely as not a single Ser residue in the S. mansoni sequence fits 
these requirements (Figure 4.18). Concurrent with bioinformatic analyses, western 
blotting of S. mansoni total proteins using antibodies that recognise the region 
surrounding and including the the Ser9/21 residues yielded no results. However, western 
blotting using antibodies that recognise the Tyr216/279 phosphorylation motif, 
demonstrated phosphorylation of GSK-3 after treatment of somules with Akt Inhibitor X. 
In mammals, the Tyr216/279 residue is autophosphorylated in quiescent cells and results 
in positive regulation of downstream substrates (Grimes and Jope, 2001). The precise 
mechanism of tyrosine phosphorylation remains unclear although it has been previously 
suggested that stimulation of cells results in the dephosphorylation of GSK-3 at the 
tyrosine residue (Woodgett et al., 1993; Murai et al., 1996). Although there is no prior 
indication that Akt is involved in the regulation of GSK-3 via tyrosine phosphorylation, 
this insight explains the results seen in Chapter 4; inhibition of Akt by Akt Inhibitor X 
allowed GSK-3 to remain constitutively phosphorylated, whereas stimulation by insulin 
and L-arginine caused dephosphorylation of the tyrosine residue detected by the anti-
phospho GSK-3 (Tyr216/279) antibodies. Given that Akt is a serine/threonine kinase, it 
cannot directly affect the status of GSK-3 tyrosine phosphorylation, but as GSK-3 is 
widely known to play a role in insulin signalling (Hughes et al., 1993; Woodgett et al., 
1993), it is not inconceivable for Akt to be involved indirectly in regulation of the tyrosine 
residue. A study of Wnt signalling revealed that in the ameboid protozoan Dictyostelium 
discoideum, GSK-3β is phosphorylated by a kinase, ZAK1, on Tyr216 (Kim et al., 1999). 
However, like in humans, there is no ZAK1 homologue in S. mansoni, with the closest 
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match being abl kinase 2 (31% identity) when ZAK1 was blasted against S. mansoni 
proteins using the NCBI database.  
7.2.2 p70S6K 
Although reported as being downstream of Akt (Cheatham et al., 1994), p70S6K is not 
directly phosphorylated by Akt, being activated instead through mTOR complex 1 
(mTORC1) (Isotani et al., 1999). One study has suggested that although both proteins 
are mediated via PDK1 signalling, Akt and p70S6K lie on separate pathways (Conus et 
al., 1998). However, as knowledge of Akt signalling in humans improved over the last 
two decades, the complex relationship between Akt and mTORC1 has been elucidated 
(Manning and Cantley, 2007), confirming an indirect link from Akt to p70S6K. Despite this, 
experiments to activate p70S6K using Akt pathway stimulants were unsuccessful (data not 
shown), indicating that the complex series of events leading to phosphorylation of p70S6K 
in humans may not be conserved in schistosomes.  
7.2.3 Ras superfamily G proteins 
Bioinformatic analysis revealed 342 medium confidence (≥0.40) and 158 high confidence 
(≥0.70) proteins with putative Akt interacting activity (Appendix 2). Further interrogation 
of the high confidence protein hit-list resulted in 32 sequences with motifs suitable for 
phosphorylation by Akt, as determined by at least two phosphorylation site prediction 
tools. Of perhaps greatest significance was the presence of proteins from the Ras 
superfamily of small monomeric G proteins. The superfamily encompasses Ras, Rho, 
Ran, Rab and Arf G proteins (Wennerberg et al., 2005), which are involved in membrane 
trafficking, including vesicle formation and transport, and vesicle/membrane fusion 
(Novick and Zerial, 1997). Present within the list of high confidence proteins containing 
phosphorylation sites predicted by more than one prediction tool were Rac (GTPase) 
(Smp_130230), Rac GTPase activating protein (Smp_021590) and Ras GTP exchange 
factor son of sevenless (Smp_242150; formerly Smp_161230) (Table 4.1). Given that 
these G proteins are ubiquitous in all eukaryotes (Hall, 1990; Ridley, 2006), a moderate 
level of homology in schistosomes can be assumed and several studies have found this 
to be true (Loeffler and Bennett, 1996; Kampkötter et al., 1999; Osman et al., 1999). A 
Ras homologue has been identified in larval and adult S. mansoni (Kampkötter et al., 
1999; Osman et al., 1999) prompted by its essential role in eukaryotic growth and 
development signal transduction (McCormick, 1993). Ras has been demonstrated as 
present in all stages of schistosome and although Osman et al. (1999) found Ras to be 
overexpressed in female worms, levels of the protein were similar between mature and 
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immature worms and levels in males were the lowest of all life stages, likely indicating 
several roles in parasite development between stages. Schüßler et al. (1997) determined 
S. mansoni Ras and GAP proteins to be developmentally regulated but also involved in 
the maturation of the adult female via male worm interaction. Additionally and more 
recently, SmRho1 has been demonstrated as active in the gonads of both male and 
female adult worms, interacting with SmTK3 (Quack et al., 2009).  
Despite differences in their specific biological functions, all members of the Ras 
superfamily share the basic activity of GTP binding in their active form, and hydrolysis of 
GTP to GDP when inactive (Jiang and Ramachandran, 2006). Rac GTPases belong the 
Rho subfamily, which is known for the regulation of cell motility and polarity via functions 
regarding cytoskeletal organisation and membrane trafficking (Fransson et al., 2003). S. 
mansoni Rac is 188 aa long and has a putative Akt phosphorylation site at Ser71. The 
GO terms associated with this protein include “small GTPase mediated signal 
transduction”, “protein transport”, “GTP binding”, “intracellular” and “plasma 
membrane”11. All GTPase proteins have a corresponding GTPase activating protein 
(GAP), which participates in the change between active and inactive forms of GTPase 
(Jiang and Ramachandran, 2006). S. mansoni Rac GAP is 610 aa in length and is 
putatively phosphorylated by Akt on Ser181. The molecular functions associated with this 
protein include “zinc ion binding”, “GTPase activator activity” and “diacylglycerol binding”, 
and locations are primarily intracellular and cytoplasmic12. In mammalian fibroblasts, Akt 
has been shown to co-localise with Rac and cell division control protein 42 homologue 
(Cdc42) at the leading edge of cells in response to platelet-derived growth factor (PDGF), 
proving crucial in Rac/Cdc42 regulated cell motility (Higuchi et al., 2001). Cdc42 is 
another low molecular weight (195 aa) GTPase of the Rho family, also present in the list 
of sequences putatively phosphorylated by Akt (Table 4.1). Higuchi et al. (2001) suggest 
that Akt is located downstream of Rac and Cdc42 and that the latter proteins induce 
phosphorylation of Akt at the critical residues Thr208 and Ser473. However, this is 
contradicted by Sánchez-Martin et al. (2004) who demonstrate that PI3K/Akt signalling 
regulates Rac activation. Whilst a connection between Akt and Rac/Cdc42 is present, 
the precise mechanisms of interaction are uncertain. 
The putative S. mansoni Ras GTP exchange factor, son of sevenless (Sos) is 1518 aa 
in length and also possesses just one Akt phosphorylation site at Ser541. Its main 
biological process is regulation of GTPase-mediated signal transduction and can be 
                                                          
11 http://www.genedb.org/gene/Smp_130230 [Accessed 29th September 2017]. 
12 http://www.genedb.org/gene/Smp_021590 [Accessed 29th September 2017]. 
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localised within cells13. Sos is a Ras-specific guanine nucleotide exchange factor protein 
required for growth factor receptor signalling via tyrosine kinases. The exchange factor 
is recruited to the cell membrane where it activates Ras by converting GDP to GTP 
(reviewed by Bar-Sagi, 1994). Very little data is published on any interactions between 
Sos and Akt, although a study by Tumurkhuu et al. (2013) reports PI3K/Akt signalling to 
be negatively affected by a mutant Sos protein, indicating an indirect link between the 
two proteins. Similarly, Sos in S. mansoni has been poorly studied and homology with 
the mammalian homologue is unknown.  
7.2.4 A functional role for small GTPase Rab11 in S. mansoni? 
In addition to the aforementioned proteins, Rab11 was identified as a high confidence 
protein with up to three potential Akt phosphorylation sites, although only confirmed by 
one prediction tool (Appendix 3). Across organisms, Rab proteins make up the largest 
subgroup of the Ras superfamily, with 60 members (Stenmark, 2009). There are three 
isoforms of Rab11 in humans (Rab11a, b and c), which all share high sequence 
homology (reviewed by Welz et al., 2014). The involvement of Ras superfamily proteins 
in cellular transport mechanisms was first identified three decades ago (Salminen and 
Novick, 1987) with one of the primary roles of Rab11 proteins in mammalian cells being 
the transport of receptors to the cell surface (Stenmark, 2009). Rab GTPase proteins 
control vesicle trafficking by interacting with the actin cytoskeleton (Peranen et al., 1996). 
Mammalian Rab11 isoforms have been located in the trans-Golgi network and recycling 
endosome, and are known to participate in both the endocytic and exocytic trafficking 
pathways (Urbé et al., 1993). Rab11 is commonly found in complex with motor proteins, 
via interaction with adaptor proteins (Welz et al., 2014). These complexes, such as the 
exocyst vesicle-tethering complex or SNARE complex, allow Rab11 to act in multiple 
biological processes aside from vesicle trafficking, including ciliogenesis, cytokinesis and 
neuritogenesis (Hobdy-Henderson et al., 2003; Shirane and Nakayama, 2006; Knödler 
et al., 2010).  
The putative S. mansoni Rab11 (Smp_267200; formerly Smp_173990) comprises 933 
aa with putative Akt phosphorylation sites at Thr82, Ser649 and Ser873. Comparable with 
other Ras superfamily G proteins, S. mansoni Rab11 is assigned GO terms including 
“GTP binding”, “small GTPase mediated signal transduction” and “protein import into 
nucleus”14. As is its role in mammalian cells, Rab11, along with other small GTPases, 
                                                          
13 http://www.genedb.org/gene/Smp_242150 [Accessed 29th September 2017]. 
14 http://www.genedb.org/gene/Smp_267200 [Accessed 2nd October 2017].  
 Chapter 7 – Discussion         139 
 
also mediates vesicle transport to the plasma membrane in helminths (Torre-Escudero 
et al., 2016). In addition to knowledge that Rab11 traffics receptors to the plasma 
membrane, this GTPase has been specifically shown to co-localise with GLUT4 
containing vesicles in cardiomyocytes (Uhlig et al., 2005). Furthermore, Rab11 
expression is substantially increased in GLUT4 transporting vesicles in response to 
insulin stimulation, which also induced the expression of Akt-2 (Kessler et al., 2000). A 
Rab GAP protein, AS160, has been identified as an Akt substrate in mammalian cells 
(Larance et al., 2005) and could provide the link between Akt and Rab11. The Rab11 
protein provides a rationale for Akt being implicated in vesicle trafficking and furthermore 
could link Akt not only with the expression of SGTP4, but also its movement within the 
tegument during the early post-transformation stage of somule development.  
7.3 A Functional Role for Akt in S. mansoni 
Whilst Akt is almost certainly present in other tissues of schistosomes, using the methods 
described in this project (tegument stripping/western blot, immunolocalisation), Akt was 
found predominately expressed in the parasite surface layer, adding Akt to the long list 
of other proteins already discovered in the S. mansoni tegument (Braschi and Wilson, 
2005; Braschi et al., 2006; Wilson, 2012). As the barrier between parasite and host, the 
tegument represents a valuable source of information on host-parasite interactions and 
putative novel drug targets. After three decades of almost exclusive treatment of 
schistosomiasis with PZQ, fears of developing resistance have stimulated the search for 
a new method of control (Cioli et al., 2014). Consensus in the scientific community exists 
that protein kinases are one of the most viable routes to find novel drug targets against 
schistosomes (Doerig, 2004; Dissous et al., 2007; Beckmann et al., 2012a). Protein 
kinase is a term encompassing several sub-groups: tyrosine kinases (TKs), receptor 
tyrosine kinases (RTKs) and serine/threonine kinases (STKs), among others (Andrade 
et al., 2011). Of particular interest recently have been those kinases already targeted in 
human cancer research, with a view to discovering if homology with schistosome kinases 
is sufficient for current drugs to be deployed in the fight against schistosomes (Dissous 
and Grevelding, 2011). Several studies have also linked protein kinases to S. mansoni 
reproductive processes (reviewed by Morel et al., 2014b), ideal targets to prevent 
proliferation of the life cycle. Elements of the TGF-β pathways are known to influence 
female worm reproductive development and egg embryogenesis. S. mansoni receptor 
kinase-1 (SmRK-1) is a receptor serine/threonine kinase present on the surface of the 
parasite, specifically the dorsal tubercles, from the immature adult stage (Davies et al., 
1998). Proposed to be mediated by FK-506 binding protein 12 (FKBP12) (Knobloch et 
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al., 2004), SmRK-1 is a divergent type I receptor; type I receptors form a complex with 
type II receptors to convey intracellular signals in TGF-β pathways (Davies et al., 1998). 
Downstream of SmRK-1, receptor-regulated SmSmad1, SmSmad2 and SmSmad4 are 
phosphorylated, leading to signalling implicated in parasite development and male-
female communication (Beall et al., 2000; Osman et al., 2004). Both SmSmad2 and 
SmSmad4 have been localised to the female reproductive organs, specifically the 
vitellaria, ovary and developing embryo (Osman et al., 2001; Osman et al., 2004), linking 
TFG-β signalling and SmRK-1 to female sexual development. In addition to TGF-β 
signalling, SmTK3 is also known to be present in the female ovary and vitelline glands, 
as well as the male testes, indicating a role in the cytoskeletal organisation of 
schistosome gonads (Kapp et al., 2004).  
More recently, post genome publication (Berriman et al., 2009; Protasio et al., 2012), 
many more S. mansoni proteins have been shown to regulate functions beyond those of 
the reproductive system (Andrade et al., 2011). The possibility of insulin signalling in 
schistosomes was first raised after discovery of two insulin receptor-like RTKs (Vicogne 
et al., 2003). One of the proteins characterised possessed a C-terminal TK domain, 
similar to that of other IR family members, but a divergent extracellular N-terminal domain 
more closely similar to venus flytrap (VFT) modules, such as the ones in bacterial 
periplasmic binding proteins (PBP) (Vicogne et al., 2003). VFTs possess two lobes that 
close around the bound ligand, stabilising the conformation (Felder et al., 1999). The 
newly characterised receptor, termed Venus Kinase Receptor 1 (SmVKR-1), was shown 
to be a part of a new family of Venus Kinase Receptors (VKRs) (Ahier et al., 2009). 
Subsequently, VKR homologues were identified in several insect species including 
seven Drosophila species and two mosquito species, evidencing that these receptors 
are not unique to schistosomes. In several of the insect species, the VKR proteins were 
primarily expressed in larval stages and in the gonads of the adult form suggesting 
another kinase with a functional role in reproductive activities, embryogenesis and larval 
development (Ahier et al., 2009). In S. mansoni, vkr1 and vkr2 proteins were present in 
all life stages and presented with very similar structures, indicating origin from a gene 
duplication event (Gouignard et al., 2012). Among the ligands identified for VKR-1 and 
VKR-2 were L-arginine (Ahier et al., 2009) and insulin (Gouignard et al., 2012). More 
recently, VKR proteins expressed in Xenopus oocytes demonstrated the capacity to 
stimulate the endogenous Xenopus Akt/PI3K pathway, revealing an alternative to the 
IRs (Morel et al., 2014a).  
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In mammalian systems, insulin mediates a wide range of processes and pathways 
including glucose metabolism, cell growth and differentiation, protein synthesis and DNA 
synthesis (You et al., 2009). The functions of insulin overlap those of Akt as they are 
implicated together in PI3K signalling (Alessi et al., 1997; Conus et al., 1998). Knowledge 
of insulin signalling in schistosomes was driven by the discovery of two insulin receptors, 
SmIR-1 and SmIR-2, which are part of the RTK family (Khayath et al., 2007). Insulin 
receptors are ancient RTKs and have been identified in organisms as primitive as marine 
sponges (Skorokhod et al., 1999). S. mansoni insulin receptors bind human insulin 
(Khayath et al. 2007) and the localisation of SmIR-1 at the tegument indicates that insulin 
receptors play a vital role in host-parasite communication (Ahier et al., 2008). A 
connection between insulin and glucose uptake was first made in Schistosoma douthitti 
(Cornford, 1974) and insulin has since been shown to increase glucose uptake in S. 
mansoni somules and adult worms by 25% and 50%, respectively (Ahier et al., 2008), 
as well as in unpaired female S. japonicum worms (You et al., 2009). Knockdown of 
SmIR-1 in somules by the RNAi soaking method (Ndegwa et al., 2007) resulted in a 
decrease of ~33% glucose uptake although this was independent of global SmIR-1 levels 
(Ahier et al., 2008). In S. japonicum, insulin has been shown to regulate the expression 
of genes controlling growth and development (You et al., 2009). In mammals, insulin-
regulated glucose uptake into adipose tissues is a well-characterised process, due to its 
dysfunction leading to type II diabetes mellitus (Kahn and Pessin, 2002). Insulin 
stimulates the translocation of glucose transporter 4 (GLUT4) from intracellular vesicles 
to the plasma membrane of fat, skeletal and cardiac muscle (Smith et al., 1991) via the 
Akt/PI3K pathway, which subsequently increases glucose uptake (Cheatham et al., 
1994; Kotani et al., 1995). An insulin mediated PI3K independent pathway has also been 
implicated in the translocation of GLUT4, linking this process with actin dynamics (Kahn 
and Pessin, 2002).  
In schistosomes, two glucose transporters have been characterised, SGTP1 and SGTP4 
(Zhong et al., 1995) through in-depth research of glucose uptake in schistosomes (Skelly 
and Shoemaker, 1996; Skelly and Shoemaker, 2001). Glucose in an essential element 
of schistosome survival in the mammalian host, but the mechanisms behind the control 
of glucose uptake remain relatively unknown. SGTP1 localises to the basal tegument 
membrane (Zhong et al., 1995) contrary to SGTP4, which is found in the apical tegument 
membrane (Skelly and Shoemaker, 1996). SGTP4 has been localised in both bilayers of 
the apical tegument membrane and also in the multilamellar bodies of adults and the 
membranous bodies of somules (Jiang et al., 1996). Interestingly, SGTP4 develops in 
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the parasite only after cercariae start to transform into somules, after which it remains 
present throughout adulthood (Skelly and Shoemaker, 1996), coinciding with the 
expression and localisation in the tegument of SmIR-1 (Khayath et al., 2007), and Akt 
(Chapter 3). Data from the current research demonstrated that insulin could stimulate 
Akt phosphorylation in somules and adult S. mansoni, adding to knowledge already 
gained in this field (Morel et al., 2014a). Given the crucial nature of Akt in mammalian 
glucose regulation, the insulin context and immunolocalisation of activated Akt in S. 
mansoni provided the rationale for a series of experiments to determine whether 
expression of SGTP4 could be influenced by manipulation of the Akt protein. Results 
revealed that SGTP4 expression can be attenuated by molecular inhibitors of Akt and 
also Akt siRNA in adult worms. Furthermore, inhibition of Akt in adult male and female 
worms significantly reduced their ability to uptake glucose, by 38% (p≤0.001) and 37% 
(p≤0.01) respectively. These results, in addition to the data gathered on the evolution of 
SGTP4 in somules, provide evidence that the Akt pathway is at least in part responsible 
for SGTP4 expression and translocation to the apical membrane, as it is responsible for 
GLUT4 translocation in mammals (Cheatham et al., 1994). Collectively, these findings, 
in addition to data that links L-arginine and insulin to Akt phosphorylation (Figures 3.17 
and 3.18) and the functional mapping of the active kinase to the schistosome tegument 
(Figures 3.12 - 3.14), provides evidence for Akt playing a role in the evolution and 
subsequent sustained expression of SGTP4 at the parasite surface. As such, a model 
for the mechanistic function of Akt in schistosome glucose uptake is proposed (Figure 
7.2), based on integrated knowledge of the findings presented here and analysis of 
comparative biology, highlighting the role of Rab and RabGAP proteins in the 
translocation of SGTP4-containing vesicles to the apical membrane. The precise 
proposed mechanism is as follows: 1) interaction of host insulin or L-arginine with the IR 
or VKR, respectively, at the parasite surface, results in receptor 
phosphorylation/activation; adaptor proteins then bind, which in turn bind PI3K causing 
the production of PIP3 (PI3K potentially could also interact directly with the receptor). 2) 
Akt, phosphorylated (activated) by PDK1, can then phosphorylate and inactivate Rab-
GAP, in turn 3) enhancing levels of GTP-bound Rab, which then promotes production of 
SGTP4 vesicles at the trans-Golgi network (TGN) that are shuttled to the parasite 
surface. 4) SGTP4 gene expression, which also seems to be dependent on Akt 
activation, is driven by signalling events, which might include mTOR activation. This 
mechanism provides a sound rationale for conducting additional research on Akt 
signalling in S. mansoni that would be beneficial towards deepening our understanding 
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of schistosome biology and that may reveal promising candidates for drug target 
development in the context of glucose uptake. 
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7.4 Priorities for Future Work 
There are several avenues of research that could be pursued to not only further 
investigate the importance of Akt signalling in S. mansoni but also to expand the current 
knowledge of Akt substrates and interacting proteins in schistosomes. Primarily, in-depth 
molecular genetic characterisation of the ~52 kDa protein to identify the putative 
alternative start site from the currently annotated 70 kDa Akt protein would be the final 
element to demonstrate that this is the only active form of the kinase in S. mansoni. 
Additionally, investigating the role of Akt in vesicle trafficking would add further support 
to the glucose transporter translocation model proposed here. Identifying the 
downstream substrates of Akt and their roles in the parasite life-cycle could lead to 
exciting insights in host-parasite communication and shed more light on the complex 
network of signalling pathways that intersect and interact with Akt, implicated by this 
project. The specific localisation of phosphorylated Akt in the gynaecophoric canal also 
warrants further investigation as this could indicate that Akt is somewhat involved in 
male-female communication. Finally, it would be useful to confirm whether the 
mechanism for SGTP4 translocation proposed here is conserved in other species of 
schistosome. Regarding Akt as a novel drug target, it is hoped that with advances in 
research of Akt in human cancer, a drug may become available that is adaptable to use 
against all three main species of human infecting schistosomes, improving the lives of 
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Appendix 1. Antibodies.Tabulated form of antibodies from Chapter 2, section 2.1.1 for easy 
referral.  
Appendix 2 












Appendix 2 Stained gel for sequencing analysis. 20 worm pairs were processed for IP using 
the crosslinking IP method. The electrophoresed gel was incubated in Gel Code Blue stain to 
reveal protein bands. The red boxes indicate the three slices of gel that were excised and sent for 
protein sequencing at Nottingham University. The middle box surrounds the area of the gel at 50 
kDa, where a band would have been expected.  
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Appendix 3 Medium confidence analysis parameters reveals 342 putative Akt interacting 
proteins. STRING analysis was performed using Smp_079360 with parameters set to ≥0.40 




            KinasePhos Scansite3 HPRD 

















Protein ID Protein Name 
E-value 
Smp_094250  Serine/threonine kinase (484 aa) 198 RQSDSTPNS -1.3 20 ●   ●   
Smp_122910  Ataxia telangiectasia mutated (Atm)-related (2611 aa) 1765 ARTLSKVNS -2.8 1.80E+02 ●   ●   
                      2470 RRANSPNRV -0.7 66 2099 PRKLTITGS 2099 PRKLTITGS 
Smp_079760.1_mRNA  Protein kinase (491 aa) None       ●   182 RARDAT 
Smp_154470  Pten, putative (597 aa)                 478 DRDVSSDEE -1.7 29 ●   ●   
Smp_072330.2_mRNA  Heat shock protein, putative 
(718 aa) 




Smp_074390  Eukaryotic translation initiation factor 4e-binding protein, putative 
(121 aa) 
    
None       
●   ●   
Smp_053130  40S ribosomal protein S6 (248 aa)               96 RRRKSVRGC 1.9 1.1 233 KRSRSHSLR ●   
                      235 SRSHSLRES 0 3 ●   ●   
Smp_099930  F-box and wd40 domain protein, putative 
(863 aa) 
            289 SRTQSIPFS 0.6 14 ●   ● 
  
                      853 SSKSSFISS -2.8 71 ●   ●   
Smp_164960  Phosphatidylinositol-4,5-bisphosphate 3-kinase PI3K 
(1340 aa) 
        
None       
●   646 RIRRPT 
Smp_159000  Expressed protein 
(1610 aa) 
                533 GRNDSVRDF -2.5 1.20E+02 ●   ●   
                      766 LRKSSNREV -1 62 ●   ●   
                      933 SSNTSTDNV -2.9 1.50E+02 ●   ●   
Smp_064010  Camp-response element binding protein-related 
(825 aa) 




                      137 PSASSSTSN -2.5 72 ●   ●   
                      209 RRRSSTLAP -1.1 38 210 RRSSTLAPP 210 RRSSTLAPP 
                      339 SRNTSSVPH -0.3 25 ●   ●   
                      574 ARFSSESDR -0.2 23 ●   ●   
                      614 QRRRSVFTA -2.5 74 ●   ●   
                      817 ESESSAPES -1.2 39 ●   ●   
Smp_142710  Fkbp-rapamycin associated protein, putative 
(4023 aa)           




                      1246 LSHPSTSAS -2.7 3.30E+02 ●   ●   
                      1543 IRQKSESAN -2 2.40E+02 ●   1545 RQKSES 




                      1822 GSSTSWTNR -1.3 1.70E+02 ●   ●   
                      2308 KRVSSKHSI -2.2 2.70E+02 2473 PRLCSIQFE ●   
                      2906 RQHASFIKT -1.5 1.90E+02 2578 ARTYSVTPL ●   
                      3309 IRISSCAIT -1.2 1.70E+02 ●   ●   
                      3858 RRSTSSESC 0.9 55 ●   ●   
Smp_008260  Glycogen synthase kinase 3-related (Gsk3) (Cmgc group III) 
(463 aa)       
427 IRLTSNNSN -1.7 18 ●   282 RPRVPS 
Smp_023550  
Beta-catenin, putative (989 aa)               None       906 SCVGSISSS ●   
Smp_159560  Transcription factor GATA-1, putative 
(735 aa)             
20 SRQESDCRA -1 28 195 NRKLTMTEG ●   
                      478 HQSQSMNSM -2.7 64 255 RRTGTICSN  309 RNRKVS 
                      571 AQLRSTPNQ -2.6 62 ●   ●   
                      669 ISSSSTSSE -2.1 48 ●   ●   
Smp_018590  
Endothelial transcription factor GATA-2, putative (565 aa)         334 KRRISANRK -1.6 30 ●   395 RNRKLT 
Rac  Rac gtpase, putative 
(188 aa) 
                None       71 LRPLSYPQT 71 RXRXXS 
Smp_139630  Protein kinase (619 aa)                 None       377 YRHSTLDAT ●   
Smp_133020  Serine/threonine kinase (237 aa)               133 IRDISKCEP -2.4 12 ●   ●   
Smp_047900  Serine/threonine kinase (201 aa)               None       138 DRLLTFNPT ●   
Smp_032000  Caspase-7 (C14 family) (379 aa)               159 NRHGSSHDA -2.8 26 ●   ●   
Smp_193170  Putative uncharacterized protein 
(79 aa) 
              
None       
●   ●   
Smp_073560.2_mRNA  G beta-like protein gbl 
(317 aa) 




Smp_081410  Ste20-related kinase 
(452 aa) 
                131 QQQTSAPDT -1.5 16 ●   ●   
                      179 VRSNSTSNR -2.9 30 ●   ●   
Smp_039490.1_mRNA  Expressed protein 
(954 aa) 




                      680 SRHSSHQSE 0.7 17 ●   ●   
                      832 KRRYSKTDS -1.4 51 ●   ●   
                      850 QSRPSLTSS -0.8 38 ●   ●   
                      853 PSLTSSGDS -2.8 98 ●   ●   
                      885 HRRRSSSNR -1.1 44 ●   ●   
                      886 RRRSSSNRP -2.1 71 ●   915 KDKTDS 
                      887 RRSSSNRPS 1.5 12 ●   ●   




                      929 RRSRSFNQR 0.7 17 ●   ●   
                      938 HRSRSTDRR -1 42 ●   ●   
                      945 RRDRSSSNR -1.4 50 947 DRSSSNRYR 947 RDRSSS 
Smp_156680  Fyve finger-containing phosphoinositide kinase, fyv1, putative 
(2289 aa) 
      160 QRACSYCAE 0 57 ● 
      
                      213 TRPKSVPSH -1.7 1.30E+02 ●       
                      266 TSTSSADEC -1.7 1.30E+02 508 SRRKTVDFT     
                      870 DRLMSNPSR -1.1 1.00E+02 591 MRDCSLESL 591 RMRDCSL 
                      876 PSRKSDNNT -2.1 1.60E+02 1062 GRLLSVSPS     
                      995 SRVKSLNKM -1.6 1.30E+02 ●   ●   
                      1756 ARTHSNSIS -1.9 1.50E+02 ●   ●   
                      2048 QSEISMANN -2.7 2.10E+02 1758 THSNSISSV     
SER Tyrosine kinase (1600 aa)                 1260 HRNNSLHRH -1.1 57 ●   190 KEKTVS 
                      1401 ESRSSVALS -2.2 95 ●   ●   
Smp_073210  ADP-ribosylation factor interacting protein, putative (341 aa)         None       ●   ●   
Smp_028500  Caspase-3Caspase-3 (C14 family) (296 aa)             None       ●   ●   
Smp_056440  Superoxide dismutase (217 aa)               None       ●   ●   
Smp_104030.3_mRNA  Scribble complex protein (Cell polarity protein) 
(1456 aa) 
          575 LSTSSAHSS -2.3 95 74 IRLLTLSDN 74 RIRLLT 
                      658 SSSESLNDG -2.9 1.20E+02 652 DGTGSASSS 495 KNRSIS 
                      891 KRFASPFGG -2.4 1.00E+02 848 ARIQSKTAD 848 RARIQS 
                              1288 LRRITVTKR     
Smp_012050  Bola-like protein my016 (77 aa)               24 ARLVSVSDV -0.4 1.1 ●   ●   
Smp_167400  Myogenic factor, putative (864 aa)               348 RSSSSLGNA -2.4 88 ●   ●   
                      465 KRTKSMMQS -0.6 36 ●   ●   
                      791 DQLNSMPNS -2.2 78 ●   ●   
Smp_178480  Wd and tetratricopeptide repeat protein, putative 
(220 aa) 
          
None       
207 RRKLTLSTY ●   
Smp_123420  Aryl hydrocarbon receptor nuclear translocator homolog, putative 
(783 aa) 




                      717 SSSISTSES -2 55 ●   ●   
Smp_105910  CREB-binding protein 1 (SmCBP1) 
(2093 aa) 
            577 HRFKSDSGT -1.4 98 ●   577 RHRFKS 
                      1266 HRHNSAASL -2.7 1.80E+02 ●   579 RFKSDS 




                      1994 GRQSSTPQA 1 29 ●   ●   
Cdc42  Cell polarity protein (Regulator of photoreceptor cell morphogenesis) (195 aa) None       75 LRPLSYPQT 75 RLRPLS 
Smp_005880  Phosphoenolpyruvate carboxykinase, putative 
(626 aa) 
          
None       
●   624 RERIQS 
Smad4  Smad4, putative (738 aa)                 241 GSHTSCSKN -1.7 38 ●       
                      375 YSSNSTPVC -2.2 49 ●       
Smp_036270.2_mRNA  Arginine/serine-rich splicing factor, putative (371 aa)           187 QRSRSGSYR -2.8 34 196 SRSDSRHSH 31 RSRSGS 
                      189 SRSGSYRSR -0.2 9.8 ●   33 RSRSGS 
                      194 YRSRSDSRH 0 8.7 ●   38 RSRSDS 
                      204 HRSRSRDSH -2.4 28 ●   40 RSRSDS 
                      233 QRSESGNDS 2.6 2.2 ●   57 RQKSRS 
                      252 PRSRSPSRR -1.9 23 ●   75 RQRSES 
                      257 PSRRSGTNR -1.6 20 ●   77 RQRSES 
                      284 SRSPSCNGR -0.8 13 ●   96 RSRSPS 
                      304 SRSRSISHS -2.2 26 ●   98 RSRSPS 
                      316 SRSRSVESR -1.6 20 ●   146 RSRSRS 
                      337 SRSRSMSHR -1.9 22 ●   148 RSRSRS 
                      339 SRSMSHRSE -1 15 ●   181 RSRSMS 
                      344 HRSESGTPR 0.6 6.5 ●   183 RSRSMS 
Smp_085700  cAMP-dependent protein kinase catalytic subunit, putative 
(104 aa) 
      
None       
●   ●   
Smp_078230  Protein kinase, cgmp-dependent, type I, putative 
(488 aa) 
          236 TRTASVKAI -1.6 20 ●   ●   
Smp_139930  Protein tyrosine phosphatase, non-receptor type nt1, putative 
(628 aa) 
      67 YRDVSPFDS 0.1 12 244 GRSGTFVLI ●   
Smp_075450  Heparan sulfate 2-o-sulfotransferase, putative 
(206 aa) 
          
None       
●   ●   
Smp_191040  P38 MAPk, putative 
(74 aa) 
                
None       
●   ●   
Smp_062950  Growth factor receptor-bound protein, putative 
(234 aa) 
          147 HRKTSISRN -1.4 6.4 155 NRLLTLVDL 
155 
RNRLLT 
Smp_044530  Growth factor receptor-bound protein, putative 
(317 aa) 
          
None       
●   ●   
hsp70  Heat shock 70 kDa protein homolog 
(637 aa) 
            138 GRTVSDAVI -1.6 23 ●   ●   
Smp_166290  Phosphotyrosyl phosphatase activator, putative 
(373 aa) 
          
None       
●   ●   
SOD Superoxide dismutase [Cu-Zn] 
(153 aa) 
              
None       
●   ●   
Smp_142450  Rap1 and, putative 
(183 aa) 
                
None       




Smp_071250  Rap1 and, putative 
(184 aa) 
                
None       
●   ●   
Smp_048990  Beclin, putative (494 aa)                 None       ●   ●   
Smp_172010  Caspase-7Caspase-7 (C14 family) (329 aa)             101 PRNGSLVDV -0.9 11 ●   ●   
Smp_182250  Serine/threonine-protein phosphatase 
(211 aa) 
            
None       
●   ●   
Smp_165490  Serine/threonine-protein phosphatase 
(423 aa) 
            
None       
●   ●   
Smp_030710  Serine/threonine-protein phosphatase 
(307 aa) 
            
None       
●   ●   
Smp_150430  Forkhead protein/ forkhead protein domain, putative 
(504 aa) 
        181 RRTNSLQRS 1.2 7.2 ●   ● 
  
                      194 LRLASYYAS -2.7 52 ●   56 RKRKLT 
                                  179 RRRTNS 
Smp_018240.3_mRNA  Cell division control protein 48 aaa family protein 
(803 aa) 
          586 ARGGSVGDA -1.8 23 744 RRSVTENDV ● 
  
Smp_017900  Serine/threonine kinase (806 aa)               302 KRTPSNRLG -1.7 33 221 DRTYSFCGT 107 RDRLRT 
                              794 VRAKSILTN 794 RVRAKS 
Smp_085680  Guanylate cyclase 
(584 aa) 
                390 ISSSSTPFE -0.7 17 124 LRRDSIPLS ● 
  
Smp_136750  Serine/threonine kinase (1767 aa)               319 RRLGSGPSD -1.6 78 282 DRRQTIDLI ●   
                      423 SRRRSGISS 0.7 24 ●   ●   
                      430 SSSSSPGFV -2.7 1.30E+02 ●   ●   
                      575 TRLVSPSSS 0.7 24 ●   ●   
                      697 KRLISAASE -0.1 38 ●   ●   
                      781 QRFDSDAEE -1.5 77 ●   ●   
                      934 HRQSSLRLR -0.9 54 ●   ●   
                      1243 QSTPSTPQS -0.9 55 1297 ARPGTVTTS ●   
                      1416 QRKSSLTSP 0.7 24 ●   1496 RRKSQS 
Smp_082030  Family C56 non-peptidase homologue (C56 family) (184 aa)         123 KRLTSYPGF -1 4.4 ●   ●   
Smp_138640  Chromatin regulatory protein sir2, putative (618 aa)           143 RRINSLEKV -1.6 31 ●   ●   
Smp_152900  Protein Wnt (1435 aa)                 1406 SSSSSVPIH -2.1 95 585 PRMRTLGTL 723 RIRMHS 
                                  900 KSKTTS 
                                  1164 KSKTTS 
Smp_072110.1_mRNA  Programmed cell death, putative (534 aa)             51 KRFHSASFS -1.9 26 ●   ●   
                      319 TRNFSDSSS 1 6 ●   ●   




Smp_165570.2_mRNA  Ras-dva small gtpase, putative 
(394 aa) 




                      205 ERRASAFAV 1.6 3.2 ●   ●   
                      284 RREPSIIKP -2.5 25 ●   ●   
                      356 IRKSSKMSS -2.9 29 ●   ●   
Smp_171530  Beta-parvin-related 
(383 aa) 
                
None       
●   ●   
Smp_035390  Protein tyrosine phosphatase n11 (Shp2), putative (708 aa)         424 TRDSSVSTK -2.3 49 708 PRTKS**** 708 RPRTKS 
                                  405 RVRHLS 
                                  706 RPRTKS 
Smp_170550.1_mRNA  Granulin, putative 
(748 aa) 
                647 SQRQSTSNH -2.6 55 ●   
    
Smp_173990  Rab11, putative (933 aa)                 649 RQSTSNHNI -2.1 43 82 YRAITAAYY   
                              873 RRRLSLELR   
Smp_078040  Tubulin beta chain, putative 
(444 aa) 
              
None       
285 YRSLTVPEL 
  
Smp_035760  Tubulin beta chain, putative 
(444 aa) 
              
None       
285 YRSLTVPEL 
  
Smp_030730  Tubulin beta chain, putative 
(443 aa) 
              
None       
285 YRSLTVPEL 
  
sat1  Alpha tubulin, putative 
(451 aa) 
                
None       
●   
  
Smp_016780  Tubulin alpha chain, putative 
(451 aa) 
              
None       
●    
 
Smp_099030  Protein kinase (357 aa)                 None       ●     
Smp_125310  Protein kinase (515 aa)                 460 DQRSSMSSI -1.5 24 ●   
  
                      462 RSSMSSIFS -2.9 44 ●     
Smp_129430  Myocyte-specific enhancer factor 2a, putative 
(661 aa) 
          139 TSSVSMALE -3 74 20 NRQVTFTKR 
  
                      262 NRGSSLIDP -2.2 53 ●     
                      341 TQRSSLTSS 0.3 15 ●     
                      374 SRSRSPILP -2.3 54 ●     
                      490 SSTPSMQER -1.9 46 ●     
Smp_139400  Tensin, putative (1704 aa)                 530 MRQTSDPLS -2.6 1.40E+02 ●   
  
                      542 IRGRSPQSS 1.4 19 ●     
                      870 QRTRSLLNE -1.6 89 ●     
                      1002 RRIYSDSEM -2.3 1.30E+02 ●     




                      1409 LRGSSNEPI -2.9 1.70E+02 ●     
                      1561 RSNRSPPAV -1.8 99 ●     
Smp_167140  Protein Wnt (448 aa)                 None       ●     
Smp_151400  Protein Wnt (462 aa)                 367 TSSTSLSPS -2.1 25 ●   
  
Smp_145140  Protein Wnt (403 aa)                 None       ●     
Smp_034670  Tubulin gamma chain, putative 
(493 aa) 
              
None       
●   
  
Smp_196030  GTPase activating protein,putative (745 aa)             90 LRSKSTDRI -2.7 65 ●   
 
 
                      264 SSSISTTEQ -2.1 49 ●     
                      503 NRSNSFSES -0.2 19 ●   
 
 
                      671 VRDASGSSS -1.5 38 ●     
Smp_081190  Rho3 GTPaseRho3 GTPase, putative 
(242 aa) 
            207 HRKKSISNG -0.2 4.8 55 GRHLTLGLW 
  
                      224 TRRSSGLKR -2.3 13 ●     
Smp_072140  Rho2 GTPase, putative (192 aa)               None       73 LRPLSYPDT   
Smp_056970.1_mRNA  Glyceraldehyde-3-phosphate dehydrogenase 
(338 aa) 
          
None       
●   
  
Smp_097800.3_mRNA  Y box binding protein, putative 
(231 aa) 
              114 GRGRSPRVF 0.3 2.4 154 GRGGSEMYG  
 
Smp_097750  Cold shock domain protein A, putative 
(175 aa) 
            
None       
●   
  
Smp_106130.2_mRNA  Heat shock protein 70 (Hsp70), putative 
(653 aa) 
            
None       
●   
  
Smp_049550  Heat shock protein 70 (Hsp70), putative 
(648 aa) 
            300 SKRPSTTVE -2.8 35 ●   
  
ral  Ral, putative (194 aa)                 None       48 RRKMTLDGV   
Smp_035010  Chibby protein pkd2 interactor, putative 
(142 aa) 
            
None       
●    
 
Smp_046690  Ubiquitin (Ribosomal protein L40), putative (349 aa)           None       ●     
Smp_009580  Ubiquitin (Ribosomal protein L40), putative (228 aa)           None       ●     
Smp_070680  Expressed protein 
(274 aa) 
                117 KRTRSETSI -0.9 10 ●   
  
                              119 TRSETSICL   
Smp_127920  Serine/threonine kinase (1028 aa)               374 SRKTSSIEQ -1.3 42 823 NRTGSLPGP   
                              954 IRKLTSTIE   
                              956 KLTSTIEVT   
Smp_127060  Serine/threonine kinase (354 aa)               None       ●     




Smp_026270  Early growth response protein, putative 
(905 aa) 
            435 RRRKSTTRN 2.1 8.2 ● 
    
                      511 QREFSRSDH -2.6 87 ●     
Smp_131050  Camp-dependent protein kinase type II regulatory subunit, putative 
(301 aa) 
    132 SRAASIIAT -0.4 7.1 ●    
 
                      254 PRAASAYAV -2.2 17 ●     
Smp_079010  Camp-dependent protein kinase type II-alpha regulatory subunit, putative 
(378 aa) None       
●   
  
Smp_030400  Camp-dependent protein kinase type I-beta regulatory subunit, putative 
(418 aa) None       
●   
  
Smp_075940  Prohibitin, putative 
(208 aa) 
                114 GREFSEAVE -1.5 8 94 QRASSFGIL 
  
Smp_021590  Rac gtpase activating protein, putative 
(610 aa) 
            181 GRASSVSHT -1 21 ●   
  
                      401 LRSRSTPSL -2.6 44 228 QRLGTINRL   
                              257 GRRITFGKA   
                              345 SRNLSLSLL   
Smp_075210.2_mRNA  Prohibitin, putative 
(288 aa) 
                
None       82 PRKITSPTG   
Smp_056390  Protein kinase (729 aa)                 45 PRISSNFGR -2.1 37 ●   
  
                      121 PKHESWFSS -2.3 41 ●     
                      603 KRNPSERPN -2.2 40 ●     
Smp_006210  Anamorsin homolog (1264 aa)               544 QRISSAHPS 1.7 13 ●     
Smp_179910  Ras-like protein (141 aa)                 None       ●     
topbp1  Topbp1, putative 
(1396 aa) 
              
  
35 KRLSSCEVI -1.7 68 
960 ARVASLNLF   
                      242 TRQASGTKY -2.4 94 1372 PRNYSWLRI   
Smp_000730  ADP-ribosylation factor family 
(176 aa) 
            
  None       
●   
  
Smp_050830  Synaptojanin, putative (526 aa)               276 QRQASPSRR -0.6 13 341 PRWFSLPVK   
                      468 HRKNSVSSA -1.2 18 ●     
Smp_022100  Camp-dependent protein kinase type I-beta regulatory subunit, putative 
(84 aa) None       41 PRAATVVAQ   
Smp_019280  Camp-dependent protein kinase regulatory chain, putative 
(251 aa) 
    
  
14 ARRQSVAAE 0.3 3.8 ● 
    
Smp_001050  Similar to Protein C20orf152 homolog, putative 
(621 aa) 
        
  
34 HRISSSRST -0.1 15 ●   
  
                      37 SSSRSTDDK -2.2 42 ●     
                      183 HSSSSLSNS -0.8 22 ●     
                      221 TSSSSSFNE -2.4 47 ●     




Smp_154140  Site-1 peptidase (S08 family) 
(988 aa) 
            
  
583 SSRFSGVAE -2.1 58 ●   
  
                      676 LRRKSYFIE -0.4 25 ●     
Smp_065840  DNA topoisomerase 2 (1599 aa)               1464 SRGASAIVS 1.5 13 901 GFTGTIEDL   
                      1482 GRQFSAPPK -0.7 41 ●     
                      1493 PSIKSMFPS -2.4 94 1313 GKGRTVPTS   
Smp_097730  Srf homolog, putative (429 aa)               102 TQQPSFTDE -1.6 26 ●     
                      302 GRTVSFCNN 1.7 4.8 ●     
Smp_095190  Apoptosis regulator bax, putative (199 aa)             55 RRRTSTDME 0.8 2 56 RRTSTDMET   
Smp_103710  Ubiquitin-conjugating enzyme E2 I, putative (166 aa)           None       ●     
Smp_005020  Cbl, putative (684 aa)                 None       ●   
 
 
Smp_165420  Zinc finger protein, putative 
(4034 aa) 
        
      
326 TRDSSIALR -2.3 3.00E+02 ●   
  
                      391 SRSVSVALS 0 99 ●     
                      468 TRLSSSKAV -2 2.60E+02 ●     
                      3874 SRAMSGHLS 0.4 81 2259 TRLTTQTNN   
                      4020 SSSPSPVPS -2.8 3.80E+02 ●     
Smp_141540  Thymidine kinase, putative (945 aa)               54 QRRWSVPFQ -1.9 62 ●     
                      147 ARNRSGEED -2.7 85 ●     
                      305 SRSISSCTR -2.5 79 ●     
                      382 PSNNSMASS -0.9 38 ●     
                      489 PRMNSYCND -2.4 77 ●     
                      877 LQRSSYGNT -2.2 70 ●     
Smp_068240  Zinc finger protein, putative 
(544 aa) 
      
        
522 SRNISKTGE -1.1 24 ●   
  
Smp_172030  DEAD box ATP-dependent RNA helicase, putative (679 aa)         None       ●     
Smp_067140  Rab9 and, putative 
(205 aa) 
        
        None       
●   
  
Smp_175500  GATA binding factor-1b (Transcription factor xgata-1b), putative 
(919 aa)       
13 LSTSSKTSS -3 98 ● 
    
                      36 CRSPSTTSS -1.2 45 ●     
                      226 SSSSSNSEV -2.8 94 ●     
                      880 SSSSSNNDN -2.2 70 ●     
Smp_080030  GATA binding factor-1b (Transcription factor xgata-1b), putative 
(227 aa)       None       
●   
  




Smp_183460_mRNA  Map/microtubule affinity-regulating kinase 2,4, putative 
(108 aa)         
95 RRRSSLDTS 1.1 1.3 ●   
  
Smp_098780  Forkhead protein/ forkhead protein domain, putative 
(619 aa)         
80 PRTTSSSSL -2 45 ● 
    
Smp_016920  Putative uncharacterized protein (203 aa)             153 RRTRSIGPS 1.4 1.9 ●     
                      162 RRSNSMNIF 0.6 2.9 ●     
                      179 RRGNSVTAI 0.7 2.8 ●     
Smp_128130  Phosphatidylinositol-4,5-bisphosphate 3-kinase PI3K 
(889 aa)         None       
●   
  
Smp_148430  Expressed protein 
(738 aa) 
      
          
320 YRNGSSSKS -1.2 31 
300 ERLLSMHRQ   
                      486 SRLSSDRFT 1.3 8.7 ●     
                      570 SRSSSLCYN -0.6 23 ●     
Smp_148420  Expressed protein 
(974 aa) 
    
            
226 ERSVSTVSL -2.6 58 
214 SRSKTLGPT   
                      597 KRLDSLTDE -1.9 44 ●     
                      766 RKTISMPPN -2.3 51 ●     
Smp_171750  Axis inhibition protein, axin, putative 
(1047 aa)             
289 HRSTSRHQF -2.7 1.00E+02 
200 TKHKSFSEY   
                      626 YRSFSRPNK -2.3 84 ●     
                      638 RSIASWDSG -1.4 56 760 LRRRSKQCE   
                      898 RSHSSTRLN -1.5 58 ●     
                      960 PSSSSISSS -2.4 89 ●     
Smp_166200  Axis inhibition protein, axin, putative 
(1142 aa)             
53 GSTASYEVG -2.4 1.00E+02 ● 
    
                      147 IRGASSSLA -2.7 1.20E+02 ●     
                      178 IRLRSETRH -2.4 1.10E+02 180 LRSETRHAI   
                      585 RRGASSRPF 1 20 ●     
                      635 SRSYSMAEH 0 33 ●     
                      778 DRTPSSGDG -0.9 51 ●     
                      1038 SSSTSAVSG -2.5 1.10E+02 ●     
CYTB  Cytochrome b, putative (199 aa)               None       ●     
Smp_190100  Jun activation domain binding protein, putative 
(84 aa)           None       
●   
  
Smp_146200.2_mRNA  Zyxin/trip6, putative 
(455 aa) 
    
            
38 MRSSSERDN -1.5 26 
120 FRTSSVLTA   
                      236 SSTNSPTES -1.8 30 ●     




                      421 RRVVSGNSN -0.6 16 379 SRPFTIDVH   
Smp_144330  Putative uncharacterized protein (244 aa)             None       ●     
Smp_131660  Jab1/MPN domain metalloenzyme (M67 family) 
(248 aa)           
100 IRTISSGKV -2.1 15 ●   
  
Smp_127310  Biogenic amine (Dopamine) receptor, putative 
(567 aa)           None       
●   
  
Smp_090080  Serpin (406 aa)                 75 IRLKSTSSS 0.9 4.6 ●     
Smp_085740  Abl-binding protein-related (583 aa)               171 TRRGSSSAS -0.7 19 ●     
                      172 RRGSSSASG 1.7 5.3 ●     
                      184 GRQHSTVAC -1.6 29 ●     
                      288 SRKSSGSSG 1 7.7 ●     
                      291 SSGSSGTGS -2.2 38 ●     
                      515 PRQPSDPAW -2.8 51 ●     
Smp_055670  Rab-2,4,14, putative 
(223 aa) 
  
              
74 ERFRSVARS 0.1 4.1 
205 PKFGSIPQV   
                      194 RQSSSLTFN -0.3 5.1 ●     
Smp_027610  40S ribosomal protein S3, putative (230 aa)             None       ●     
Smp_149150  Acyl-CoA-binding protein (Acbp) (Diazepam binding inhibitor) (Dbi) 
(343 aa)     
125 DRGFSLSKV -1.2 14 ●   
  
                              22 TRWNTIQVV   
Smp_166010  Ankyrin repeat-containing, putative 
(1291 aa)             
515 GSVTSNPNS -3 1.00E+02 ● 
    
                      1174 SSSSSTSAS -3 1.00E+02 ●     
                      1182 SSSSSGNNV -2 66 ●     
Smp_173810  Protein phosphatase pp2a regulatory subunit B, putative 
(490 aa)         None       
●   
  
Smp_172290  Serine/threonine protein phosphatase 2a regulatory subunit A, putative 
(392 aa) None       
●   
  
Smp_172280  Serine/threonine protein phosphatase 2a regulatory subunit A, putative 
(535 aa) None       
●   
  
Smp_153410  Serine/threonine protein phosphatase 2a regulatory subunit A, putative 
(821 aa) None       
●   
  
Smp_056760  Protein disulfide-isomerase, putative 
(482 aa)             None       
●   
  
Smp_151420  Phospholipase D (906 aa)                 109 NRFGSYAPS -1.9 38 ●     
                      240 RRIRSLRKR 0.2 13 ●     
                      601 HRQASDHLQ -1 25 ●     
Smp_161230  Ras GTP exchange factor, son of sevenless, putative 
(1518 aa)         
10 SRHTSTVSL -1.2 66 ●   
  




                      408 HRNISNNNS 0.5 29 ●     
                      539 PRRRSTSTT -0.3 44 ●     
                      541 RRSTSTTAT 3.6 5.2 ●     
                      700 GSHVSCASM -2 98 ●     
                      1356 LRRESIHNP -2 1.00E+02 ●     
                      1367 QRTSSSSSS 0.5 28 ●     
Smp_196040  Shc transforming protein, putative (409 aa)             75 PSNRSADKS -2.5 27 ●     
                      213 SQNTSMPNN -0.5 11 ●     
Smp_023150  Serine/threonine-protein phosphatase 
(302 aa)             None       251 GRLITIWSA   
Smp_145810.1_mRNA  Poly [ADP-ribose] polymerase, putative 
(536 aa)             
280 IRTMSEVKS -0.7 14 ● 
    
Smp_129260  Poly [ADP-ribose] polymerase, putative 
(977 aa)             None       108 TRKFTVKLS   
                              705 TRFYTLIPH   
Smp_082490  Cyclin B, putative (414 aa)                 None       388 GRVASLPQL   
 
 Appendix 4 Analysis of interacting proteins revealed 48 with putative Akt phosphorylation sites. Phosphorylation prediction 
tools Kinasephos, Scansite and HRPD were used to search for putative Ser/Thr phosphorylation motifs with an arginine (R) in the -3 
and -5 position, suitable for Akt.  
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Appendix 6 Combined graph of the molecular function root term. Blast2GO software was 
used to create a combined graph revealing all terms under the umbrella molecular function. 
Seven generations of terms are visible.  
Appendix 7 






Appendix 7 Combined graph of the cellular component root term. Blast2GO software 
was used to create a combined graph revealing all terms under the umbrella cellular 
component. Eight generations of terms are visible.  
